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INTRODUCTION 
 
 
Biological medicine 
During the past two decades, advance in recombinant DNA technology has led to a 
significant increase in the number of approved biological medicines, and they recently 
represent a major part of the drug development pipeline across the pharmaceutical industry1,2. 
Biological medicines include recombinant protein3,4, monoclonal antibody, RNA interference 
and synthetic peptides and others5,6. Today, there are more than 300 distinct biological 
medicines on market or in human clinical trials, and that cover nearly 150 diseases including 
cancer, autoimmune disease, Alzheimer disease and chronic inflammation6–8. 
 
 
Protein-protein interaction 
Protein-protein interactions (PPIs) are crucial for all biological processes9. The advance 
in technology for analysis of protein has given us many new insights into protein function. In 
consequence, we can know that many human diseases (i.e. cancer10,11, Alzheimer disease12,13 
and diabetes mellitus14) are the result of abnormal PPIs, such as the loss of an essential 
interaction or the formation of a protein complex at an inappropriate time or location15. 
Therefore, such PPIs are most likely to be closely linked to disease states across a wide 
variety of therapeutic areas, and a highly popular in the targets for drug development. 
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Screening technology 
Advances in molecular biology have continued to produce therapeutic innovation. Until 
now, PPI and other high-throughput screening research have defined many protein functions 
and regulation and have led many molecules for inhibition or activation of a biological 
function. In case of techniques for studying PPIs, biochemical methods such as 
cross-linking16 and co-immunoprecipitation17 of protein, and co-fractionation by 
chromatography18 have made important discovery in the past19. Limitations of these 
techniques include restricted sensitivity and bias towards high affinity interactions. Recent 
year, for high-throughput screening of PPIs, novel cell-based assays are in widespread use.  
In addition, directed evolution is a general term covering several approaches and used in 
protein engineering to alter a wide range of protein functions, such as activity, stability, 
selectivity, specificity and affinity20–22. In instances of in vitro assays, there are various 
display techniques23 (e.g., phage display24,25, ribosome display26, yeast display27 and 
others28,29) that are active in field of selection for antibody isolation and engineering. In vivo 
assays, there are main two categories of yeast two hybrid systems (Y2Hs)30 and 
protein-fragment complementation assays (PCAs)31–33. These techniques allow detection of 
interacting proteins in living cells. In vivo screening method are valuable tools for studying 
biological processes and for blocking proteins inside cells because we can know PPIs directly 
in the intracellular environment. 
 
Yeast Saccharomyces cerevisiae. 
The unicellular bakers’ yeast Saccharomyces cerevisiae is a simple eukaryotic 
organism with just approximately 6000 genes. The complete sequence is known since 1996, 
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and more than 60% of the genes have an assigned function34. Yeast growth and division can 
be controlled efficiently and effectively by adjusting environmental conditions. Moreover, 
yeast has been as ideal test organism, due to its ease of genetic manipulation35.  
 
Yeast two-hybrid systems (Y2H) 
The Y2H allows detection of interacting proteins in living yeast cells19. Fields and Song 
developed detection system of protein interactions (classical yeast two-hybrid system) in the 
yeast in 198919, and until now, there are various Y2H tools (Fig. 1). Y2Hs allow PPIs 
screening, including membrane proteins, transcriptionally active proteins and proteins 
localized in different subcellular copartments30.  
The classic Y2H is a nuclear Y2H system, which requires protein recruitment and 
target-library (X-Y) interaction at nuclear DNA. The classic Y2H engages RNA polymerase 
Ⅱ (RNA Pol Ⅱ) transcription either by its activation or its non-activation19 (Fig. 1). The SOS 
recruitment system (SRS Y2H)36,37, the Ras recruitment system (RRS Y2H)38 and the reverse 
Ras recruitment system (rRRS Y2H)39 are Ras signaling based Y2H, which are based on 
protein recruitment to the plasma membrane via target-library interaction and subsequent 
activation of MAPK downstream signaling. In SRS, RRS and rRRS Y2Hs, the target or 
library is anchored at the membrane via the lipidation motif (Y) to analyzed interactions with 
cytosol library or target (X) (Fig. 1). Split-ubiquitin based Y2H systems40 involve 
reconstitution of ubiquitin from two upon target-library interaction. The split-ubiquitin Y2H40 
uses non-transcriptional reporting of protein interaction in the cytosol (Fig. 1). The 
membrane split-ubiquitin system (MbY2H)41 is used for interaction analysis with membrane 
target and library, the cytosolic split-ubiquitin system (cytoY2H)42 is used for membrane 
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anchored cytosol target and library, and occurs close to the endoplasmic reticulum (ER) 
membrane (Fig. 1).  
These techniques are very useful, however each technique is sometimes annoyed with 
the false positive and their limitation43. For example, the classic Y2H sometimes induce the 
false positive due to unexplained induction of reporter gene and cannot detect protein 
interactions involving membrane proteins30. The SRS Y2H and RRS Y2H suffer from 
technical complexities, such as the different temperatures required for growth and screening 
(25°C and 36°C), slow growth at suboptimal temperatures, obligatory replica-plating steps 
(glucose to galactose medium), and the total time required for the procedure (~7 days 
including precultivation)44–46.  
We previously developed a method, the Gγ recruitment system, which is G-protein 
signaling based Y2H, which are based on Gγ mutant recruitment to the plasma membrane via 
target-library (X-Y) interaction and subsequent activation of G-protein downstream signaling. 
This system is explained in detail below. 
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Yeast G-protein signaling 
Many extracellular signals are detected by cell surface receptors and further transmitted 
inside the cell by G proteins. In yeast, the G-protein-coupled receptor (GPCR) undergoes a 
conformational change after binding ligands (mating pheromones) and then activates 
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Figure 1. Various yeast two-hybrid systems.
Yeast  two-hybrid  systems,  their  subcellular  location  within  a  yeast  cell,  and  their 
operating mode (represented at the moment of target-candidate (X-Y) interaction). 
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heterotrimeric G-proteins. The activated G-proteins trigger the dissociation of the Gβ/Gγ 
complex from Gα concurrently with the exchange of guanosine triphosphate (GTP) for 
guanosine diphosphate (GDP) on the Gα subunit. The Gβ subunit (complexed with 
membrane-associated Gγ) then acts upon the effectors, thereby activating the downstream 
signaling cascade for mating47 (Fig. 2). 
Figure 2. Schematic illustrations of pheromone signaling pathway
(A) In the absence of α-factor, heterotrimeric G protein is unable to activate pheromone signaling pathway. 
(B) Binding of α-factor to Ste2p receptor activate pheromone signaling pathway through heterotorimeric G 
protein. Sequestered Gβγ complex from Gα activates following MAPK cascade, resulting in global changes 
in transcription.
Gβ
Gγ EffectorGα
GPCR (STE2)
Ligand (-factor)
MAPK cascade
Nucleus 
Transcriptional  
activation  
Gβ
Gγ EffectorGα
GPCR (STE2)
Nucleus 
(A) (B)
 
 
Original Gγ recruitment system 
The Gγ recruitment system for detecting PPIs is based on the fundamental principle 
that yeast pheromone (mating) signaling requires the localization of a complex consisting of 
the β- and γ-subunits of heterotrimeric G-proteins (Gβ/Gγ) to the inner leaflet of the plasma 
membrane48. Our Gγ recruitment system specifically makes use of a cytosolic truncated 
variant of Gγ (named Gγcyto) that is fused to a soluble target protein of interest, ‘X’ (Gγcyto-X), 
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as shown in Fig. 3. For the library, the candidate proteins (Y) should be attached to the 
artificial lipidation site to ensure localization to the membrane (Fig. 3). When an interaction 
occurs between target ‘X’ and candidate ‘Y’, the Gγcyto-X fusion protein brings Gβ to the 
membrane and induces subsequent activation of the pheromone signaling pathway. The 
promoted signaling can be detected by a fluorescent reporter assay or a mating growth assay 
after growth in simple glucose media at the optimal temperature (30°C). Briefly, the 
expression of GFP under the control of a pheromone-responsive FIG1 promoter or mating 
with intact haploid cells of the opposite mating type permits the detection of PPIs. Because 
the localization of Gγcyto in the cytosol completely prevents this signaling activation, the Gγ 
recruitment system allows for extremely reliable, low-background growth screening that 
excludes false-positive candidates at the optimal temperature (30°C)48. The procedures for 
screening involve simply mixing the different mating-type cells (recombinant a-cells and 
intact α-cells) and plating on selective media (~4 days including precultivation). 
Figure . Schematic outline of original Gγ recruitment system to detect PPIs using yeast G-protein 
signaling. 
When protein  ‘X’ fused  to  Gγcyto  interacts  with  protein  ‘Y1’,  the  Gβ  and  Gγcyto  complex  (Gβγcyto) 
migrates to the inner leaflet of the plasma membrane and restores the signaling function. If protein ‘X’ 
cannot interact with protein ‘Y’, Gβγcyto is released into the cytosol and signaling is blocked. 
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Green fluorescent protein (GFP) 
Since Shimomura et al. purified and characterized the first green fluorescent protein 
(avGFP) from the jellyfish Aequorea victoria49, GFP is widely known for its usefulness in 
biotechnology. Its unique ability to synthesize chromophore within itself, without any need 
for external substrates or cofactors except molecular oxygen, made it a wonderful in vivo 
marker of gene expression and protein localization in various biological systems50.  
The avGFP is composed of 238 amino acids and an 11-stranded β-barrel threaded by an 
α-helix running up the axis of the cylinder (Fig. 4)51. The chromophore is attached to the 
α-helix and is buried almost perfectly in the center of the cylinder, which has been called a 
β-can52. 
Figure 4. Structure of the green fluorescent protein derived from the Aequorea victoria.  
The avGFP has a weak dimeric character, complicated photochemistry, does not fold 
well above room temperature and matures slowly50,53,54. Mutagenesis studies have led to the 
development of engineered GFP with new colors, improved fluorescence, and other 
biochemical properties52. The enhanced GFP (EGFP), which has been generated as the 
 9 
mutant of original GFP through the mutagenesis studies, is one of the most popular and 
widely used monomeric GFP and has a single excitation peak at 488nm55. It contains the 
optimized codons for mammalian cells, and the Ser65	Thr65 and Phe64	Leu64 mutations to 
improve the spectral characteristics, brightness and stability, and efficiency of protein 
maturation at 37°C55,56. In addition, GFPs and GFP-like molecules have been cloned from 
other organisms such as different Aequorea species57,58, copepods59, amphioxus60,61 and coral 
reefs62–65, and they are now commercially available. 
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SYNOPSIS 
 
Part Ⅰ. 
 
Desired alteration of protein affinities: competitive selection of protein variants using 
yeast signal transduction machinery 
 
Molecules that can control protein-protein interactions (PPIs) have recently drawn attention 
as new drug pipeline compounds. Here, we report a technique to screen desirable 
affinity-altered (affinity-enhanced and affinity-attenuated) protein variants. We previously 
constructed a screening system based on a target protein fused to a mutated G-protein γ 
subunit (Gγcyto) lacking membrane localization ability. This ability, required for signal 
transmission, is restored by recruiting Gγcyto into the membrane only when the target protein 
interacts with an artificially membrane-anchored candidate protein, thereby allowing 
interacting partners (Gγ recruitment system) to be searched and identified. In the present 
study, the Gγ recruitment system was altered by integrating the cytosolic expression of a 
third protein as a competitor to set a desirable affinity threshold. This enabled the reliable 
selection of both affinity-enhanced and affinity-attenuated protein variants. The presented 
approach may facilitate the development of therapeutic proteins that allow the control of 
PPIs. 
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Part Ⅱ. 
 
Gγ recruitment systems specifically select PPI and affinity-enhanced candidate proteins 
that interact with membrane protein targets 
 
Protein-protein interactions (PPIs) are crucial for the vast majority of biological processes. 
We previously constructed a Gγ recruitment system to screen PPI candidate proteins and 
desirable affinity-altered (affinity-enhanced and affinity-attenuated) protein variants. The 
methods utilized a target protein fused to a mutated G-protein γ subunit (Gγcyto) lacking the 
ability to localize to the inner leaflet of the plasma membrane. However, the previous 
systems were adapted to use only soluble cytosolic proteins as targets. Recently, membrane 
proteins have been found to form the principal nodes of signaling involved in diseases and 
have attracted a great deal of interest as primary drug targets. Here, we describe new 
protocols for the Gγ recruitment systems that are specifically designed to use membrane 
proteins as targets to overcome previous limitations. These systems represent an attractive 
approach to exploring novel interacting candidates and affinity-altered protein variants and 
their interactions with proteins on the inner side of the plasma membrane, with high 
specificity and selectivity. 
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Part Ⅲ. 
 
Expression of varied GFPs in Saccharomyces cerevisiae: codon optimization offers a 
stronger impact for expression and bright fluorescence levels than expected 
 
Green fluorescent protein (GFP), originally isolated from jellyfish, has been intensively used 
for biological researches, and its homologs from various organisms are now available. 
However, most biologists are faced with a question: which GFP is the most suitable for a host. 
Here, we therefore expressed the GFPs from several sources with codon-optimized and non 
codon-optimized forms in yeast Saccharomyces cerevisiae as an ideal eukaryotic model for 
the study. Surprisingly, codon-optimized mWasabi and mNeonGreen that are known as the 
brightest GFPs exhibited lower green fluorescence than other five codon-optimized GFPs 
tested in S. cerevisiae. Further, the commercially available GFPs, which were optimized for 
mammalian codon usage (e.g., EGFP, AcGFP1 and TagGFP2), unexpectedly exhibited 
extremely low expression levels in S. cerevisiae. In contrast, the codon-optimizations of 
GFPs for S. cerevisiae drastically increased the expression levels, and the fluorescence 
intensity of the cells multiplied by maximally 101-folds. Thus, codon-optimizations of GFPs 
offered a stronger impact than we expected. Among the GFPs we tested, the codon-optimized 
monomeric mUkG1 (ymUkG1) from soft coral showed highest levels of both expression and 
fluorescence, and its expression as the fusion tagged protein successfully improved the 
reporting systems to sense signal transduction and protein–protein interactions in S. 
cerevisiae. 
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Part Ⅰ. 
 
 
Desired alteration of protein affinities: competitive selection of 
protein variants using yeast signal transduction machinery 
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Introduction 
 
All biological processes require the control of protein activity, and especially the 
control of protein-protein interactions (PPIs)9. The selection and screening of PPIs has 
therefore been important for extending our fundamental understanding of biological protein 
interaction networks and protein functions. Innovative methodologies for identifying PPIs 
have rapidly grown in all biological fields, in particular in the areas of selection and 
screening19. 
Recently, molecules that can control PPIs have drawn attention as therapeutic targets 
and as new pipeline compounds because of their potential to manage pathological activities 
and the pathogenesis of various diseases via signal transduction, transcriptional regulation, 
and intracellular metabolism66–68. PPIs are also used in diagnostic applications in medicinal 
and biological research fields69,70; for example, these fields are making increasing use of 
antibodies71,72, which can recognize target proteins in a specific manner. For all these 
applications, directed evolution is a powerful technology for producing protein variants with 
desirable properties that are not found in nature. 
Directed evolution is a general term covering several approaches used in protein 
engineering to alter a wide range of protein functions, such as activity, stability, selectivity, 
specificity and affinity20–22. Affinity maturation is one approach especially used for the 
engineering of protein affinity and the cell surface display approach, such as phage display 
and bacterial display techniques, is the most traditional in vitro methodology for isolating 
affinity-enhanced variants from a mutated library73–78. However, the drawback of this 
technique is that it requires enrichment procedures and multiple rounds of affinity 
purification and amplification. In addition, affinity maturation can provide disappointing 
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results due to the inability to completely exclude protein variants causing nonspecific binding 
or unintentional affinities79,80.  
For resolving these problems, protein-fragment complementation assays using split 
β-galactosidase81, split-GFP82,83, split-luciferase84 and others40,85,86 were developed. These in 
vivo techniques monitor the reassociation of split reporters as indicators for protein affinities, 
permitting the selective discrimination of protein variants with different affinities87. However, 
the executable size of library to screen protein variants is limited by the throughput of 
reporter assays. For example, β-galactosidase reporter is basically compatible with plate 
assays in 96-well or 384-well formats. Although the GFP is a favorable reporter for 
high-throughput sorting, an expensive instrument flow cytometer and a skillful technique to 
set the gating area are needed. Additionally, it has great difficulty separating the variants with 
the close range of affinities due to the individual variability in the fluorescence levels88,89. 
Therefore, clear-cut and rapid growth selection on agar plates, which can selectively pick the 
protein variants with intended affinities, would be a more simple, powerful, versatile 
approach to screen the large-scale library. 
We previously developed a method, the Gγ recruitment system48, to detect PPIs based 
on the fundamental principle that yeast pheromone (mating) signaling requires localization of 
a complex between guanine nucleotide binding protein (G-protein) β- and γ-subunits (Gβγ) 
to the inner leaflet of the plasma membrane47. In brief, an engineered Gγ mutant (named 
Gγcyto) lacks a membrane localization sequence (lipidation motif) that is normally expressed 
in the cytosol. This mutant is prepared in a fused form with a target protein (X) (Gγcyto-X), as 
shown in Figure Ⅰ-1A. Conversely, candidate proteins (Y) in a library are prepared in an 
attached form with an artificial lipidation motif in order to anchor into the membrane (Fig. 
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Ⅰ-1A). If Y has affinity against X, then Gγcyto complexed with Gβ is recruited onto the 
membrane and restores the signaling function, thereby permitting the detection of PPIs (Fig. 
Ⅰ-1B). Using the transcription activation or mating process provoked by this signaling, PPI 
interactive partners can be isolated from the library proteins through the GFP reporter assay 
or the mating growth selection. Since Gγcyto localized in the cytosol completely interrupts this 
signaling, this selection system (Gγ recruitment system) allows very high sensitivity 
screening48,90. In addition, we have also introduced an attractive approach for screening 
affinity-enhanced proteins by expressing a binding competitor in the cytosol of the Gγ 
recruitment system91. This approach is applicable for screening affinity-enhanced protein 
variants selectively. In contrast, a ‘swingable’ screening methodology, which allows 
alternative screening based on both affinity-enhancement and affinity-attenuation, would 
allow the selective isolation of protein variants with desired affinities and provide a powerful 
tool with numerous applications. 
Strong PPIs are clearly involved in maintaining the structures of cellular components, 
but weak interactions are also required for many signaling, transcription networks and cell 
adhesion phenomena92. The ability to fine-tune both strong and weak PPIs flexibly is 
important because the ability to control PPIs holds great potential for the generation of drugs 
with reduced side effects and maximum efficacy93. The goal of affinity maturation, however, 
is generally to enhance the protein affinity, while the methodology for massive screening to 
attenuate the protein affinity scarcely exists. The affinity-attenuated protein variants are 
indispensable for offering structural information, such as critical amino acid residues for the 
interactions, to guide the designs of new drugs. Moreover, in recent years, a new field of 
medicine called multi-target drugs94 or dirty drugs95 has attracted attention as a better way of 
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treating complex diseases. To develop such drugs, interaction molecules with weaker 
affinities than single-target molecules must be developed because these drugs must be able to 
dissociate from and bind to a variety of different targets96–98. 
We here describe the redesign of the previously developed Gγ recruitment system to 
allow alteration of the affinity of the target protein. This new system allows the mating 
growth selection to screen selectively both affinity-enhanced and affinity-attenuated protein 
variants and employs the cytosolic expression of a third protein as a competitor, allowing 
targeting of a specified affinity threshold. We demonstrate the desirable and reliable selection 
of both affinity-enhanced and affinity-attenuated protein variants. 
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Table Ⅰ-1. Yeast strains used in this study 
 
Strain  Relevant feature     Source 
BY4741  MATa his3∆1 ura3∆0 leu2∆0 met15∆   [99] 
BY4742  MATα his3∆1 ura3∆0 leu2∆0 lys2∆0   [99] 
MC-F1  BY4741 fig1::FIG1-EGFP    [100] 
BFG2118  MC-F1 ste18∆::kanMX4  his3∆::URA3-PSTE18-Gγcyto-Fc  [48] 
 
Yeast strains expressing target X (Fc) and parental Y2 (Z variants) in the cytosol 
[For testing the affinity-enhancement system] 
 
BFG2118-ZZcyto MC-F1 ste18∆::kanMX4 his3∆::URA3-PSTE18-Gγcyto-Fc 
PHOP2::LEU2-PPGK-ZZcyto-PHOP2    This study 
BFG2118-ZWTcyto MC-F1 ste18∆::kanMX4 his3∆::URA3-PSTE18-Gγcyto-Fc 
PHOP2::LEU2-PPGK-ZWT,cyto-PHOP2    This study 
BFG2118-ZK35Acyto MC-F1 ste18∆::kanMX4 his3∆::URA3-PSTE18-Gγcyto-Fc 
PHOP2::LEU2-PPGK-ZK35A,cyto-PHOP2    This study 
BFG2118-ZI31Acyto MC-F1 ste18∆::kanMX4 his3∆::URA3-PSTE18-Gγcyto-Fc 
PHOP2::LEU2-PPGK-Z I31A,cyto-PHOP2    This study 
 
Yeast strains expressing target X (Fc) and parental Y1 (Z variants) on the membrane  
[For testing the affinity-attenuation system] 
 
BZFG2118  MC-F1 ste18∆::kanMX4-PPGK1-ZZmem 
his3∆::URA3-PSTE18-Gγcyto-Fc    [48] 
BFG2Z18-WT MC-F1 ste18∆::kanMX4-PPGK1-ZWT,mem 
his3∆::URA3-PSTE18-Gγcyto-Fc    [48] 
BFG2Z18-K35A MC-F1 ste18∆::kanMX4-PPGK1-ZK35A,mem  
his3∆::URA3-PSTE18-Gγcyto-Fc    [48] 
BFG2Z18-I31A MC-F1 ste18∆::kanMX4-PPGK-ZI31A,mem  
  his3∆::URA3-PSTE18-Gγcyto-Fc    [48] 
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Table Ⅰ-2. List of affinity constants of the Z variants for the Fc part of human IgG 
 
 
Type of Z domain Affinity constant for the Fc part 
of human IgG [M-1] 
Source 
ZZ 6.8 × 10 8 [101] 
ZWT 5.9 × 10 7 [101] 
ZK35A 4.6 × 10 6 [101] 
ZI31A 8.0 × 10 3 [101] 
Z955 None [102] 
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Figure Ⅰ-1. Detection principle behind the competitive Gγ recruitment system.
(A) Schematic of the Gγcyto–X and Y1 genes.  The Gγcyto–X fusion gene is designed to exclude the 
lipidation motif of the yeast endogenous Gγ (Ste18p). The lipidation motif is artificially attached to the 
Y1 protein to be anchored on the plasma membrane. (B) Schematic outline of previously established Gγ 
recruitment system to detect PPIs using yeast G-protein signaling. When protein ‘X’ fused to Gγcyto 
interacts with protein ‘Y1’, the Gβ  and Gγcyto complex (Gβγcyto) migrates to the inner leaflet of the 
plasma membrane and restores the signaling function. If protein ‘X’ cannot interact with protein ‘Y1’, 
Gβγcyto is released into the cytosol and signaling is blocked. (C) Schematic outline of the competitive 
method for creating affinity-altered proteins. Protein “Y1” should be anchored on the plasma membrane, 
whereas “Y2” should be expressed in the cytosol. By putting “Y1” and “Y2” as the parental (known) 
proteins originally bound to the target ‘X’ or to the candidate variant proteins, respectively, ‘Y1’ and 
‘Y2’ compete to bind against target ‘X’. When “X” has higher affinity for “Y2”, G-protein signaling is 
prevented by sequestration of Gγcyto from the plasma membrane. When “X” has higher affinity for “Y1”, 
G-protein signaling is transmitted into the yeast cells and invokes the mating process. Thus, affinity-
enhanced proteins or affinity-attenuated proteins can be screened in a specific manner. In our system, a 
transcription  assay  using  the  GFP  reporter  gene  fused  to  the  signal-responsive  FIG1  gene  allows 
detection of the signaling. Mating growth selection to isolate the methionine- and lysine-prototrophic 
diploids can also detect the signaling and permits the selective screening of signal-promoted cells.
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Results 
 
General strategy used 
First, target ‘X’ is expressed as a fusion protein with the Gγ mutant (Gγcyto-X), as 
shown in Figure Ⅰ-1A and B. Then, another protein, ‘Y1’, is expressed as an anchored 
protein on the inner leaflet of the plasma membrane (Fig. Ⅰ-1A and B). A third protein, ‘Y2’, 
is expressed in the cytosol (Fig. Ⅰ-1C). By placing ‘Y1’ and ‘Y2’ either as the parental 
(known) proteins originally bound to target ‘X’, or as the candidate variant proteins, ‘Y1’ and 
‘Y2’ compete to bind against target ‘X’. If ‘Y1’ binds to ‘X’ preferentially (rather than to 
‘Y2’), Gγcyto should gravitate toward the plasma membrane and restore the signaling function 
(Fig. Ⅰ-1C). On the basis of this tenet, we devised an adjustable method for screening protein 
variants for desirable affinities, as follows. 
To isolate affinity-enhanced proteins, the parental protein known to bind to target ‘X’ is 
expressed as a cytosolic ‘Y2’ protein (Fig. Ⅰ-2A). When introducing the mutant library 
containing the candidates as membrane-anchored ‘Y1’ proteins into the yeast, only the 
transformants that express the candidate proteins (Y1) exhibiting stronger affinity against 
target ‘X’ than the parental protein (Y2) can transduce the signal inside the cells (Fig. Ⅰ-2A). 
Conversely, to isolate the affinity-attenuated proteins, the parental protein bound to target ‘X’ 
and the candidate mutant library are expressed as membrane-anchored ‘Y1’ and cytosolic ‘Y2’, 
respectively; in this instance, only the transformants that express the candidate proteins (Y2) 
exhibiting lower affinity against target ‘X’ than the parental protein (Y1) can activate signal 
transduction in the yeast (Fig. Ⅰ-2B). Thus, our competitive approach should selectively 
exclude unsolicited protein variants and preserve only the desirable protein variants by using 
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signal transmission as the indicator. 
We employed yeast BY4741 (haploid a-cell) with a-specific methionine auxotrophy99 
as a parent to construct our recombinant strains (TableⅠ-1). Mating with wild-type BY4742 
haploid α-specific lysine-auxotroph99 allowed convenient screening of the signal-promoted 
a-cells using the selective growth of diploid cells on solid media lacking methionine and 
lysine (Fig. Ⅰ-3). The recombinant a-type strain was additionally engineered to induce the 
transcription of the GFP reporter gene in response to the mating signal (Table 1; MC-F1 
derivative strains), thereby allowing fluorescence to be used as the output signal100 (Fig. Ⅰ-3).  
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Figure Ⅰ-2. Flow diagram of the selection principle behind the competitive Gγ recruitment system. 
(A) Outline for the selection of desirable affinity-enhanced proteins. The yeast stain expressing target 
protein  ‘X’ fused  with  the  Gγ  mutant  (Gγcyto-X)  and the  competitor  protein  ‘Y2’ in  the  cytosol  is 
transformed with the plasmid expressing the mutant library on the inner leaflet of the plasma membrane 
(Y1).  Preferential  binding of “X” to “Y1” (Ka1>Ka2)  restores the signaling function and permits  the 
selective screening of affinity-enhanced proteins. (B) Outline for screening affinity-attenuated proteins. 
The yeast stain expressing a target protein ‘X’ fused with the Gγ mutant (Gγcyto-X) and a competitor 
protein ‘Y1’ on the inner leaflet of the plasma membrane is transformed with the plasmid expressing the 
mutant library in the cytosol (Y2). Preferential binding of “X” to “Y1” (Ka2<Ka1) restores the signaling 
function and permits the selective screening of affinity-attenuated proteins.
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Figure Ⅰ-3. Flow diagram of the screening procedure for the competitive Gγ recruitment system. Two 
selection methods are available to screen affinity-altered proteins. One is to use the GFP reporter gene. When 
target  candidate  proteins  are  expressed  in  the  yeast  cells  and  interact  with  each  other,  they  induce  GFP 
expression and are isolated by flow cytometry. Another method is to use yeast mating detected using a growth 
assay. When target candidate proteins are expressed in yeast cells, they restore mating ability and grow on the 
diploid-selective medium.
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Validation of the concept for screening affinity-enhanced proteins 
To demonstrate our strategy for selecting affinity-enhanced proteins specifically (Fig. 
Ⅰ-2A), we used the Fc portion of human immunoglobulin G (IgG) as the target protein ‘X’. 
The candidate ‘Y1’ proteins or the known ‘Y2’ parental proteins were constructed from the Z 
domain derived from Staphylococcus aureus protein A (ZWT) to yield several Z variants (ZZ, 
ZK35A, ZI31A and Z955) with different affinities against the Fc portion (TableⅠ-2)101–105. In order 
to make this method easily accessible, the DNA cassettes for expressing the candidate ‘Y1’ 
proteins were introduced using autonomous replication plasmids (TableⅠ-S1), whereas those 
for expressing the target protein ‘X’ and known ‘Y2’ parental proteins were stably integrated 
into the yeast chromosome (Table Ⅰ-1 and Table Ⅰ-S6). 
First, we selected ZWT as the parental ‘Y2’ protein and expressed five different Z 
variants (ZZ, ZWT, ZK35A, ZI31A and Z955) as the candidate ‘Y1’ protein in place of the mutant 
library (Table Ⅰ-S3). Flow cytometric analyses and fluorescence microscopic observations 
were conducted after incubation in medium containing the a-cell-specific mating pheromone 
(α-factor). The engineered yeast strain expressing the membrane-anchored ZZ as the 
candidate ‘Y1’ specifically induced the transcription of the GFP reporter gene (Fig. Ⅰ-4A and 
D). This shows that the target-fused Gγcyto-Fc protein permitted signal transmission only by 
using the ZZ protein as an intermediary in the presence of the parental ZWT protein in the 
cytosol, and not the other membrane-bound variants. These results suggest that the 
competitive expression of the cytosolic ‘Y2’ parental protein could specifically discern the 
affinity-enhanced proteins. Mating selection on diploid-selective medium followed the 
transcription assays (Fig. Ⅰ-5A).  
Other variants (ZK35A and ZI31A) expressed as cytosolic ‘Y2’ proteins (Table Ⅰ-S3) 
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showed similar trends as ZWT, verifying that the competitive approach using Gγcyto can 
effectively isolate affinity-enhanced proteins (Figs. Ⅰ-4B, E and Ⅰ-5B) (Figs. Ⅰ-4C, F and 
Ⅰ-5C). Supportively, it was confirmed that the lipidated candidate protein (Y1) fused with 
EGFP (EGFP-ZWT-Ste18C) (Table Ⅰ-S1) successfully localized to the inner leaflet of the 
plasma membrane in the engineered a-type yeast cells (Fig. Ⅰ-S1). 
To further test the capabilities of our system for screening affinity-enhanced proteins, 
ZK35A was selected as the model of parental ‘Y2’ protein. Plasmid libraries with four different 
compositions were prepared to express the Z variants as the candidate ‘Y1’ proteins on the 
membrane (Table Ⅰ-S5). The prepared plasmid libraries were introduced into the engineered 
a-type yeast cells, in which the ZK35A was competitively expressed as cytosolic ‘Y2’ 
(BFG2118-ZK35Acyto) (Table Ⅰ-1). The obtained four yeast a-cell libraries were 
respectively co-cultured with α-type BY4742 wild-type yeast cells and mating selection on 
diploid-selective media was performed. As shown in Table Ⅰ-3, the accuracy rates to yield 
the target protein (ZWT,mem) have been maintained at 75% even when the library with 0.1% 
frequency of target plasmid was used, while they gradually decreased as the initial rates had 
become smaller. It was further notable that our affinity-enhancement system enabled to 
isolate the target plasmid by just one cycle screening procedure. 
Thus, the results demonstrate that this approach can exclude unwanted proteins and 
isolate promising affinity-enhanced candidate proteins specifically, indicating that our 
method holds promise as a practical tool for screening affinity-enhanced proteins specifically 
from a mutant library.  
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Figure Ⅰ-4. GFP transcription assays to test the selection of affinity-enhanced proteins. 
(A–C) Flow cytometry analyses. Fluorescence intensities of the engineered strains expressing cytosolic 
ZWT (A), ZK35A (B) and ZI31A (C) as the parental ‘Y2’ proteins. White bars indicate control yeast strains 
without  the  expression  of  ‘Y1’  (transformed  with  pGK413  mock  vector).  (D–F)  Fluorescence 
microscope observations. Fluorescence micrographs of the engineered strains expressing cytosolic ZWT 
(D), ZK35A (E) and ZI31A (F) as the parental ‘Y2’ proteins. Five Z variants (ZZ, ZWT, ZK35A, ZI31A and 
Z955) were expressed as the membrane-anchored ‘Y1’ candidate proteins in each strain. To investigate 
transmission  of  the  signal,  5  mM of  a-factor  was  used  for  each  strain.  Standard  errors  of  three 
independent experiments are shown.  
 28 
Figure Ⅰ-5. Mating growth selection to test the screening of affinity-enhanced proteins. 
The signal-promoted cells were isolated as methionine- and lysine-prototrophic diploids. Growth of the 
engineered strains expressing cytosolic ZWT (A), ZK35A (B) and ZI31A (C) as the parental ‘Y2’ proteins. 
Five  Z  variants  (ZZ,  ZWT,  ZK35A,  ZI31A  and  Z955)  were  expressed  as  the  membrane-anchored  ‘Y1’ 
candidate  proteins  in  each  strain.  Control  indicates  the  yeast  strains  without  the  expression  of 
‘Y1’ (transformed with pGK413 mock vector). BY4742 was used as the mating partner.   
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Validation of the concept for screening affinity-attenuated proteins 
To validate our hypothesis for selectively sorting affinity-attenuated proteins (Fig. 
Ⅰ-2B), we used ZWT, ZK35A and ZI31A as parental ‘Y1’ proteins, and the five Z variants as 
candidate ‘Y2’ proteins in the mutant library (Table Ⅰ-S4). As described above, the Fc portion 
was used as the target protein ‘X’. The DNA cassettes for expressing the candidate ‘Y2’ 
proteins were introduced using autonomous replication plasmids (Table Ⅰ-S1), whereas those 
for expressing the target protein ‘X’ and known ‘Y1’ parental proteins were stably integrated 
into the yeast chromosome (Table Ⅰ-1 and Table Ⅰ-S6). 
When using ZWT as the membrane-anchored parental protein (Table Ⅰ-S4), the 
engineered yeast cells expressing the three cytosolic Z variants with lower affinities than ZWT 
(ZK35A, ZI31A and Z955) predictably displayed green fluorescence following incubation in 
α-factor-containing medium (Fig. Ⅰ-6A and D). The GFP transcription assays were followed 
by mating growth selection to isolate the methionine- and lysine-prototrophic diploids (Fig. 
Ⅰ-7A). The engineered yeast strains expressing ZK35A and ZI31A as membrane-anchored 
parental proteins also provided predictable results (Figs. Ⅰ-6B, E and Ⅰ-7B) (Fig. Ⅰ-6C and 
F), although mating selection using ZI31A as Y1 provided no colonies (Fig. Ⅰ-7C). These 
results indicate that mating selection using our methodology allows the specific screening of 
affinity-attenuated candidate proteins, although it has limited ability to detect candidate 
proteins exhibiting extremely low affinities. 
Next, to demonstrate the feasibility of the system for screening affinity 
attenuated-proteins, we tested a two-step selection (Fig. Ⅰ-S2). The original Gγ recruitment 
system (Fig. Ⅰ-1B) was used as the first selection to screen all protein mutants with affinity to 
the target protein, and then the competitive method (Fig. Ⅰ-2B) was used as the second 
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selection to narrow down the affinity-attenuated candidate proteins. For the first selection, 
plasmid libraries with two different compositions were prepared to express the Z variants as 
the candidate ‘Y1’ proteins on the membrane (Table Ⅰ-S5, Fig. Ⅰ-S2 and Fig. Ⅰ-S3). The 
prepared plasmid libraries were introduced into the engineered a-type yeast cells lacking the 
expression of competitive cytosolic proteins (BFG2118) (Table Ⅰ-1). The obtained two yeast 
a-cell libraries were respectively co-cultured with α-type BY4742 yeast cells and the mating 
selection on diploid-selective media was carried out. One-hundred colonies were picked up to 
amplify the fragments containing the candidate genes and checked whether the false positive 
candidates lacking affinity to the Fc were omitted in the first selection as expected (data not 
shown). Then, the fragments corresponding to the gene encoding regions of Z variants were 
digested from the mixture of fragments and inserted into the pGK415-TAA plasmid (Table 
Ⅰ-S1) for cytosolic ‘Y2’ expression to screen the affinity-attenuated proteins (Fig. Ⅰ-S2). The 
constructed pGK415-Library was introduced into engineered a-type yeast cells, in which the 
ZWT was competitively expressed as membrane ‘Y1’ (BFG2Z18-WT) (Table Ⅰ-1). The 
obtained a-cell library was co-cultured with BY4742 and the mating selection on 
diploid-selective media was performed. As shown in Table 3, the accuracy rate to yield the 
target proteins (ZK35A and ZI31A) was 95% when the library with 2% frequency of target 
plasmids was used. Even when using the library with 0.2% target frequency, the yeast cells 
expressing the target proteins were successfully attained with 55% of accuracy rate (Table 
Ⅰ-3). As the available option to increase the accuracy rate, an additional round of second-step 
screening was tested. As the result, the accuracy rate for screening of targets was elevated up 
to 85% (Table Ⅰ-3). In addition, when the Z variant genes were directly amplified from the 
mixture of massive colonies (>1000 colonies) obtained by the first mating selection, target 
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clones were also screened after the second-step selection (data not shown). Thus, we 
successfully proved that the selective screening of affinity-attenuated proteins by two-step (or 
three-step) selection was feasible, although the system has still significant scope for 
improvement. 
Finally, we clarified unique aspects of our method. When the tandem fusion form of Z 
domain (ZZ) was used as the parental protein, both affinity enhancement (Table Ⅰ-S3 and 
Fig. Ⅰ-S4) and affinity attenuation systems (Table Ⅰ-S4 and Fig. Ⅰ-S5) were accompanied by 
candidate proteins which exhibited the same affinity as the original protein, ZZ. This 
indicated that the expression level of ZZ as the cytosolic ‘Y2’ was insufficient and needed to 
be increased. We therefore introduced an additional one- or multi-copy replication plasmid to 
overexpress ZZ as the ‘Y2’ parental protein in the affinity enhancement system, in addition to 
the chromosomally-integrated ZZ gene (Table Ⅰ-S3 and Fig. Ⅰ-S6). Using the multi-copy 
plasmid, the affinity enhancement system displayed the desired outcome, namely, no 
activation of the GFP transcription (Fig. Ⅰ-S6). For the affinity attenuation system when 
expressing ZZ as the parental Y1 protein, we introduced a multi-copy plasmid instead of the 
one-copy plasmid to overexpress ZZ as the ‘Y2’ candidate protein (Table Ⅰ-S4 and Fig. Ⅰ-S7) 
and observed the desired outcome, namely, suppression of GFP transcription activation 
similar to that in the affinity enhancement system (Fig. Ⅰ-S7). Thus, controlling the 
expression level of the parental protein is important for robust screening of both 
affinity-enhanced and affinity-attenuated proteins. 
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Figure Ⅰ-6. GFP transcription assays to test the selection of affinity-attenuated proteins.
 (A–C)  Flow  cytometry  analyses.  Fluorescence  intensities  of  the  engineered  strains  expressing 
membrane-anchored ZWT  (A),  ZK35A  (B)  and ZI31A  (C)  as  the  parental  ‘Y1’ proteins.  White  bars 
indicate control yeast strain lacking expression of ‘Y1’ and ‘Y2’ (transformed with pGK415 mock 
vector to BFG2118). (D–F) Fluorescence microscope observations. Fluorescence micrographs of the 
engineered strains expressing membrane-anchored ZWT (D), ZK35A (E) and ZI31A (F) as the parental 
‘Y2’ proteins. Five Z variants (ZZ, ZWT, ZK35A, ZI31A and Z955) were expressed as the cytosolic ‘Y2’ 
candidate proteins in each strain. To investigate transmission of the signal, 5 mM of a-factor was used 
for each strain. Standard errors of three independent experiments are shown.  
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Figure Ⅰ-7. Mating growth selection to test the screening of affinity-attenuated proteins. 
The  signal-promoted  cells  were  isolated  following  formation  of  methionine-  and  lysine-
prototrophic diploids. Growth of the engineered strains expressing membrane-anchored ZWT (A), 
ZK35A (B) and ZI31A (C) as the parental ‘Y1’ proteins. Five Z variants (ZZ, ZWT, ZK35A, ZI31A and 
Z955) were expressed as the cytosolic ‘Y2’ candidate proteins in each strain. Control indicates the 
yeast  strain  lacking  expression  of  ‘Y1’ and  ‘Y2’ (transformed  with  pGK415  mock  vector  to 
BFG2118). BY4742 was used as the mating partner.  
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Table Ⅰ-3. Screening efficiency of target plasmids from model libraries using growth 
selection. 
 
Screening efficiency of the affinity-enhancement system 
 
 
Initial ratio of 
target plasmid (ZWT) 
Final ratio of 
target plasmid (ZWT) 
1 10% 100% 
2 1% 90% 
3 0.5% 85% 
4 0.1% 75% 
 
Screening efficiency of the affinity-attenuation system 
 
 
Initial ratio of 
target plasmids  
Final ratio of 
target plasmids 
Final ratio of 
total target plasmids 
 
(ZK35A + ZI31A) ZK35A ZI31A (ZK35A + ZI31A) 
1 2.0% 80% 15% 95% 
2-1* 
2-2** 
0.2% 
0.2% 
55% 
85% 
0% 
0% 
55% 
85% 
* “2-1” shows the screening efficiency for No. 2 library after one round of second-step selection.  
** “2-2” shows the screening efficiency for No. 2 library after two round of second-step selection. 
 
Discussion 
The above results demonstrate the utility of our system for screening affinity-altered 
protein variants. While various screening studies can be performed using existing screening 
systems, many, such as phage display or yeast two-hybrid systems, screen protein variants 
exhibiting any affinity, making it difficult or impossible to screen affinity-altered proteins 
selectively. To address this issue, we expanded our previously constructed Gγ recruitment 
system into a competitive-binding system, thereby opening the door to the selective and 
reliable screening of both affinity-enhanced and affinity-attenuated protein variants.  
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The competitive approach allows the specific selection of cells expressing 
affinity-enhanced candidate proteins (Figs. Ⅰ-4, Ⅰ-5, and Table Ⅰ-3), since signal transmission 
requires the localization of Gγ onto the membrane. Consequently, the inability to localize 
into the membrane leads to insensitivity to the transmission of background signals48,90. Thus, 
our system could be useful as an alternate technique for the phage display technology and 
protein-fragment complementation assays40,73–77,81–86, which can screen affinity-enhanced 
protein variants. Because yeast can express a variety of affinity proteins, including full-length 
antibodies 106 and antibody-like proteins, our system will be easily applicable to a wide range 
of directed evolution research and be able to screen protein variants with stronger affinities. 
In addition, for example, a protein scaffold that is a constrained polypeptide consisting of 
either an α-helix or a β-sheet and one or several binding activity domains107–109 could be used 
in our system to engineer novel binding proteins. Furthermore, using the original Gγ 
recruitment system48 (Fig. Ⅰ-1B) in combination with the current system (Fig. Ⅰ-2A), it will be 
possible to make variants of novel protein scaffolds that strongly bind to the target protein. 
Our results demonstrate that the competitive approach successfully screens cells expressing 
the desired affinity-attenuated protein variants (Figs. Ⅰ-6, Ⅰ-7 and Table Ⅰ-3). Until recently, 
there were few practical methods for selectively screening protein variants with weak 
affinities. In that sense, the current method opens new possibilities for designing multi-target 
drugs and dirty drugs, and for making drugs with relatively few side effects.  
In the attenuated system, extremely low affinity, as in the case of mating selection with 
ZI31A parental protein (Fig. Ⅰ-7C), cannot be detected. Due to the very low affinity between 
ZI31A and the Fc region (8.0×103 M-1), the signaling level was likely insufficient for the mating 
process. This affinity (8.0×103 M-1) seems to be less than a lower limit of the mating selection, 
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although it is unlikely that a protein mutant exhibiting such extremely low association 
constant would be required. It is important to note that this method detects both 
affinity-attenuated and approximately zero-affinity proteins such as Z955 (Figs. Ⅰ-6 and Ⅰ-7). 
Therefore, care must be taken to screen the affinity-attenuated proteins specifically. For 
instance, a two-step selection would be advisable as shown in Fig. Ⅰ-S2. Specifically, the 
original Gγ recruitment system (Fig. Ⅰ-1B) was used as the first selection to screen for 
protein mutants with affinity to the target protein, while the competitive method (Fig. Ⅰ-2B) 
was used as the second selection to narrow down the affinity-attenuated candidate proteins. 
Additionally, we used Z955 expression plasmid and mock vector as alternatives to a significant 
part of incomplete error-prone PCR products (due to frame shifts and stop codons) to test 
whether our system can efficiently eliminate the false positive clones. As a consequence, we 
actually succeeded in demonstration of the viability of the two-step (or three-step) screening 
for screen the affinity-attenuated proteins (Table Ⅰ-3 and Table Ⅰ-S5), even though the 
system will still need to improve the accuracy rate to yield the target plasmid by two-step 
screening and to enable the screen of library with much smaller target frequency in the future. 
We used the Z domain derived from S. aureus protein A as the candidate or known 
parental protein in the current study. As stated above, when the dimer of Z domain (ZZ) was 
used as the parental protein, the original ZZ proteins were identified as candidates (Figs. Ⅰ-S4 
and Ⅰ-S5). However, controlling the expression levels (ratios) of the parental and candidate 
proteins should have allowed reliable selection (Figs. Ⅰ-S6 and Ⅰ-S7). In principle, the 
competitive approach binds candidate variants with similar affinities to the parental protein if 
the protein expression levels of ‘Y1’ and ‘Y2’ are identical (Fig. Ⅰ-2A and B). However, due 
to the low expression of proteins containing the lipidation motif and the low efficiency of 
 37 
lipidation modification, the relative amounts of the membrane-bound proteins (Y1) are 
generally lower than of the identical protein expressed in the cytosol (Y2). This highlights the 
unique feature of our system, namely, the ability to exclude protein mutants with the same 
affinity as the original proteins when using the monomeric Z variants (Figs. Ⅰ-4–Ⅰ-7). 
Nevertheless, calibration of the parental and candidate protein expression levels is important 
to ensure a successful outcome using this screening method. 
Our approach to create a desirable and ‘swingable’ screening methodology, which 
allows screening based on both affinity enhancement and affinity-attenuation, could prove 
innovative in research fields such as biochemistry and antibody mimetics, and could 
contribute to investigations of protein function or the development of new drugs. 
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Materials and Methods 
 
Strains and media  
Details regarding Saccharomyces cerevisiae BY474199, MC-F1100, BY474299 and other 
recombinant strains used in this study and their genotypes are provided in Table 1. The yeast 
strains were grown in YPD medium containing 1% (w/v) yeast extract, 2% peptone and 2% 
glucose, or in SD medium containing 0.67% yeast nitrogen base without amino acids 
(BD-Diagnostic Systems, Sparks, MD, USA) and 2% glucose. Amino acids and nucleotides 
(20 mg/L histidine, 60 mg/L leucine, 20 mg/L methionine, or 20 mg/L uracil) were 
supplemented into SD medium as required by the auxotrophic strains. Agar (2%; w⁄v) was 
added to the medium to produce YPD and SD solid media. 
 
Construction of plasmids 
All plasmids and primers used in this study are listed in Table Ⅰ-S1 and Table Ⅰ-S2. 
Plasmids used for the expression of the Z variants (ZZ, ZWT, ZK35A, ZI31A and Z955)101–105 as the 
library protein on the plasma membrane were constructed as follows. The fragments 
encoding Z variants with lipidation motifs were amplified from pUMGPT-ZZK, 
pUMGPT-ZK-WT, pUMGPT-ZK-K35A, pUMGPT-ZK-I31A48 and pUMGPT-PGKZ955 
[unpublished plasmid; ZWT gene has been replaced by Z955 gene in pUMGPT-ZK-WT] using 
primer 1 and primer 2, and inserted into the SalI-BamHI sites of the autonomous replication 
plasmid pGK413110, yielding plasmids pGK-HsZZm, pGK-HsZm, pGK-HsZK35Am, 
pGK-HsZI31Am and pGK-HsZ955m, respectively.  
Plasmids used for the expression of the Z variants (ZZ, ZWT, ZK35A, ZI31A and Z955) as the 
library protein in the cytosol were constructed as follows. The fragments encoding Z variants 
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were amplified from pGK-HsZZm, pGK-HsZm, pGK-HsZK35Am, pGK-HsZI31Am and 
pGK-HsZ955m using primer 3 and primer 4, and inserted into the SalI-BamHI sites of the 
autonomous replication plasmid pGK415110, yielding plasmids pGK-LsZZc, pGK-LsZWTc, 
pGK-LsZK35Ac, pGK-LsZI31Ac and pGK-LsZ955c, respectively.  
Plasmids used for the integration of the DNA cassettes for expressing Z variants (ZZ 
and ZI31A) upstream of the HOP2 gene (PHOP2: HOP2 promoter region) on the yeast 
chromosome as the competitor in the cytosol were constructed as follows. The fragments 
encoding Z variants were amplified from pGK-LsZZc and pGK-LsZI35Ac using primer 3 
and primer 4 and inserted into the SalI-BamHI sites of pLMZ-WT-H91, yielding plasmids 
pLMZ-ZZ-H and pLMZ-I31A-H, respectively.  
Plasmids used for screening of affinity-enhanced proteins and for first step screening of 
affinity-attenuated proteins (to express the library protein on the plasma membrane) were 
constructed as follows. The fragments encoding PGK1 terminator with lipidation motif was 
amplified from pGK413110 using primer 5 and primer 6, and inserted into the XmaI-NotI sites 
of the autonomous replication plasmid pGK413110, yielding plasmid pGK413-Ste18C. The 
fragments encoding Z variants were amplified from pGK-LsZWTc, pGK-LsZK35Ac, 
pGK-LsZI31Ac and pGK-LsZ955c using primer 7 and primer 8, and inserted into the 
SalI-BamHI sites of pGK413-Ste18C, yielding plasmids pGK413-ZWTmem, 
pGK413-ZK35Amem, pGK413-ZI31Amem and pGK413-Z955mem, respectively.  
Plasmids used for second step screening of affinity-attenuated proteins (to transfer the 
coding sequences of screened Z variants and express the library protein in the cytosol) were 
constructed as follows. The fragments encoding PGK1 terminator with stop codon (TAA) 
was amplified from pGK415110 using primer 9 and primer 6, and inserted into the 
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BamHI-NotI sites of the autonomous replication plasmid pGK415110, yielding plasmid 
pGK415-TAA. 
Plasmids used for confirming that the lipidated candidate protein (Y1) localized to the 
inner leaflet of the plasma membrane were constructed as follows. The fragment encoding 
EGFP was amplified from pGK416-EGFP110 using primer 10 and primer 11, and inserted into 
the SalI-BamHI sites of the autonomous replication plasmid pGK413110, yielding plasmid 
pGK413-EGFP-N. The fragment encoding ZWT with lipidation motif was amplified from 
pGK-HsZm using primer 12 and primer 13, and inserted into the BamHI-XmaI sites of the 
autonomous replication plasmid pGK416-EGFP-N, yielding plasmid 
pGK413-EGFP-ZWTmem. 
 
Construction of yeast strains 
All strains used in this study are listed in Table Ⅰ-1, and all transformants used in this 
study are listed in Table Ⅰ-S3 and Table Ⅰ-S4. Integration of the DNA cassettes for expressing 
Z variants (ZZ, ZWT, ZK35A and ZI31A) as the competitor in the cytosol was achieved as follows. 
The DNA fragments containing LEU2-PGK5’-Z-PGK3’-PHOP2 (PGK5’, PGK1 promoter; 
PGK3’, PGK1 terminator) were amplified from pLMZ-ZZ-H, pLMZ-WT-H, 
pLMZ-K35A-H91 and pLMZ-I31A-H using primers 14 (containing the homologous regions 
of PHOP2 upstream) and 15. The amplified DNA fragments were used to transform BFG211848 
using the lithium acetate method111. The transformants were selected on SD-Leu, -Ura plate 
(SD solid medium without leucine and uracil, but containing histidine and methionine), to 
yield BFG2118-ZZcyto, BFG2118-ZWTcyto, BFG2118-ZK35Acyto and 
BFG2118-ZI31Acyto (Table Ⅰ-1). All transformants were obtained by introducing the 
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plasmids into the yeast strains using the lithium acetate method (Table Ⅰ-S3, Table Ⅰ-S4 and 
Table Ⅰ-S7). 
 
Fluorescence imaging by confocal laser scanning microscopy 
The pGK413-EGFP-ZWTmem-introduced BFG2118-ZK35Acyto yeast, which 
expressed the GFP-fused ZWT with an artificial lipidation motif, was grown in SD-His, -Leu, 
-Ura medium at 30°C for 18 hours. The cultured cells were washed and resuspended in 
distilled water to yield an optical density of 40 at 600 nm (OD600 of 40). The cell suspensions 
were observed with a LSM 5 PASCAL confocal laser scanning microscope (Carl Zeiss, 
Oberkochen, Germany). Fluorescence image was acquired using the 488nm line of an argon 
laser for excitation and a 505-nm band pass filter for emission. 
 
GFP reporter expression analysis 
GFP reporter expression analysis basically followed previous methods48,91 with some 
modifications. The engineered yeast a-cells were grown in 5 mL of SD-His, -Leu, -Ura media 
(for affinity enhancement) or SD-Leu, -Ura media (for affinity attenuation) at 30°C overnight. 
The cultured cells were inoculated into fresh 2 mL of SD-His, -Leu, -Ura or SD-Leu, -Ura 
media containing 5 μM α-factor (Zymo Research, Orange, CA, USA) to give an initial OD600 
of 0.1. Then, the expression of FIG1-EGFP fusion reporter gene was stimulated by growing 
at 30ºC for 6 hours. 
Fluorescence intensities of cultured cells were measured using a BD FACSCanto II 
flow cytometer equipped with a 488-nm blue laser (BD Biosciences, San Jose, CA, USA)112. 
The EGFP fluorescence signal was collected through a 530/30-nm band-pass filter. The mean 
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of fluorescence intensity was defined as the GFP-A mean of 10,000 cells. The data were 
analyzed using BD FACSDiva software (version 5.0, BD Biosciences).  
After washing the cultured cells three times, the cells were resuspended in distilled 
water and observed under a BIOREVO BZ-9000 fluorescence microscope (KEYENCE, 
Osaka, Japan). Green fluorescence images were acquired with a 470/40 band-pass filter for 
excitation and a 535/50 band-pass filter for emission. 
 
Mating growth spotting assay 
The mating growth spotting assay basically followed a previous method91 with some 
modifications. Each engineered yeast a-cell strain was grown in 5 mL of SD-His, -Leu, -Ura 
medium (for affinity enhancement) or SD-Leu, -Ura medium (for affinity attenuation) at 
30°C overnight, and then cultivated in 5 mL of YPD medium with the mating partner, 
BY4742 α-cell99, at 30ºC for 3 hours. The initial OD600 of each haploid cell strain was set at 
0.1. After cultivation, the yeast cells were harvested, washed, and resuspended in distilled 
water. To quantify the mating ability of each strain, a dilution series of each yeast cell 
suspension was prepared (OD600 = 1.0, 0.1, 0.01, 0.001 and 0.0001), then 30 μL of each 
dilution was spotted on a diploid-selective SD plate (lacking methionine, lysine, histidine, 
leucine and uracil; for affinity enhancement) or SD+His plate (lacking methionine, lysine, 
leucine and uracil; for affinity attenuation). 
 
Screening of affinity-enhanced proteins from model libraries 
Flow diagram for screening of affinity-enhanced proteins is shown in Figure 2A. 
Plasmid libraries (to express Z variants as membrane ‘Y1’) with varied compositions were 
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prepared by mixing the target plasmid (pGK413-ZWTmem) and the control plasmids 
(pGK413-ZK35Amem, pGK413-ZI31Amem, pGK413-Z955mem and pGK413) (Table 
Ⅰ-S5) and introduced into yeast BFG2118-ZK35Acyto (to express competitive ZK35A as 
cytosolic ‘Y2’) by the lithium acetate method111 with some modifications. Briefly, overnight 
cultured cells in YPD media were washed with distilled water, pelleted, and then resuspended 
in 1500 μl of TE/LiAc solution (10 mM Tris-HCl, 1 mM 
ethylenediaminetetraacetate (EDTA) and 100 mM lithium acetate; pH 7.5). Aliquots of 100 
μl of yeast competent cells were mixed with 20 μg of plasmid libraries, 200 μg 
heat-denatured carrier DNA (Takara/Clontech Laboratories, Shiga, Japan) and 600 μl of 
PEG/LiAc solution (10 mM Tris-HCl, 1 mM EDTA, 100 mM lithium acetate and 40% 
polyethylene glycol 4000 (PEG4000)) and incubated at 30°C for 30 minutes. After adding 70 
μl of dimethyl sulfoxide (DMSO) (Nakarai Tesque, Kyoto, Japan), the cell suspensions were 
incubated at 42°C for 15 minutes, transferred into 20 mL of SD-His, -Leu, -Ura media, and 
then cultured at 30°C for 1 day.  
The cultured cells were inoculated into 100 mL of YPD media to set the initial OD600 of 
each haploid cell at 0.1 with the mating partner BY4742, and cultivated at 30°C for 6 hours 
(for library No. 1 and No. 2) or 9 hours (for library No. 3 and No. 4) (Table Ⅰ-S5). After 
cultivation, yeast cells were harvested by centrifugation (3000 g, 5 min), washed and 
resuspended with distilled water, and then spread on diploid-selective SD plates (lacking 
methionine, lysine, histidine, leucine and uracil). After incubation at 30°C for 2 days, 20 
colonies were picked up and analyzed to determine the screened candidate proteins by direct 
colony PCR using primer 16 and primer 17 and sequencing of the amplified fragments. The 
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final ratio of target plasmid was determined by the number of colonies retaining the target 
plasmid (ZWT) divided by the number of picked colonies (20 colonies). 
 
Screening of affinity-attenuated proteins from model libraries 
Flow diagram for screening of affinity-attenuated proteins is shown in Figure Ⅰ-S1. For 
first step screening, plasmid libraries (to express Z variants as membrane ‘Y1’) with varied 
compositions were prepared by mixing the target plasmid (pGK413-ZK35Amem and 
pGK413-ZI31Amem) and the control plasmids (pGK413-ZWTmem, pGK413-Z955mem and 
pGK413) (Table Ⅰ-S5) and introduced into yeast BFG211848 (lacking the expression of 
competitive proteins) by the same procedures described in the previous section. The 
transfomants were cultured in SD-His, -Ura media for 1 day, inoculated into YPD media with 
BY4742, and cultivated for 6 hours. After washing, the cells were spread on diploid-selective 
SD+Leu plates (lacking methionine, lysine, histidine and uracil) and incubated for 2 days. 
One-hundred colonies were picked up and the fragments containing genes encoding the 
screened candidate proteins were amplified individually by direct colony PCR using primer 
16 and primer 17 and the sequences of screened candidates were analyzed. Then, the 
amplified fragments were mixed and digested with SalI and BamHI and inserted into the 
SalI-BamHI sites of the autonomous replication plasmid pGK415-TAA, yielding the plasmid 
pGK415-Library for the second step screening. 
For second step screening, the obtained pGK415-Library (to express Z variants as 
cytosolic ‘Y2’) were introduced into yeast BFG2Z18-WT48 (to express competitive ZWT as 
membrane ‘Y1’) by the same procedures described in the previous section. The transfomants 
were cultured in SD-Leu, -Ura media for 1 day, inoculated into YPD media with BY4742, 
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and cultivated for 1 hour. After washing, the cells were spread on diploid-selective SD+His 
plates (lacking methionine, lysine, leucine and uracil) and incubated for 2 days. Twenty 
colonies were picked up and analyzed to determine the screened candidate proteins by direct 
colony PCR using primer 18 and primer 19 and sequencing of the amplified fragments. The 
final ratio of target plasmids were determined by the number of colonies retaining the target 
plasmids (ZK35A and ZI31A) divided by the number of picked colonies (20 colonies). 
For an additional second round of second step screening, one-hundred colonies were 
picked up from the plate after the second step screening and the retaining plasmids were 
collectively extracted using the SpeedPrep Yeast Plasmid Isolation kit (DualSytems Biotech 
AG, Schlieren, Switzerland) with some modifications. The incubation time for Lytic agent 
was prolonged up to overnight and the MonoFas Spin column (GL Science, Tokyo, Japan) 
was alternatively used for the plasmid recovery. The extracted plasmid mixture was 
introduced into yeast BFG2Z18-WT and then the same screening procedure described above 
(in the second step screening section) was performed.  
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Supplementary information 
 
Figure  Ⅰ-S1.  Localization  of  membrane-
anchored Z protein with lipidation motif. 
The  pGK413-EGFP-ZWTmem-introduced 
BFG2118-ZK35Acyto  yeast,  which 
expressed  the  GFP-fused  ZWT  with  an 
artificial lipidation motif, was grown in SD-
His,  -Leu,  -Ura  medium  at  30°C  for  18 
hours.  The  cell  suspensions  were  observed 
with a confocal laser scanning microscope.
Figure Ⅰ-S2. Flow diagram of two-step screening for screening of affinity-
attenuated proteins.   
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Figure  Ⅰ-S3.  GFP  transcription  assays  of  the  engineered  yeast  strains  using  original  Gγ 
recruitment system. 
To enable  two-step screening,  the plasmids with additional  restriction enzyme cleavage sites  were 
constructed  (pGK413-ZWTmem,  pGK413-ZK35Amem,  pGK413-ZI31Amem  and  pGK413-
Z955mem).  The  plasmids  were  introduced  into  the  engineered  yeast  lacking  the  expression  of 
competitive  proteins  (BFG2118).  Control  yeast  strain  was  transformed with  pGK413 (Mock).  The 
abilities for transducing the signal were identical to the strains with the equivalent plasmids without the 
restriction enzyme cleavage sites. 
Figure  Ⅰ-S4.  GFP  transcription  assays  to  test 
the selection of affinity-enhanced proteins. 
(A)  Flow  cytometry  analyses.  (B)  Fluorescence 
microscope observations. Fluorescence intensities 
and  fluorescence  micrographs  of  the  engineered 
strains expressing cytosolic ZZ are shown. 
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Figure Ⅰ-S5. GFP transcription assays to test 
the  selection  of  affinity-attenuated  proteins. 
(A) Flow cytometry analyses. (B) Fluorescence 
microscope  observations.  Fluorescence 
intensities and fluorescence micrographs of the 
engineered  strains  expressing  membrane-
anchored ZZ are shown. 
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Figure Ⅰ-S6. GFP transcription assays of the engineered yeast strains overexpressing cytosolic 
ZZ in the affinity-enhancement system. 
To test whether cytosolic ZZ expression levels could reduce background signaling, ZZ as the ‘Y2’ 
parental  protein  was  overexpressed  using  plasmid  insertion  in  the  affinity-enhanced  system in 
addition to integration into the yeast chromosome. Using the multi-copy replication plasmid, the 
affinity-enhancement system never induced false-positive transcription of the GFP reporter gene.  
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Figure Ⅰ-S7. GFP transcription assays of the engineered yeast strains overexpressing cytosolic 
ZZ in  the  affinity-attenuation  system.  To  test  whether  cytosolic  ZZ expression  levels  affect 
background signaling,  ZZ as  the  ‘Y2’ candidate  protein  was overexpressed using a  multi-copy 
replication plasmid instead of the single-copy replication plasmid in the affinity-attenuation system. 
Using  the  multi-copy  replication  plasmid,  the  affinity-attenuation  system never  induced  false-
positive transcription of the GFP reporter gene.
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Figure Ⅰ-S8. GFP transcription assays of the engineered yeast strains using original Gγ recruitment system of 
various lipid anchor. 
To check which lipid anchor is available, we expressed membrane-anchored ZWT fused several types of lipidation 
motifs  at  both the N-terminus (Vac8p motif;  Vac8N, Psr1p motif;  Psr1N,  Meh1p motif;  Meh1N, vSrcp motif; 
vSrcN, Gpa2p motif; Gpa2N and Gpa1p motif; Gpa1N) and the C-terminus (Rho3p motif; Rho3C, Rho2p motif; 
Rho2C, Ras1p motif; Ras1C, nRasp motif; nRasC. Ycp4p motif; Ycp4C, Yck1C motif; Yck1C and Ste18p motif; 
Ste18C)  by  using  multi-copy  plasmid.  The  plasmids  were  introduced  into  the  engineered  yeast  lacking  the 
expression of competitive proteins (BFG2118). Control yeast strain was transformed with pGK425 (Mock).  (A) 
Amino-acid sequences of N-terminus lipid anchor. (B) Flow cytometry analyses of the engineered yeast strains 
expressing ZWT fused the lipidation motifs at the N-terminus using original Gγ recruitment system. .  (C) Amino-
acid sequences of C-terminus lipid anchor. (D) Flow cytometry analyses of the engineered yeast strains expressing 
ZWT fused the lipidation motifs at the C-terminus using original Gγ recruitment system.  
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Table Ⅰ-S2. List of primers used in this study. 
 
Number  Primer name      Sequence (5’ to 3’) 
   1  SalI-EZZ-fw       ttttgtcgacgcgcaacacgatgaagccgt 
   2  BamHI-Ste18c30-Z(131-174)-rv  aaaaggatccttacataagcgtacaacaaacactatttgatttcggcgcctgagcatcatttagctttttagcttctgctaaaatttt 
-gtcgacgcgcaacacgatgaagccgt 
   3  SalI-atg-FlagEZ(1-20)-fw    ttttgtcgacatggactacaaggatgacgatgacaaggcgcaacacgatgaagccgtagacaacaaattcaacaa 
   4  BamHI-tag-Z(154-174)-rv    tttttggatccctatttcggcgcctgagcatca 
   5  Xmal-Ste18C-PGK3’-fw    aaaacccgggtcaaatagtgtttgttgtacgcttatgtaaaaagatgccgatttgggcgcgaatc 
   6  Notl-PGK3’end-rv     ttttgcggccgcagctttaacgaacgcagaattt 
   7  Sall-atg-EZ(1-20)-fw     ttttgtcgacatggcgcaacacgatgaagccgtagacaacaaattcaacaa 
   8  BamHl-Z(160-174)-rv     ttttggatcctttcggcgcctgagc 
   9  BamHl-TAA-XmaI-PGK3’-fw   aaaaggatcctaacccgggtctagagaattcagatct 
  10  Sall-start-EGFP-fw     aaaagtcgacatggtgagcaagggc 
  11  BamHl-EGFP-rv      ttttggatcccttgtacagctcgtcca 
  12  BamHl-E domain-fw     aaaaggatccgcgcaacacgatgaagcc 
  13  Xmal-end-Ste18C-rv     ttttcccgggttacataagcgtacaacaaa 
  14  Hop2p 150-200-LEU2-fw    atacaattaattgacatcagcagacagcaaatgcacttgatatacgcagctcgactacgtcgtaaggccgt 
  15  Hop2p 800-rv      atctttcaaatagagcctgg 
  16  pGK413-fw       gcatcagagcagattgtactgagagtgcaccataaattcc 
  17  pGK413-rv       cgcaaaccgcctctccccgcgcgttggccgattcattaat 
  18  pGK415-fw       cttacctgtattcctttactatcctcctttttctccttct 
  19  pGK415-rv       ggaattgtgagcggataacaatttcacacaggaaacagct 
 
 
 
 
 
 
 
Table Ⅰ-S3. List of yeast transformants used to screen affinity-enhanced proteins. 
 
              Parent      Candidate   Target 
Transformants         Y2 (cytosol)    Y1 (membrane)    X   Figures 
[ BFG2118-ZWTcyto ] 
BFG2118-ZWTcyto + (pGK-Hs-ZZm)     ZWT (Gen)    ZZmem (Pla)    Fc  Figs 4a,d and 5a 
BFG2118-ZWTcyto + (pGK-Hs-ZWTm)     ZWT (Gen)    ZWT,mem (Pla)    Fc  Figs 4a,d and 5a 
BFG2118-ZWTcyto + (pGK-Hs-ZK35Am)     ZWT (Gen)    ZK35A,mem (Pla)    Fc  Figs 4a,d and 5a 
BFG2118-ZWTcyto + (pGK-Hs-ZI31Am)     ZWT (Gen)    ZI31A,mem (Pla)    Fc  Figs 4a,d and 5a 
BFG2118-ZWTcyto + (pGK-Hs-Z955m)     ZWT (Gen)    Z955,mem (Pla)    Fc  Figs 4a,d and 5a 
BFG2118-ZWTcyto + (pGK413) [control]     ZWT (Gen)    –  (Pla)    Fc  Figs 4a,d and 5a 
 
[ BFG2118-ZK35Acyto ] 
BFG2118-ZK35Acyto + (pGK-Hs-ZZm)     ZK35A  (Gen)    ZZmem (Pla)    Fc  Figs 4b,e and 5b 
BFG2118-ZK35Acyto + (pGK-Hs-ZWTm)     ZK35A  (Gen)    ZWT,mem (Pla)    Fc  Figs 4b,e and 5b 
BFG2118-ZK35Acyto + (pGK-Hs-ZK35Am)    ZK35A  (Gen)    ZK35A,mem (Pla)    Fc  Figs 4b,e and 5b 
BFG2118-ZK35Acyto + (pGK-Hs-ZI31Am)    ZK35A  (Gen)    ZI31A,mem (Pla)    Fc  Figs 4b,e and 5b 
BFG2118-ZK35Acyto + (pGK-Hs-Z955m)    ZK35A  (Gen)    Z955,mem (Pla)    Fc  Figs 4b,e and 5b 
BFG2118-ZK35Acyto + (pGK413) [control]    ZK35A  (Gen)    –  (Pla)    Fc  Figs 4b,e and 5b 
 
[ BFG2118-ZI31Acyto ] 
BFG2118-ZI31Acyto + (pGK-Hs-ZZm)     ZI31A  (Gen)    ZZmem (Pla)    Fc  Figs 4c,f and 5c 
BFG2118-ZI31Acyto + (pGK-Hs-ZWTm)     ZI31A  (Gen)    ZWT,mem (Pla)    Fc  Figs 4c,f and 5c 
BFG2118-ZI31Acyto + (pGK-Hs-ZK35Am)    ZI31A  (Gen)    ZK35A,mem (Pla)    Fc  Figs 4c,f and 5c 
BFG2118-ZI31Acyto + (pGK-Hs-ZI31Am)    ZI31A  (Gen)    ZI31A,mem (Pla)    Fc  Figs 4c,f and 5c 
BFG2118-ZI31Acyto + (pGK-Hs-Z955m)     ZI31A  (Gen)    Z955,mem (Pla)    Fc  Figs 4c,f and 5c 
BFG2118-ZI31Acyto + (pGK413) [control]    ZI31A  (Gen)    –  (Pla)    Fc  Figs 4c,f and 5c 
 
[ BFG2118-ZZcyto ] 
BFG2118-ZZcyto + (pGK-Hs-ZZm)      ZZ  (Gen)    ZZmem (Pla)    Fc  Supplementary Figs S3a,b and S5 
BFG2118-ZZcyto + (pGK-Hs-ZWTm)     ZZ  (Gen)    ZWT,mem (Pla)    Fc  Supplementary Fig. S3a,b 
BFG2118-ZZcyto + (pGK-Hs-ZK35Am)     ZZ  (Gen)    ZK35A,mem (Pla)    Fc  Supplementary Fig. S3a,b 
BFG2118-ZZcyto + (pGK-Hs-ZI31Am)     ZZ  (Gen)    Z955,mem (Pla)    Fc  Supplementary Fig. S3a,b 
BFG2118-ZZcyto + (pGK413) [control]     ZZ  (Gen)    –  (Pla)    Fc  Supplementary Figs S3a,b and S5 
 
BFG2118-ZZcyto + (pGK-Ls-ZZc) + (pGK-Hs-ZZm)  ZZ (Gen) + ZZ (Pla)  ZZmem (Pla)    Fc  Supplementary Fig. S5 
BFG2118-ZZcyto + (pGK-Lm-ZZc) + (pGK-Hs-ZZm)  ZZ (Gen) + ZZ (Hi-Pla)  ZZmem (Pla)    Fc  Supplementary Fig. S5 
 
* “Gen” means Genome expression. “Pla” means One-copy Plasmid expression. “Hi-Pla” means High-copy Plasmid expression. 
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Table Ⅰ-S4. List of yeast transformants used to screen affinity-attenuated proteins. 
 
             Parent     Candidate   Target 
Transformants       Y1 (membrane)   Y2 (cytosol)     X   Figures 
[ BFG2Z18-WT ] 
BFG2Z18-WT + (pGK-Ls-ZZc)     ZWT,mem (Gen)   ZZ   (Pla)     Fc  Figs 6a,d and 7a 
BFG2Z18-WT + (pGK-Ls-ZWTc)    ZWT,mem (Gen)   ZWT   (Pla)     Fc  Figs 6a,d and 7a 
BFG2Z18-WT + (pGK-Ls-ZK35Ac)    ZWT,mem (Gen)   ZK35A  (Pla)     Fc  Figs 6a,d and 7a 
BFG2Z18-WT + (pGK-Ls-ZI31Ac)    ZWT,mem (Gen)   ZI31A   (Pla)     Fc  Figs 6a,d and 7a 
BFG2Z18-WT + (pGK-Ls-Z955Ac)    ZWT,mem (Gen)   Z955   (Pla)     Fc  Figs 6a,d and 7a 
BFG2118+ (pGK415) [control]       –     –   (Pla)     Fc  Figs 6a,d and 7a 
 
[ BFG2Z18-K35A ] 
BFG2Z18-K35A + (pGK-Ls-ZZc)    ZK35A,mem (Gen)   ZZ   (Pla)     Fc  Figs 6b,e and 7b 
BFG2Z18-K35A + (pGK-Ls-ZWTc)    ZK35A,mem (Gen)   ZWT   (Pla)     Fc  Figs 6b,e and 7b 
BFG2Z18-K35A + (pGK-Ls-ZK35Ac)    ZK35A,mem (Gen)   ZK35A  (Pla)     Fc  Figs 6b,e and 7b 
BFG2Z18-K35A + (pGK-Ls-ZI31Ac)    ZK35A,mem (Gen)   ZI31A   (Pla)     Fc  Figs 6b,e and 7b 
BFG2Z18-K35A + (pGK-Ls-Z955c)    ZK35A,mem (Gen)   Z955   (Pla)     Fc  Figs 6b,e and 7b 
BFG2118 + (pGK415) [control]     –     –   (Pla)     Fc  Figs 6b,e and 7b 
 
[ BFG2Z18-I31A ] 
BFG2Z18-I31A + (pGK-Ls-ZZc)     ZI31A,mem (Gen)   ZZ   (Pla)     Fc  Figs 6c,f and 7c 
BFG2Z18-I31A + (pGK-Ls-ZWTc)    ZI31A,mem (Gen)   ZWT   (Pla)     Fc  Figs 6c,f and 7c 
BFG2Z18-I31A + (pGK-Ls-ZK35Ac)    ZI31A,mem (Gen)   ZK35A  (Pla)     Fc  Figs 6c,f and 7c 
BFG2Z18-I31A + (pGK-Ls-ZI31Ac)    ZI31A,mem (Gen)   ZI31A   (Pla)     Fc  Figs 6c,f and 7c 
BFG2Z18-I31A + (pGK-Ls-Z955)    ZI31A,mem (Gen)   Z955   (Pla)     Fc  Figs 6c,f and 7c 
BFG2118 + (pGK415) [control]       –     –   (Pla)     Fc  Figs 6c,f and 7c 
 
[ BZFG2118 ] 
BZFG2118 + (pGK-Ls-ZZc)     ZZ (Gen)    ZZ   (Pla)     Fc  Supplementary Figs S4a,b and S6 
BZFG2118 + (pGK-Ls-ZWTc)     ZZ (Gen)    ZWT   (Pla)     Fc  Supplementary Fig. S4a,b 
BZFG2118 + (pGK-Ls-ZK35Ac)     ZZ (Gen)    ZK35A  (Pla)     Fc  Supplementary Fig. S4a,b 
BZFG2118 + (pGK-Ls-ZI31Ac)     ZZ (Gen)    ZI31A   (Pla)     Fc  Supplementary Fig. S4a,b 
BZFG2118 + (pGK-Ls-Z955c)     ZZ (Gen)    Z955   (Pla)     Fc  Supplementary Fig. S4a,b 
BFG2118 + (pGK415) [control]       –     –   (Pla)     Fc  Supplementary Figs S4a,b and S6 
 
BZFG2118 + (pGK-Lm-ZZc)     ZZ (Gen)    ZZ (Hi-Pla)     Fc  Supplementary Fig S6 
 
* “Gen” means Genome expression. “Pla” means One-copy Plasmid expression. “Hi-Pla” means High-copy Plasmid expression. 
  
 
 
 
 
 
 
Table Ⅰ-S5. Composition of plasmid library. 
 
Model library for testing the affinity-enhancement system 
 
No. 
Model library composition 
 
Initial ratio of target plasmid  
(ZWT) 
1  ZWT : ZK35A : ZI31A : Z955 : Mock (pGK413) = 10 : 10 : 25 : 25 : 30  10.0% 
2  ZWT : ZK35A : ZI31A : Z955 : Mock (pGK413) = 1 : 10 : 30 : 30 : 30  1.0% 
3  ZWT : ZK35A : ZI31A : Z955 : Mock (pGK413) = 0.5 : 1 : 35 : 35 : 30  0.5% 
4  ZWT : ZK35A : ZI31A : Z955 : Mock (pGK413) = 0.1 : 1 : 35 : 35 : 30  0.1% 
 
 
 
Model library for testing the affinity-attenuation system 
 
No. Model library composition 
Initial ratio of target plasmid 
(ZK35A + ZI31A) 
1  ZWT : ZK35A : ZI31A : Z955 : Mock (pGK413) = 1 : 1 : 1 : 70 : 30 2.0% 
2  ZWT : ZK35A : ZI31A : Z955 : Mock (pGK413) = 0.1 : 0.1 : 0.1 : 55 : 45 0.2% 
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Table Ⅰ-S6. List of expressed proteins in the engineered yeast strains. 
 
 
Strain        Gγcyto-fused   Membrane-anchored    Cytosolic 
          target protein (X)    parental protein (Y1)   parental protein (Y2) 
Control 
BFG2118         Gγcyto-Fc        –        –  
 
Yeast strains for screening affinity-enhanced proteins 
BFG2118-ZZcyto       Gγcyto-Fc        –       ZZ 
BFG2118-ZWTcyto       Gγcyto-Fc        –       ZWT 
BFG2118-ZK35Acyto      Gγcyto-Fc        –       ZK35A 
BFG2118-ZI31Acyto      Gγcyto-Fc        –       ZI31A 
 
Yeast strains for screening affinity-attenuated proteins 
BZFG2118          Gγcyto-Fc      ZZmem       –  
BFG2Z18-WT        Gγcyto-Fc      ZWT,mem       –  
BFG2Z18-K35A       Gγcyto-Fc      ZK35A,mem      –  
BFG2Z18-I31A        Gγcyto-Fc      ZI31A,mem      –  
 
 
 
 
 
 
 
Table Ⅰ-S7. List of yeast transformants for supporting information. 
 
Transformants          Y1 (membrane)   Y2 (cytosol)     X (Target)   Figures 
 [ BFG2118-ZK35Acyto ] 
BFG2118-ZK35Acyto + (pGK413-EGFP-ZWTmwm)   EGFP-ZWT,mem  (Pla)  ZK35A  (Gen)      Fc  Supplementary Fig S1 
 
 
               Candidate     Target 
Transformants          Y1 (membrane)      X         Figures 
[ BFG2118-ZWTcyto ] 
BFG2118 + (pGK413-ZWTmem)        ZWT,mem (Pla)     Fc       Supplementary Fig S7 
BFG2118 + (pGK413-ZK35Amem)        ZK35A,mem (Pla)     Fc       Supplementary Fig S7 
BFG2118 + (pGK413-ZI31Amem)        ZI31A,mem (Pla)     Fc       Supplementary Fig S7 
BFG2118 + (pGK413-Z955mem)        Z955,mem (Pla)     Fc       Supplementary Fig S7 
BFG2118 + (pGK413) [control]         – (Pla)     Fc       Supplementary Fig S7 
 
* “Gen” means Genome expression. “Pla” means One-copy Plasmid expression.  
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Table Ⅰ-S8. List of plasmids used for supplementary figure Ⅰ-8. 
 
 Plasmids Genotype Reference  
pGK425 Expression vector containing PGK1 promoter, 2µ origin and LEU2 marker [45] 
pGK425-Vac8N N-terminus of Vac8 (14 a.a.) expression, in pGK425 This study 
pGK425-Psr1N N-terminus of Psr1 (14 a.a.) expression, in pGK425 This study 
pGK425-Meh1N N-terminus of Meh1 (14 a.a.) expression, in pGK425 This study 
pGK425-vSrcN N-terminus of vSrc (9 a.a.) expression, in pGK425 This study 
pGK425-Gpa2N N-terminus of Gpa2 (9 a.a.) expression, in pGK425 This study 
pGK425-Gpa1N N-terminus of Gpa1 (9 a.a.) expression, in pGK425 [182] 
pGK425-Rho3C C-terminus of Rho3 (9 a.a.) expression, in pGK425 This study 
pGK425-Rho2C C-terminus of Rho2 (9 a.a.) expression, in pGK425 This study 
pGK425-Ras1C C-terminus of Ras1 (9 a.a.) expression, in pGK425 [182] 
pGK425-nRasC C-terminus of nRas (14 a.a.) expression, in pGK425 This study 
pGK425-Ycp4C C-terminus of Ycp4 (14 a.a.) expression, in pGK425 This study 
pGK425-Yck1C C-terminus of Yck1 (14 a.a.) expression, in pGK425 This study 
pGK425-Ste18C C-terminus of Ste18 (9 a.a.) expression, in pGK425 [182] 
pGK425-Vac8N ZWT expression, in pGK425-Vac8N This study 
pGK425-Psr1N ZWT expression, in pGK425-Psr1N This study 
pGK425-Meh1N ZWT expression, in pGK425-Meh1N This study 
pGK425-vSrcN ZWT expression, in pGK425-vSrcN This study 
pGK425-Gpa2N ZWT expression, in pGK425-Gpa2N This study 
pGK425-Gpa1N ZWT expression, in pGK425-Gpa1N This study 
pGK425-Rho3C ZWT expression, in pGK425-Rho3C This study 
pGK425-Rho2C ZWT expression, in pGK425-Rho2C This study 
pGK425-Ras1C ZWT expression, in pGK425-Ras1C This study 
pGK425-nRasC ZWT expression, pGK425-nRasC This study 
pGK425-Ycp4C ZWT expression, in pGK425-Ycp4C This study 
pGK425-Yck1C ZWT expression, in pGK425-Yck1C This study 
pGK425-Ste18C ZWT expression, in pGK425-Ste18C This study 
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Part Ⅱ. 
 
 
Gγ recruitment systems specifically select PPI and 
affinity-enhanced candidate proteins that interact with 
membrane protein targets 
 
 57 
Introduction 
 
Protein-protein interactions (PPIs) are attracting increased attention in drug discovery 
studies. PPIs have functions in the regulation of cellular states involved in various 
diseases9,113. In particular, membrane-mediated PPIs play central roles in vital biological 
processes and are prime drug targets. For example, tumorigenesis is often the result of gene 
mutations that lead to alterations in membrane PPIs and aberrant signaling cascades114. 
Because the molecules that control (inhibit or activate) these membrane PPIs can be used as 
drug candidates, rapid and unbiased screening of these molecules is essential for drug 
development.  
The major targets of membrane proteins are G-protein-coupled receptors (GPCRs), ion 
channels, transporters, receptor serine/threonine and tyrosine protein kinases115,116 (e.g. 
epidermal growth factor receptor (EGFR)117,118, human epidermal growth factor receptor 2 
(HER2)119,120, and vascular endothelial growth factor receptor (VEGFR)121,122). The 
extracellular domains of these transmembrane proteins are commonly targeted to identify 
agonistic and antagonistic ligands. However, recently developed drug therapies have 
increasingly targeted the intracellular domains (kinase domains) of these transmembrane 
proteins to control interactions with the components of downstream signaling cascades123. 
Similarly, membrane-associated proteins, such as guanine nucleotide-binding protein 
(G-protein), small GTPases, kinase proteins and other signal transducers, hold enormous 
potential for use in the development of novel drugs. As a representative example, protein 
kinases are responsible for the reversible phosphorylation of proteins via PPIs and have a 
strong relationship with growth, infiltration and apoptosis in cancer cells. A multitude of 
these membrane-associated proteins are involved in various diseases and are often associated 
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with the inner side of the plasma membrane124. Several kinase and GTPase inhibitors have 
been developed in the pharmaceutical industry125–127. More recently, intracellular antibodies 
(intrabodies), which can inhibit signal transducers, including membrane-associated proteins, 
have been studied as valuable tools for controlling PPIs inside cells128–130. Thus, molecules 
that can control the PPIs of transmembrane and membrane-associated proteins on the inner 
side of the plasma membrane have a potential to become an important group of drug targets. 
Various useful screening systems for PPIs exist and have yielded significant findings19,78,90,131. 
These techniques are required for screening of large numbers of proteins and are preferable in 
the in vivo cellular context. In particular, yeast two-hybrid systems are the typical tools for 
such screening of candidate proteins in vivo132–135. Among them, split-ubiquitin system is a 
well-established, useful technique to screen the candidate proteins with the PPIs for 
membrane target proteins41,136. As in other yeast systems, small G-protein-based methods, 
including the Sos recruitment system and the Ras recruitment system, are occasionally used 
to study the PPIs of membrane proteins38,131,137. These methods remain useful alternatives to 
the original two-hybrid system; however, they suffer from technical complexities, such as the 
different temperatures required for growth and screening (25°C and 36°C), slow growth at 
suboptimal temperatures, obligatory replica-plating steps (glucose to galactose medium), and 
the total time required for the procedure (~7 days including precultivation)44–46. In addition to 
bioluminescence resonance energy transfer (BRET) and fluorescence resonance energy 
transfer (FRET)138, protein fragment complementation assays using split-GFP and 
split-luciferase139–143 are useful tools for detecting the association of two proteins in living 
cells and have the potential to resolve these limitations. Among the varied systems used, 
growth reporters are generally applicable to library screening because of their convenience. 
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Our previously developed screening method using yeast heterotrimeric G-proteins, called the 
Gγ recruitment system48,100,144, also makes it possible to screen PPIs between a target protein 
and candidate proteins by the mating growth assay without false-positive clones. The details 
of the mechanism utilized for detecting PPIs are presented below.  
The Gγ recruitment system for detecting PPIs is based on the fundamental principle 
that yeast pheromone (mating) signaling requires the localization of a complex consisting of 
the β- and γ-subunits of heterotrimeric G-proteins (Gβ/Gγ) to the inner leaflet of the plasma 
membrane48. In yeast, the G-protein-coupled receptor (GPCR) undergoes a conformational 
change after binding ligands and then activates heterotrimeric G-proteins. The activated 
G-proteins trigger the dissociation of the Gβ/Gγ complex from Gα concurrently with the 
exchange of GDP/GTP on the Gα subunit. The Gβ subunit (complexed with 
membrane-associated Gγ) then acts upon the effectors, thereby activating the downstream 
signaling cascade for mating47. Notably, localization of the Gβ/Gγ complex to the inner 
leaflet of the plasma membrane via the lipidation motif of the Gγ subunit is required for 
initiating G-protein signaling. Our Gγ recruitment system specifically makes use of a 
cytosolic truncated variant of Gγ (named Gγcyto) that is fused to a soluble target protein of 
interest, ‘X’ (Gγcyto-X), as shown in Fig. Ⅱ-1A. For the library, the candidate proteins (Y1) 
should be attached to the artificial lipidation site to ensure localization to the membrane (Fig. 
Ⅱ-1A). When an interaction occurs between target ‘X’ and candidate ‘Y1’, the Gγcyto-X fusion 
protein brings Gβ to the membrane and induces subsequent activation of the pheromone 
signaling pathway. The promoted signaling can be detected by a fluorescent reporter assay or 
a mating growth assay after growth in simple glucose media at the optimal temperature 
(30°C). Briefly, the expression of GFP under the control of a pheromone-responsive FIG1 
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promoter or mating with intact haploid cells of the opposite mating type permits the detection 
of PPIs (Figs. Ⅱ-1A and Ⅱ-S1). Because the localization of Gγcyto in the cytosol completely 
prevents this signaling activation, the Gγ recruitment system allows for extremely reliable, 
low-background growth screening that excludes false-positive candidates at the optimal 
temperature (30°C)48. The procedures for screening involve simply mixing the different 
mating-type cells (recombinant a-cells and intact α-cells) and plating on selective media (~4 
days including precultivation) (Fig. Ⅱ-S1; right). The advanced system 
(competitor-introduced Gγ recruitment system), which additionally expresses an interaction 
competitor protein (Y2) in the cytosol (Fig. Ⅱ-2A), can offer highly selective screening for 
protein variants whose affinities have been intentionally altered to exceed the set threshold144. 
This approach is applicable to selectively screening affinity-enhanced or affinity-attenuated 
protein variants by exchanging the positions of the competitor protein and the library proteins 
(Y1 and Y2)91,144. 
The localization of Gγ is of key importance for the low background of the Gγ 
recruitment system48. The previous Gγ recruitment system was limited to using only soluble 
cytosolic proteins as the target (X), as candidate proteins (Y1) should be expressed on the 
membrane (Fig. Ⅱ-1A). The competitor-introduced system also had a similar problem, 
restricting the target X to cytosolic proteins (Fig. Ⅱ-2A). Thus, these previous systems could 
not target membrane proteins. In the current study, we have reevaluated the Gγ recruitment 
system by changing the localization of target proteins from the cytosol to the membrane; 
however, the prior protocol did not work well. With the aim of expanding the applicability of 
the system, we considered new protocols for the Gγ recruitment systems that might be 
suitable for evaluating membrane proteins as targets. The updated method allows the Gγ 
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recruitment system to be used in the analysis of both cytoplasmic and membrane target 
proteins. 
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Figure Ⅱ-2. Schematic diagram of competitor-introduced Gγ recruitment systems to screen 
affinity-altered protein variants for cytosolic or membrane target proteins.
(A) Schematic outline of the previously established competitor-introduced Gγ recruitment system 
for cytosolic target proteins. Target protein ‘X’ should be expressed as a fusion with Gγcyto in the 
cytosol.  Protein  ‘Y1’ should  be  anchored  to  the  plasma  membrane,  whereas  ‘Y2’ should  be 
expressed in the cytosol. By establishing ‘Y1’ and ‘Y2’ as the parental (known) proteins originally 
bound to target ‘X’ and the candidate variant proteins, respectively, ‘Y1’ and ‘Y2’ compete to bind 
to target ‘X.’ When ‘X’ has higher affinity for ‘Y2,’ G-protein signaling is prevented due to the 
inability of Gγcyto to migrate to the plasma membrane. When ‘X’ has higher affinity for ‘Y1,’ G-
protein signaling is transmitted into the yeast cells and invokes the mating process. Thus, affinity-
enhanced  proteins  or  affinity-attenuated  proteins  can  be  screened  in  a  specific  manner.  (B) 
Schematic outline of competitor-introduced Gγ recruitment system for membrane protein targets. 
Target protein ‘X’ is a transmembrane or membrane-associated protein. Protein ‘Y1’ should be 
fused to Gγcyto, whereas ‘Y2’ should be expressed in the cytosol. By establishing ‘Y1’ and ‘Y2’ as 
the parental  (known) proteins originally bound to the membrane target  ‘X’ and the candidate 
variant proteins, respectively, ‘Y1’ and ‘Y2’ compete to bind to target ‘X.’ When ‘X’ has a higher 
affinity for ‘Y2,’ G-protein signaling is prevented due to the inability of Gγcyto to migrate to the 
plasma membrane. When ‘X’ has higher affinity for ‘Y1’ fused to Gγcyto, G-protein signaling is 
transmitted into the yeast cells and initiates the mating process.
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Results 
 
Selection of candidate proteins interacting with membrane protein targets using a 
previously established PPI-detecting Gγ recruitment system 
First, we tested whether the previous Gγ recruitment system could target membrane 
proteins. In the previous system, the Fc protein of human immunoglobulin G (IgG) and the Z 
domain of Staphylococcus aureus protein A (ZWT)103 were used for the PPI models. Several Z 
variants (ZWT, ZK35A, ZI31A and Z955) with varied affinities for the Fc protein were also used for 
the PPI models (ZWT, 5.9×107 M-1; ZK35A, 4.6×106 M-1; ZI31A, 8.0×103 M-1; and Z955, none)102,145. 
In contrast to the previous system, target protein ‘X’ was set to localize to the inner leaflet of 
the plasma membrane (previously, target ‘X’ was fused to Gγcyto in the cytosol), and 
candidate protein ‘Y1’ was fused to Gγcyto (previously, candidate protein ‘Y1’ was artificially 
localized to the inner leaflet of the membrane) (Figs. Ⅱ-1A and Ⅱ-1B). As the fictive model 
of target protein ‘X,’ the Fc fragment was fused to the lipidation motifs in this study (Fig. 
Ⅱ-1B). It was also notable that the lipidation motifs were fused to the Fc fragment at both the 
N-terminus (Gpa1p motif; Gpa1N) and the C-terminus (Ste18p motif; Ste18C) to test the 
accessibility between the Fc fragment and the Z variants (the C-terminal Ste18p motif was 
used to express the Z variants as the candidate ‘Y1’ proteins described in the previous study) 
(Fig. Ⅱ-1B). As the models of ‘Y1’ proteins for the candidate library, the Z variants were 
fused to the C-terminus of Gγcyto to express Gγcyto-Y1 fusion proteins in the cytosol (Fig. 
Ⅱ-1B). 
To express the target membrane proteins, the genes encoding the Fc fragment attached 
to artificial lipidation motifs were stably integrated into the ste18 locus of an a-type haploid 
yeast chromosome, resulting in MC-FC and MC-FN yeast strains (Table Ⅱ-1). For the 
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candidate proteins, autonomous replication plasmids for the expression of the four different Z 
variants (ZWT, ZK35A, ZI31A and Z955) fused to Gγcyto (Gγcyto-Y1) (pGK413-Gγ-EZWT, 
pGK413-Gγ-EZK35A, pGK413-Gγ-EZI31A and pGK413-Gγ-EZ955) (Table Ⅱ-2) were 
introduced into the MC-FC and MC-FN yeast cells (Figs. Ⅱ-3A and Ⅱ-S2A). Flow 
cytometric analysis of the transformants was conducted after incubation in medium 
containing the α-cell-specific mating pheromone (α-factor) (Fig. Ⅱ-S1; left). The engineered 
yeast strains expressing the Gγcyto-ZWT and Gγcyto-ZK35A fusion proteins as candidates slightly 
induced the transcription of GFP reporter genes via interaction with the membrane-associated 
Fc fragment, although the fluorescence levels were extremely low (Figs. Ⅱ-3B and Ⅱ-S2B). 
In mating selection with intact α-type yeast cells (Fig. Ⅱ-S1; right), the strains expressing 
Gγcyto-ZWT and Gγcyto-ZK35A exhibited specific but negligible cell growth on selective medium 
(Figs. Ⅱ-3C and Ⅱ-S2C). In both GFP transcription assays and mating growth selection, 
interactions of Gγcyto-ZI31A (very low affinity for Fc) and Gγcyto-Z955 (negative control) with the 
membrane-associated Fc fragment were not detected. These results showed that the previous 
protocol was not sufficient to screen the interactions between membrane-associated target ‘X’ 
and candidate ‘Y1’-fused Gγcyto proteins. 
 
PPI-detecting Gγ recruitment system for the selection of candidate proteins interacting 
with membrane protein targets 
Next, we tested the new protocol, in which we changed the method used to introduce 
the Gγcyto-Y1 candidate genes. The DNA cassettes for cytosolic expression of the Gγcyto-fused 
candidate Z variants (ZWT, ZK35A, ZI31A and Z955) as a library were stably integrated into the 
MC-FC and MC-FN yeast chromosomes, generating FC(FN)-GW, FC(FN)-GK, FC(FN)-GI 
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and FC(FN)-G9 strains (Table Ⅱ-1) (Figs. Ⅱ-3D and Ⅱ-S2D). The engineered yeast strains 
chromosomally harboring Gγcyto-ZWT and Gγcyto-ZK35A genes showed apparent fluorescence in 
the GFP transcription assays (Figs. Ⅱ-3E and Ⅱ-S2E). Similarly, in the mating selection, the 
same strains grew well on the selective medium (Figs. Ⅱ-3F and Ⅱ-S2F). Compared with the 
Gpa1p-derived N-terminal lipidation motif, the C-terminally attached Ste18p lipidation motif 
was likely slightly favorable for PPI detection due to a reduction in accessibility between the 
membrane-associated Fc fragment and the Gγcyto-fused Z domain (Figs. Ⅱ-3D-F and 
Ⅱ-S2D-F). These results were clearly different from those following expression of 
Gγcyto-fused candidate ‘Y1’ using autonomous replicating plasmids (Figs. Ⅱ-3A-C and 
Ⅱ-S2A-C). 
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Figure Ⅱ-3. Selection of Z variants binding to a membrane-associated target Fc protein 
using previous and new Gγ recruitment systems.
(A)  Previous  Gγ  recruitment  system for  membrane  proteins  as  targets.  (B and C)  Flow 
cytometric analyses and mating growth assay. The fluorescence and growth intensities of the 
engineered strains expressing C-terminally membrane-associated Fc via stable integration 
into  the  yeast  chromosome  as  well  as  cytosolic  Z  variants  fused  to  Gγcyto  ‘Y1’  via 
autonomous replication plasmids. The control yeast shows the strain without the expression 
of ‘Y1’ fused to Gγcyto (transformed with pGK413 mock vector). (D) New Gγ recruitment 
system for membrane proteins as targets. (E and F) Flow cytometric analyses and mating 
growth assay. The fluorescence and growth intensities of the engineered strains expressing C-
terminally  membrane-associated  Fc  and  cytosolic  Z  variants  fused  to  Gγcyto  via  stable 
integration  into  the  yeast  chromosome.  The  control  yeast  shows  the  strain  without  the 
expression of ‘Y1’ fused to Gγcyto (MC-FC in Table 1).   
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Competitive selection of affinity-enhanced protein variants interacting with membrane 
protein targets using a previous protocol 
Previously, we established the competitor-introduced Gγ recruitment system for 
selective screening of protein variants that exceed a specified affinity threshold144 (Fig. 
Ⅱ-2A). In the conventional Gγ recruitment system, additional expression of a cytosolic 
parental (known) protein (Y2) that binds to Gγcyto-fused target protein ‘X’ competes with 
artificially membrane-associated protein variants as a candidate library (Y1), thereby 
permitting the selective screening of affinity-enhanced protein variants (Fig. Ⅱ-2A). 
To test whether the previous competitor-introduced Gγ recruitment system allows for 
the use of membrane proteins as target ‘X’ (Figs. Ⅱ-2B and Ⅱ-S3A), we consistently used 
the membrane-associated Fc fragment and the Gγcyto-fused Z variants as target ‘X’ and 
candidate ‘Y1’ proteins, respectively (Figs. Ⅱ-4A and Ⅱ-S4A). ZI31A (low affinity for Fc; 
8.0×103 M-1) was utilized as the model of the competitive parental ‘Y2’ protein (Figs. Ⅱ-4B 
and Ⅱ-S4B). Therefore, the ZWT and ZK35A candidate proteins (Y1), with higher affinities, 
should have outcompeted the interaction between membrane-associated Fc (X) and cytosolic 
ZI31A (Y2), recovering the signaling in the system (Fig. Ⅱ-S3A). In the previous system, the 
DNA cassette for ZI31A expression as a competitor ‘Y2’ protein in the cytosol was stably 
integrated into the yeast chromosome of MC-FC, in which the C-terminally 
membrane-associated Fc fragment (X) (with the Ste18p lipidation motif) was expressed, 
generating an FC-I strain (Table Ⅱ-1). Autonomous replication plasmids for expression of 
the Gγcyto-fused Z variants as candidate ‘Y1’ (pGK413-Gγ-EZWT, pGK413-Gγ-EZK35A, 
pGK413-Gγ-EZI31A and pGK413-Gγ-EZ955) (Table Ⅱ-2) were then introduced into the 
FC-I strain. However, both flow cytometric analysis and mating selection were barely able to 
detect the interactions between the membrane-associated Fc fragment (target ‘X’) and the 
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Gγcyto-fused Z variants (candidate ‘Y1’) relative to the interactions between the 
membrane-associated Fc fragment and cytosolic ZI31A in all transformants (Fig. Ⅱ-4B). 
Additionally, when using an FN-I strain chromosomally expressing an N-terminally 
membrane-associated Fc fragment (X) (with a Gpa1p lipidation motif) and competitive ZI31A 
protein (Y2) (Table Ⅱ-1), the transformants in which the candidate autonomous plasmids 
were introduced to express the Gγcyto-fused Z variants (Y1) provided similar results to the 
C-terminally membrane-associated Fc fragment (Fig. Ⅱ-S4B). These results showed that the 
previous system was unable to screen the interactions between membrane-associated target 
‘X’ and candidate ‘Y1’-fused Gγcyto proteins relative to the interactions between membrane 
target ‘X’ and the cytosolic ‘Y2’ competitor. 
 
Competitor-introduced Gγ recruitment system that specifically selects 
affinity-enhanced protein variants interacting with membrane protein targets 
Similar to what was described in the previous section, we attempted to change the 
protocol by introducing the expression cassettes for Gγcyto-Y1 candidate genes into the 
competitor-introduced Gγ recruitment system (Figs. Ⅱ-4C and Ⅱ-S4C). As competitive 
parental ‘Y2’ proteins, the genes for expressing the four different Z variants (ZWT, ZK35A, ZI31A 
and Z955) in the cytosol were integrated into the MC-FC yeast chromosome (also expressing 
the C-terminally membrane-associated Fc fragment with the Ste18p lipidation motif as target 
‘X’), generating FC-W, FC-K, FC-I and FC-9. The DNA cassettes for expressing the 
Gγcyto-fused candidate Z variants as model library Y1 proteins were then stably integrated into 
the chromosome of the four yeast strains, generating 16 engineered yeast strains (FC-GWW 
through FC-G99; Table Ⅱ-1) (Fig. Ⅱ-4C).  
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Both flow cytometric analysis and mating selection revealed the interactor 
combinations between membrane-associated Fc and the Gγcyto-fused Z variants serving as 
candidate ‘Y1’ proteins, with higher affinities than when the cytosolic Z variants served as 
competitor ‘Y2’ proteins (e.g., Y1 and Y2: ZWT and ZK35A; ZWT and ZI31A; and ZK35A and ZI31A), 
although the very weak interactions between Fc and Gγcyto-fused ZI31A (Y1 and Y2: ZI31A and 
Z955) could not be detected (Figs. Ⅱ-4D and Ⅱ-4E). These results clearly showed that the 
strains recovered signal transmission only when interactions between the 
membrane-associated Fc fragment (target ‘X’) and the Gγcyto-fused Z variants (candidate 
‘Y1’) overcame the competitive interactions between Fc (target ‘X’) and the cytosolic Z 
variants (competitor ‘Y2’). Additionally, when using a strain chromosomally expressing the 
N-terminally membrane-associated Fc fragment (X) (with the Gpa1p lipidation motif) 
(FN-GWW through FN-G99; Table Ⅱ-1), similar results were obtained (Figs. Ⅱ-S4C-E). 
Thus, Gγcyto-fused ‘Y1’ candidate proteins should be stably integrated into the yeast 
chromosome to specifically select the affinity-enhanced protein variants against 
membrane-associated protein ‘X’ in the competitor-introduced Gγ recruitment system. This 
modification of the method made the competitor-introduced Gγ recruitment system able to 
screen affinity-enhanced protein variants by using membrane proteins as the target proteins. 
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Figure Ⅱ-4.  Competitive selection of Z variants with higher affinities for membrane-
associated target Fc using previous and new methods for affinity-enhanced systems.
(A) Previous affinity-enhanced system for membrane proteins as targets. (B) Flow cytometric 
analyses and mating growth assay. The fluorescence and growth intensities of the engineered 
strains  expressing C-terminally  membrane-associated Fc and competitor  ZI31A  as  cytosolic 
‘Y2’ via stable integration into the yeast chromosome as well as cytosolic Z variants ‘Y1’ fused 
to Gγcyto via autonomous replication plasmids. Control yeast strains lacked the expression of 
‘Y1’ fused to  Gγcyto  (transformed with  pGK413 mock vector).  (C)  New affinity-enhanced 
system for  membrane proteins  as  target.  (D and E) Flow cytometric  analyses and mating 
growth assay. The fluorescence and growth intensities of the engineered strains expressing C-
terminally  membrane-associated  Fc,  competitor  cytosolic  Z  variants  ‘Y2’ and  cytosolic  Z 
variants ‘Y1’ fused to Gγcyto via stable integration into the yeast chromosome. The control 
yeast shows the strain without the expression of ‘Y1’ fused to Gγcyto.   
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Competitive selection of affinity-attenuated protein variants interacting with membrane 
protein targets using a previous protocol 
Previously, we also established a system that permits the selective screening of 
affinity-attenuated protein variants. In the conventional Gγ recruitment system, by setting the 
cytosolic protein (Y2) as the candidate library and the artificially membrane-associated 
protein (Y1) as the parental (known) competitor that binds to Gγcyto-fused target protein ‘X,’ 
the system permits the selective screening of affinity-attenuated protein variants (Fig. Ⅱ-2A). 
To test whether the previous competitor-introduced Gγ recruitment system allows for the use 
of membrane proteins as target ‘X’ (Figs. Ⅱ-2B and Ⅱ-S3B), we consistently used the 
membrane-associated Fc fragment and the cytosolic Z variants as target ‘X’ and candidate 
‘Y2’ proteins, respectively (Figs. Ⅱ-5A and Ⅱ-S5A). ZWT was utilized as the model of the 
competitive parental ‘Y1’ protein. Therefore, Gγcyto-fused ZWT (Y1) should have outcompeted 
the interactions between membrane-associated Fc (X) and the ZK35A, ZI31A and Z955 candidate 
proteins (Y2), which have lower affinities, recovering the signaling in the system.  
In the previous system, autonomous replication plasmids for expression of the Z 
variants in the cytosol as candidate ‘Y2’ proteins (pGK-LsZWTc, pGK-LsZK35Ac, 
pGK-LsZI31Ac and pGK-LsZ955c) (Table Ⅱ-2) were introduced into the FC-GW strain, 
which chromosomally expresses Fc-Ste18C as ‘X’ and Gγcyto-ZWT as competitor ‘Y1’ (Table 
1). Both flow cytometric analysis and mating selection revealed the interactor combinations 
between membrane-associated Fc and the cytosolic Z variants serving as candidate ‘Y2’ 
proteins, whose affinities were lower than that of Gγcyto-fused ZWT as the competitor ‘Y1’ 
protein (Figs. Ⅱ-5B and Ⅱ-5C). Additionally, when using the FN-GW strain chromosomally 
expressing Gpa1N-Fc as ‘X’ and Gγcyto-fused ZWT as competitor ‘Y1’ (Table Ⅱ-1), the 
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transformants in which the candidate autonomous plasmids were introduced to express the Z 
variants in the cytosol (Y2) provided similar results (Fig. Ⅱ-S5B and Ⅱ-S5C). In contrast to 
the affinity-enhanced system, these results showed that the previous competitor-introduced 
Gγ recruitment system was able to screen affinity-attenuated protein variants using 
membrane proteins as the target proteins. 
 
 
 
Figure  Ⅱ-5.  Competitive  selection  of  Z  variants  with  lower  affinities  for 
membrane-associated target Fc using the previous affinity-attenuated system.
(A) Previous affinity-attenuated system for membrane proteins as targets. (B and 
C)  Flow  cytometric  analyses  and  mating  growth  assay.  The  fluorescence  and 
growth intensities of the engineered strains expressing C-terminally membrane-
associated  Fc  and  competitor  ZWT  as  cytosolic  ‘Y1’ fused  to  Gγcyto  via  stable 
integration  into  the  yeast  chromosome  and  cytosolic  Z  variants  ‘Y2’  via 
autonomous replication plasmids. The control yeast shows the strain without the 
expression of ‘Y1’ fused to Gγcyto and cytosolic Z variants ‘Y2.’ 
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Demonstration of applicability of our system using intracellular domain of EGFR and 
Grb2 
To demonstrate the applicability of our system, we selected the intracellular domain of 
EGFR (EGFRcyto), which contains a tyrosine kinase domain and tyrosine phosphorylation 
sites, and the adaptor protein Grb2 protein for the PPI pair146. In normal cells, binding of the 
epidermal growth factor (EGF) to the extracellular domain of EGFR leads to dimerization of 
the receptor and autophosphorylation of the receptor intracellular domain147,148. Grb2 binds to 
the phosphotyrosines of EGFR and links to the activation of subsequent intracellular 
signaling cascades149,150. In yeast, the intracellular domain of EGFR and its mutant derivatives 
have been often used to test the interaction with Grb2 protein151–153. To assay the interaction 
between EGFR and Grb2 in yeast, we used the intracellular domain of EGFR with L834R 
mutation (EGFRL834R,cyto; that is constitutively dimerized and activated even in the absence of 
EGF146,154) as the membrane protein by fusing several types of lipidation motifs at both the 
N-terminus (Gpa1p motif; Gpa1N) and the C-terminus (Ras1p motif; Ras1C and Ste18p 
motif; Ste18C). The Grb2 adaptor was fused to Gγcyto at the N-terminus and the C-terminus to 
test the accessibility between the membrane-associated EGFRL834R,cyto and the cytosolic 
Gγcyto-fused Grb2.  
To express the membrane-associated EGFRL834R,cyto protein, the genes encoding the 
EGFRL834R,cyto attached to the artificial lipidation motifs (Ras1C, Ste18C and Gpa1N) were 
stably integrated into the ste18 locus of an a-type haploid yeast chromosome, resulting in 
MC-ErC, MC-EsC and MC-EgN yeast strains (Table Ⅱ-1). For the candidate proteins, the 
DNA cassettes for cytosolic expression of the Gγcyto-fused Grb2 at the N-terminus and the 
C-terminus (Gγcyto-Grb2 and Grb2-Gγcyto) were stably integrated into the MC-ErC, MC-EsC 
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and MC-EgN yeast chromosomes, generating ErC-Ggrb(grbG), EsC-Ggrb(grbG) and 
EgN-Ggrb(grbG) (Table Ⅱ-1) (Figs. Ⅱ-S6A and Ⅱ-S6D). As a consequence of GFP 
transcription assays and mating selection, the engineered strains co-expressing the 
EGFRL834R,cyto with C-terminal lipidation motifs (Ras1C and Ste18C) and the C-terminally 
Gγcyto-fused Grb2 (Grb2-Gγcyto) specifically showed apparent fluorescence and cell growth on 
the selective medium (Figs. S6A-F). The accessibility between the phosphotyrosines of 
membrane-associated EGFRL834R,cyto and the SH2 domains of Grb2 or the distance of Gβγcyto 
complex from the membrane might have influenced the interactions of these proteins or to 
the subsequent membrane-anchored effector molecule146,149. Compared with the MC-ErC 
strain introducing the Grb2-Gγcyto-expressing autonomous replicating plasmid 
(pGK413-Grb2-Gγ) (Table 2), the ErC-grbG strain that chromosomally expressed 
Grb2-Gγcyto was determinably more suitable for recovering the signaling (Figs. Ⅱ-6A-E). 
To further test whether the competitor-introduced Gγ recruitment system that has 
designed to select the affinity-enhanced protein variants interacting with membrane target 
proteins is applicable to the intracellular domain of EGFR, we consistently used the 
membrane-associated EGFRL834R,cyto and the Gγcyto-fused Grb2 as membrane target ‘X’ and 
candidate ‘Y1’ proteins, respectively (Fig. Ⅱ-6F). Several Grb2 variants (Grb2, Grb2E89K and 
Grb2R86G) with different affinities for the phosphotyrosines of EGFR were utilized for the 
competitive parental ‘Y2’ proteins (Ka; Grb2 > Grb2E89K > Grb2R86G)155. 
Similar to what was described in the previous section, we tested the new protocol by 
chromosomally integrating the expression cassettes for Y1-Gγcyto candidate genes (Fig. Ⅱ-6F). 
As competitive parental ‘Y2’ proteins, the genes for expressing the three different Grb2 
variants (Grb2, Grb2E89K and Grb2R86G) in the cytosol were integrated into the ErC-grbG yeast 
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chromosome (also co-expressing the membrane-associated EGFRL834R,cyto with the Ras1p 
lipidation motif as target ‘X’ and the Grb2-Gγcyto fusion protein as candidate ‘Y1-Gγcyto’), 
generating ErC-grbG-grb, ErC-grbG-E89K and ErC-grbG-R86G (Table Ⅱ-1). 
ErC-grbG-LEU yeast strain never expressing any competitor proteins was also generated as 
positive control (Table Ⅱ-1). 
Both flow cytometric analysis and mating selection displayed the consistent results 
with the Z variants as expected (Figs. Ⅱ-6G and Ⅱ-6H). When using the strains respectively 
expressing Grb2E89K and Grb2R86G as the competitive parental ‘Y2’ proteins (ErC-grbG-E89K 
and ErC-grbG-R86G), the Gγcyto-fused Grb2 expressed as candidate ‘Y1’ (Grb2-Gγcyto) 
predictably recovered the signaling in accordance with the order of difference in the affinity 
strengths between the competitive proteins and the candidate proteins. Similarly, the strain 
co-expressing the same Grb2 protein as the candidate ‘Y1’ and the parental ‘Y2’ proteins 
(ErC-grbG-grb) barely showed GFP fluorescence and cell growth on the selective medium. 
Thus, we demonstrated that our systems were applicable to the membrane protein, which 
linked to the cellular states involved in various diseases. 
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Figure Ⅱ-6. Competitive selection of Grb2 for membrane-associated intracellular domain of EGFR. 
(A) Previous Gγ  recruitment system for intracellular domain of EGFR as the membrane target.  (B) Flow 
cytometric analyses and mating growth assay. The fluorescence and growth intensities of the engineered strains 
expressing C-terminally membrane-associated intracellular domain of EGFR L834R mutant (EGFRL834R,cyto) via stable integration into the yeast chromosome as well as cytosolic Grb2 fused to Gγcyto ‘Y1’ (Grb2-Gγcyto) via autonomous replication plasmids. The control yeast shows the strain without the expression of Grb2-Gγcyto (transformed with pGK413 mock vector). (C) New Gγ recruitment system for intracellular domain of EGFR as 
the membrane target. (D and E) Flow cytometric analyses and mating growth assay. The fluorescence and 
growth intensities of the engineered strains expressing C-terminally membrane-associated EGFRL834R,cyto and cytosolic Grb2-Gγcyto via stable integration into the yeast chromosome. The control yeast shows the strain without the expression of Grb2-Gγcyto (MC-ErC in Table 1). (F) New affinity-enhanced system for intracellular domain of EGFR as the membrane target. (G and H) Flow cytometric analyses and mating growth assay. The 
fluorescence and growth intensities of the engineered strains expressing C-terminally membrane-associated 
EGFRL834R,cyto,  competitor cytosolic Grb2 variants ‘Y2’ (Grb2, Grb2E89K and Grb2R86G) and cytosolic Grb2 ‘Y1’ fused to Gγcyto (Grb2-Gγcyto) via stable integration into the yeast chromosome. The control yeast shows the strain without the expression of any competitive ‘Y2’ proteins (ErC-grbG-LEU in Table 1). The negative control yeast shows the strain without the expression of ‘Y1’ fused to Gγcyto.   
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Discussion 
 
In this study, we found that the previously established Gγ recruitment systems48,144 were 
basically unable to utilize membrane proteins as target protein ‘X.’ The new systems 
described here successfully enable the use of membrane proteins as target ‘X,’ both in the 
conventional (for screening of PPI candidate ‘Y1’ proteins) and competitor-introduced (for 
screening of affinity-enhanced candidate ‘Y1’ protein variants) Gγ recruitment systems. In 
the new systems, only the protocol for expression of Gγcyto-fused candidate ‘Y1’ proteins was 
changed: instead of autonomous replicating plasmids, chromosomal integration was 
employed. These new systems are therefore very simple but highly useful. The results of the 
intracellular domain of EGFR and Grb2 interaction showed that our Gγ recruitment systems 
could be exploited as a convenient heterologous system to discern the strong binders to the 
phosphotyrosines in the intracellular domain of EGFR, and therefore would provide the basis 
for studying other receptor tyrosine kinases as well. In this manner, the screening of binding 
partners and affinity-enhanced variants targeted to the inner domains of these membrane 
proteins has great potential for applications in the treatment of human diseases. 
Previously, we demonstrated that Gγ recruitment systems enabled extremely reliable 
screening that could completely exclude false-positive candidates48,144. Generally, membrane 
yeast two-hybrid systems38,45,46,137 and protein fragment complementation assays131,141 
sometimes exhibit background readouts131,156 due to the use of directly fused artificial 
transcription factors and automatic self-associations of the split proteins. These background 
readouts are a critical problem, even when they are negligible, especially in the case of 
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growth screening using a large-scale library131. The exclusive selection in Gγ recruitment 
systems is made possible by using the signal transduction machinery, which requires the 
localization of Gβ/Gγ in GFP transcription assays and mating selection (Figs. Ⅱ-3, Ⅱ-4 and 
Ⅱ-5). This extremely disciplined selection machinery makes Gγ recruitment systems worth 
using. 
In the Gγ recruitment system that has designed for membrane proteins as the target, ZI31A with 
extremely low affinity could not be detected in both cases of the flow cytometric analysis and 
the mating selection (Fig. Ⅱ-3). Due to the very low affinity between ZI31A and the Fc region 
(8.0×103 M-1), the migration of Gγcyto to the membrane was likely insufficient for the 
recovering of the signal transduction. This affinity (8.0×103 M-1) seems to be less than a 
lower limit of our present system, although it is unlikely that a protein mutant exhibiting such 
extremely low affinity would be required.  
From the perspective of screening for a target membrane protein ‘X,’ the new methods 
that chromosomally integrate the DNA cassettes expressing Gγcyto-fused candidate ‘Y1’ 
proteins might have a handicap in constructing a library. Specifically, the transformation 
efficiencies of homologous integrations into the yeast chromosome are commonly 101-102 
fold lower than those of autonomous replicating plasmids (approximately 105-106 
cfu/µg)157–159. Therefore, constructing a large-scale library might require a little ingenuity to 
increase the transformation efficiencies, such as via the use of large amounts of DNA, the 
electroporation method158,160, the spheroplasting method161, and use of I-SceI meganuclease162. 
Even allowing for this additional effort, however, the conventional Gγ recruitment system is 
a powerful tool because of its extremely reliable selection of binding partners. In addition, the 
competitor-introduced Gγ recruitment system, which allows for the specific screening of 
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affinity-enhanced protein variants (specifically excluding protein variants showing equal or 
lower affinities144), is valuable as a unique and irreplaceable growth selection technique. 
A similar approach for screening for affinity-attenuated protein variants among 
membrane proteins serving as target ‘X’ made it possible to apply the previous method using 
autonomous replicating plasmids to express the candidate ‘Y2’ in the cytosol (Fig. Ⅱ-5). We 
believe that the unstable expression of ‘Y1’-fused Gγcyto using autonomous replicating 
plasmids rendered the Gγ recruitment system useless. Because it has been reported that 
plasmid retentions become unstable during signal-promoted states163, ‘Y1’-fused Gγcyto might 
be more affected by this unstable plasmid retention than cytosolic ‘Y2’ is. In any event, the 
chromosomal expression of ‘Y1’-fused Gγcyto is favorable in our Gγ recruitment systems.  
In summary, new Gγ recruitment systems make it possible for membrane proteins to be 
target protein ‘X.’ These systems permit reliable and specific screens for binding partners and 
affinity-enhanced protein variants. We envision that our selection method will provide a 
powerful, broadly applicable tool for studying biological processes, creating new 
opportunities to develop new drugs targeting a wide range of membrane-associated proteins 
and inner domains of transmembrane proteins. 
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Methods 
 
Strains and media  
The genotypes of Saccharomyces cerevisiae BY474199, MC-F1100, and BY474299 and 
the other recombinant strains used in this study are provided in Table 1. The yeast strains 
were grown in YPD medium containing 1% (w/v) yeast extract, 2% peptone and 2% glucose 
or in SD medium containing 0.67% yeast nitrogen base without amino acids (BD Diagnostic 
Systems, Sparks, MD, USA) and 2% glucose. The SD medium was supplemented with amino 
acids and nucleotides (20 mg/L histidine, 60 mg/L leucine, 20 mg/L methionine, or 20 mg/L 
uracil), as required by the auxotrophic strains. Agar (2%; w/v) was added to the medium to 
produce YPD and SD solid media. 
 
Construction of plasmids 
All plasmids and primers used in this study are listed in Table Ⅱ-2 and Table Ⅱ-S1. 
Plasmids inserting lipidation motifs were constructed as follows. The fragments of the PGK1 
promoter (PPGK1) fused to the lipidation motif of Gpa1p (9 a.a. of N-terminus) and the 
multi-cloning site were amplified from pGK425110 using primer 1, primer 2 and primer 3 and 
inserted into the XhoI-BglII sites of the autonomous replication plasmid pGK425110, yielding 
plasmid pGK425-Gpa1N. The fragments of the PGK1 promoter fused to the lipidation motif 
of Ste18p (9 a.a. of C-terminus) and the multi-cloning site were amplified from pGK425110 
using primer 1, primer 4 and primer 5 and inserted into the XhoI-BglII sites of the 
autonomous replication plasmid pGK425110, yielding plasmid pGK425-Ste18C. The 
fragments of the PGK1 promoter fused to the lipidation motif of Ras1p (10 a.a. of 
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C-terminus) and the multi-cloning site were amplified from pGK425110 using primer 1, 
primer 6 and primer 7 and inserted into the XhoI-BglII sites of the autonomous replication 
plasmid pGK425110, yielding plasmid pGK425-Ras1C. 
The plasmids used for the expression of the Fc fragment on the membrane were 
constructed as follows. The fragments encoding the Fc protein were amplified from 
pUMGP-GγMFcH48 using primers 8 and 9 or primers 10 and 11 and inserted into the 
SalI-BamHI sites of the autonomous replication plasmid pGK425-Gpa1N or pGK425-Ste18C, 
yielding pGK425-Gpa1N-Fc and pGK425-Fc-Ste18C, respectively. The cassettes for 
expression of the membrane-associated Fc protein for integration at the ste18 locus on the 
yeast chromosome were then amplified from pGK425-Gpa1N-Fc or pGK425-Fc-Ste18C 
using primer 12 and primer 13 and inserted into the XhoI sites of pGK426-GPTK48 using an 
In-Fusion HD Cloning Kit (Clontech Laboratories–Takara Bio, Shiga, Japan), yielding 
pUMGPTK-Gpa1N-Fc and pUMGPTK-Fc-Ste18C, respectively.  
The plasmids used for the expression of the Gγcyto-Z domain variants in the cytosol 
were constructed as follows. The fragment encoding Gγ lacking the lipidation sites (Gγcyto) 
was amplified from pUMGP-GγMFcH48 using primer 14 and primer 15. The fragments 
encoding the Z variants (ZWT, ZK35A, ZI31A and Z955) were amplified from pGK-LsZWTc, 
pGK-LsZK35Ac, pGK-LsZI31Ac and pGK-LsZ955c144 using primer 16 and primer 17. The 
fusion fragments encoding the Gγcyto-Z domain were then amplified from these two fragments 
by overlap PCR using primer 14 and primer 17 and inserted into the SalI-EcoRI sites of the 
autonomous replication plasmid pGK413110, yielding plasmids pGK413-Gγ-EZWT, 
pGK413-Gγ-EZK35A, pGK413-Gγ-EZI31A and pGK413-Gγ-EZ955, respectively. 
Subsequently, the cassettes for expression of the Gγcyto-Z variants for integration at the his3 
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locus on the yeast chromosome were constructed as follows. The fragment containing the 
STE18 promoter (PSTE18) and the gene encoding Gγcyto were amplified from 
pUMGP-GγMFcH48 using primer 18 and primer 19 and inserted into the XhoI-NheI sites of 
pGK426110, yielding plasmid pUSTE18p-Gγcyto. The fragment encoding HIS3 terminator 
(THIS3) was amplified from the BY4741 genome using primer 20 and primer 21 and inserted 
into the NotI-SacI sites of pUSTE18p-Gγcyto, yielding plasmid pUSTE18p-Gγcyto-HIS3t. 
Finally, the fragments encoding the Z variants were amplified from pGK-LsZWTc, 
pGK-LsZK35Ac, pGK-LsZI31Ac and pGK-LsZ955c144 using primer 22 and primer 23 and 
inserted into the SalI-BamHI sites of pUSTE18p-Gγcyto-HIS3t, yielding plasmids 
pUSTE18p-Gγcyto-ZWT-HIS3t, pUSTE18p-Gγcyto-ZK35A-HIS3t, 
pUSTE18p-Gγcyto-ZI31A-HIS3t and pUSTE18p-Gγcyto-Z955-HIS3t, respectively. 
The cassettes for expression of the cytosolic Z variants as competitors for integration 
upstream of the HOP2 gene locus (PHOP2: HOP2 promoter region) on the yeast chromosome 
were constructed as follows. The fragments encoding PHOP2 were amplified using primer 24 
and primer 25 and inserted into the NotI-SacI sites of pGK-LsZWTc, pGK-LsZK35Ac, 
pGK-LsZI31Ac and pGK-LsZ955c144, yielding plasmids pGK-LsZWTc-HOP, 
pGK-LsZK35Ac-HOP, pGK-LsZI31Ac-HOP and pGK-LsZ955c-HOP, respectively.  
The plasmids used for the expression of the intracellular domain of EGFR L834R 
mutant (EGFRL834R,cyto) on the membrane were constructed as follows. The fragments 
encoding the intracellular domain of EGFRL834R,cyto mutant were amplified from the B1U-GL 
146 genome using primers 26 and 27 or primers 28 and 29 and inserted into the SalI-MluI sites 
of pGK425-Gpa1N, pGK425-Ste18C and pGK425-Ras1C, yielding 
pGK425-Gpa1N-EGFR(LR), pGK425-EGFR(LR)-Ste18C and pGK425-EGFR(LR)-Ras1C, 
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respectively. The cassettes for expression of the membrane-associated EGFRL834R,cyto for 
integration at the ste18 locus on the yeast chromosome were then amplified from 
pGK425-Gpa1N-EGFR(LR), pGK425-EGFR(LR)-Ste18C and pGK425-EGFR(LR)-Ras1C 
using primer 12 and primer 13 and inserted into the XhoI sites of pGK426-GPTK48 using an 
In-Fusion HD Cloning Kit, yielding pUMGPTK-Gpa1N-EGFR(LR), 
pUMGPTK-EGFR(LR)-Ste18C and pUMGPTK-EGFR(LR)-Ras1C, respectively. 
The plasmids used for the expression of the Grb2-Gγcyto in the cytosol were constructed 
as follows. The fragment encoding the Grb2-Gγcyto was amplified from B1U-GL146 using 
primer 30 and primer 31 and inserted into the SalI-EcoRI sites of the autonomous replication 
plasmid pGK413110 using an In-Fusion HD Cloning Kit, yielding plasmid pGK413-Grb2-Gγ. 
Subsequently, the cassettes for expression of the Grb2-Gγcyto for integration at the his3 locus 
on the yeast chromosome were constructed as follows. The fragment containing the STE18 
promoter (PSTE18) was amplified from pUMGP-GγMFcH48 using primer 32 and primer 33 and 
inserted into the XhoI-NheI sites of pGK416110, yielding plasmid Ste18p-416. The fragment 
containing the gene encoding Gγcyto were amplified from pUMGP-GγMFcH48 using primer 
34 and primer 35 and inserted into the XbaI-EcoRI sites of Ste18p-416, yielding plasmid 
pUSTE18p-c-Gγcyto. The fragment encoding HIS3 terminator (THIS3) was amplified from the 
BY4741 genome using primer 20 and primer 21 and inserted into the NotI-SacI sites of 
pUSTE18p-c-Gγcyto, yielding plasmid pUSTE18p-c-Gγcyto-HIS3t. Finally, the fragment 
encoding Grb2 was amplified from pGK413-Grb2-Gγ using primer 36 and primer 37 and 
inserted into the NheI-XmaI sites of pUSTE18p-c-Gγcyto-HIS3t, yielding plasmid 
pUSTE18p-Grb2-Gγcyto-HIS3t. 
The plasmids used for the expression cassettes of the Gγcyto-Grb2 for integration at the 
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his3 locus on the yeast chromosome were constructed as follows. The fragment encoding 
Grb2 was amplified from pGK413-Grb2-Gγ using primer 38 and primer 39 and inserted into 
the NheI-XmaI sites of pUSTE18p-Gγcyto-HIS3t, yielding plasmid 
pUSTE18p-Gγcyto-Grb2-HIS3t. 
The cassettes for expression of the cytosolic Grb2 variants as competitors for 
integration at the upstream of the HOP2 gene locus (PHOP2: HOP2 promoter region) on the 
yeast chromosome were constructed as follows. The fragments encoding PHOP2 were 
amplified using primer 24 and primer 25 and inserted into the NotI-SacI sites of pGK415110, 
yielding plasmid pGK415-HOP2p. The fragment encoding Grb2 was amplified from 
pGK413-Grb2-Gγ using primers 38 and 39 and inserted into the SalI-XmaI sites of 
pGK415-HOP2p using an In-Fusion HD Cloning Kit, yielding plasmid 
pGK415-Grb2-HOP2p. The fragment encoding Grb2R86G mutant was amplified from 
pGK413-Grb2-Gγ using primers 40 and 42, primers 41 and 43 and the fragments encoding 
the Grb2R86G mutant was amplified from these two fragments by overlap PCR using primer 40 
and primer 41, and inserted into the SalI-XmaI sites of pGK415-HOP2p using an In-Fusion 
HD Cloning Kit, yielding plasmid pGK415-Grb2R86G-HOP2p. The fragment encoding 
Grb2E89K mutant was amplified from pGK413-Grb2-Gγ using primers 40 and 44, primers 41 
and 45 and the fragments encoding the Grb2E89K mutant was amplified from these two 
fragments by overlap PCR using primer 40 and primer 41, and inserted into the SalI-XmaI 
sites of pGK415-HOP2p using an In-Fusion HD Cloning Kit, yielding plasmid 
pGK415-Grb2E89K-HOP2p. 
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Construction of yeast strains 
All strains used in this study are listed in Table Ⅱ-1. Integration of the DNA cassettes for 
expressing the membrane-associated Fc protein was achieved as follows. The DNA 
fragments containing PSTE18-PPGK1-Fc-Ste18C-TPGK1-kanMX4-TSTE18 and 
PSTE18-PPGK1-Gpa1N-Fc-TPGK1-kanMX4-TSTE18 were amplified from pUMGPTK-Fc-Ste18C and 
pUMGPTK-Gpa1N-Fc using primer 46 and primer 47. The amplified DNA fragments were 
then used to transform MC-F1100 using the lithium acetate method111. The transformants were 
selected on a YPD+G418 plate to yield MC-FC and MC-FN (Table Ⅱ-1). 
Integration of the DNA cassettes for the Gγcyto-Z domain variants (ZWT, ZK35A, ZI31A and 
Z955) in the cytosol was achieved as follows. The DNA fragments containing 
URA3-PPGK1-Gγcyto-ZWT(-ZK35A, -ZI31A and -Z955)-TPGK1-THIS3 were amplified from 
pUSTE18p-Gγcyto-ZWT(-ZK35A, -ZI31A and -Z955)-HIS3t using primer 48 (containing 
the homologous regions of the HIS3 promoter) and primer 49. The amplified DNA fragments 
were used to transform MC-FC and MC-FN using the lithium acetate method111. The 
transformants were then selected on an SD-Ura plate (containing leucine, histidine and 
methionine) to yield FC-GW, FC-GK, FC-GI, and FC-G9 and FN-GW, FN-GK, FN-GI and 
FN-G9 (Table Ⅱ-1).  
Integration of the DNA cassettes for expressing the Z variants (ZWT, ZK35A, ZI31A and 
Z955) as competitors in the cytosol was achieved as follows. The DNA fragments containing 
LEU2-PPGK1-ZWT(-ZK35A, -ZI31A and -Z955)-TPGK1-PHOP2 were amplified from 
pGK-LsZWTc(-LsZK35Ac, -LsZI31Ac and -LsZ955c)-HOP using primer 50 (containing the 
homologous regions of PHOP2 upstream) and primer 51. The amplified DNA fragments were 
used to transform FC-GW, FC-GK, FC-GI, and FC-G9 and FN-GW, FN-GK, FN-GI and 
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FN-G9. The transformants were then selected on an SD-Leu/-Ura plate (containing histidine 
and methionine) to yield FC-GWW, FC-GWK, FC-GWI, and FC-GW9; FC-GKW, FC-GKK, 
FC-GKI, and FC-GK9; FC-GIW, FC-GIK, FC-GII, and FC-GI9; and FC-G9W, FC-G9K, 
FC-G9I, and FC-G99 as well as FN-GWW, FN-GWK, FN-GWI, and FN-GW9; FN-GKW, 
FN-GKK, FN-GKI, and FN-GK9; FN-GIW, FN-GIK, FN-GII, and FN-GI9; and FN-G9W, 
FN-G9K, FN-G9I, and FN-G99 (Table Ⅱ-1). 
Integration of the DNA cassettes for expressing the membrane-associated intracellular 
domain of EGFR L834R mutant (EGFRL834R,cyto) was achieved as follows. The DNA 
fragments containing PSTE18-PPGK1-EGFRL834R,cyto-Ras1C-TPGK1-kanMX4-TSTE18, 
PSTE18-PPGK1-EGFRL834R,cyto-Ste18C-TPGK1-kanMX4-TSTE18 and 
PSTE18-PPGK1-Gpa1N-EGFRL834R,cyto-TPGK1-kanMX4-TSTE18 were amplified from 
pUMGPTK-EGFR(LR)-Ras1C, pUMGPTK-EGFR(LR)-Ste18C and 
pUMGPTK-Gpa1N-EGFR(LR) using primer 46 and primer 47. The amplified DNA 
fragments were then used to transform MC-F1100 using the lithium acetate method111. The 
transformants were selected on a YPD+G418 plate to yield MC-ErC, MC-EsC and MC-EgN 
(Table Ⅱ-1). 
Integration of the DNA cassettes for the Grb2-Gγcyto in the cytosol was achieved as 
follows. The DNA fragments containing URA3-PPGK1-Grb2-Gγcyto-TPGK1-THIS3 was amplified 
from pUSTE18p-Grb2-Gγcyto-HIS3t using primer 48 (containing the homologous regions of 
the HIS3 promoter) and primer 49. The amplified DNA fragments were used to transform 
MC-ErC, MC-EsC and MC-EgN using the lithium acetate method111. The transformants were 
the selected on an SD-Ura plate to yield ErC-grbG, EsC-grbG and EgC-grbG (Table Ⅱ-1). 
Integration of the DNA cassettes for the Gγcyto-Grb2 in the cytosol was achieved as follows. 
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The DNA fragments containing URA3-PPGK1-Gγcyto-Grb2-TPGK1-THIS3 was amplified from 
pUSTE18p-Gγcyto-Grb2-HIS3t using primer 48 (containing the homologous regions of the 
HIS3 promoter) and primer 49. The amplified DNA fragments were used to transform 
MC-ErC, MC-EsC and MC-EgN using the lithium acetate method 111. The transformants 
were then selected on an SD-Ura plate to yield ErC-Ggrb, EsC-Ggrb and EgC-Ggrb (Table 
Ⅱ-1).  
Integration of the DNA cassettes for expressing Grb2 variants (Grb2, Grb2E89K and 
Grb2R86G) and positive control (no competitor expression) as the competitor in the cytosol was 
achieved as follows. The DNA fragments containing LEU2-PPGK1-Grb2(-Grb2E89K and 
-Grb2R86G)-TPGK1-PHOP2 and LEU2-PPGK1-TPGK1-PHOP2 were amplified from 
pGK-LsGrb2(-LsGrb2(R89K) and -LsGrb2(R86G))-HOP and pGK415-HOP2p using primer 
50 (containing the homologous regions of PHOP2 upstream) and primer 51. The amplified 
DNA fragments were used to transform ErC-grbG. The transformants were then selected on 
an SD-Leu/-Ura plate to yield ErC-grbG-grb, ErC-grbG-E89K, ErC-grbG-R86G and 
ErC-grbG-LEU (Table Ⅱ-1). 
All transformants were obtained by introducing the autonomous replicating plasmids 
(Table Ⅱ-2) into these yeast strains using the lithium acetate method111. 
 
GFP reporter expression analysis 
GFP reporter expression analysis basically followed previous methods144, with certain 
modifications. In the case of the previous method, the engineered yeast a-cells were grown in 
5 mL of SD-His medium (for the PPI detection system), SD-His/-Leu medium (for the 
affinity-enhanced system) or SD-Leu/-Ura medium (for the affinity-attenuated system) at 
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30°C overnight. The cultured cells were then inoculated in 2 mL of fresh SD-His, 
SD-His/-Leu or SD-Leu/-Ura medium containing 5 μM α-factor (Zymo Research, Orange, 
CA, USA) to obtain an initial OD600 of 0.1 (OD600 = 0.1). In the case of the new method, the 
engineered yeast a-cells were grown in 5 mL of YPD medium (for the PPI detection system 
and affinity-enhanced system) at 30°C overnight. The cultured cells were then inoculated in 2 
mL of fresh YPD medium containing 5 μM α-factor (Zymo Research, Orange, CA, USA) to 
obtain an initial OD600 of 0.1 (OD600 = 0.1). The expression of the FIG1-EGFP fusion 
reporter gene was then stimulated by growth at 30°C for 6 hours. 
The fluorescence intensities of the cultured cells were measured using a BD 
FACSCanto II flow cytometer equipped with a 488-nm blue laser (BD Biosciences, San Jose, 
CA, USA)112. The GFP fluorescence signal was specifically collected through a 530/30-nm 
band-pass filter. The mean fluorescence intensity was defined as the GFP-A mean of 10,000 
cells. The data were analyzed using BD FACSDiva software (version 5.0, BD Biosciences).  
 
Mating growth spotting assay 
The mating growth spotting assay basically followed a previous method 144, with certain 
modifications. For the previous method, each engineered yeast a-cell was grown in 5 mL of 
SD-His media (for PPI detection system), SD-His/-Leu medium (for the affinity-enhanced 
system) or SD-Leu/-Ura medium (for the affinity-attenuated system) at 30°C overnight and 
then cultivated in 5 mL of YPD medium with the mating partner, or the BY4742 α-cell99, at 
30°C for 3 hours. The initial OD600 of each haploid cell was set at 0.1 (OD600 = 0.1). For the 
new method, each engineered yeast a-cell was grown in 5 mL of YPD medium (for the PPI 
detection system and the affinity-enhanced system) at 30°C overnight and then cultivated in 5 
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mL of YPD medium with the mating partner, or the BY4742 α-cell99, at 30°C for 3 hours. 
The initial OD600 of each haploid cell was again set at 0.1 (OD600 = 0.1). After cultivation, the 
yeast cells were harvested, washed, and resuspended in distilled water. To quantify the 
mating ability of each strain, a dilution series of each yeast cell suspension was prepared 
(OD600 = 1.0, 0.1, 0.01, 0.001 and 0.0001), and 40 μL of each dilution was then spotted on a 
selective SD-Ura/Leu plate (lacking methionine, lysine and histidine; for the PPI detection 
system generated by the previous method), SD-Ura plate (lacking methionine, lysine, 
histidine and leucine; for the affinity-enhanced system generated by the previous method), 
SD-His plate (lacking methionine, lysine, leucine and uracil; for the affinity-attenuated 
system generated by the previous method), SD-His/Leu plate (lacking methionine, lysine and 
uracil; for the PPI detection system generated by the new method) or SD-His plate (lacking 
methionine, lysine, uracil and leucine; for the affinity-enhanced system generated by the new 
method). 
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Table Ⅱ-1. Yeast strains used in this study. 
 
Strain Relevant feature Source 
BY4741 MATa his3∆1 ura3∆0 leu2∆0 met15∆ [99] 
BY4742 MATα his3∆1 ura3∆0 leu2∆0 lys2∆0 [99] 
MC-F1 BY4741 fig1::FIG1-EGFP [100] 
MC-FC MC-F1 ste18∆::kanMX4-PPGK1-Fc-Ste18C This study 
MC-FN MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-Fc This study 
FC-GW MC-F1 ste18∆::kanMX4-PPGK1-Fc-Ste18C his3∆::URA3-PSTE18-Gγcyto-ZWT This study 
FC-GK MC-F1 ste18∆::kanMX4-PPGK1-Fc-Ste18C his3∆::URA3-PSTE18-Gγcyto-ZK35A This study 
FC-GI MC-F1 ste18∆::kanMX4-PPGK1-Fc-Ste18C his3∆::URA3-PSTE18-Gγcyto-ZI31A This study 
FC-G9 MC-F1 ste18∆::kanMX4-PPGK1-Fc-Ste18C his3∆::URA3-PSTE18-Gγcyto-Z955 This study 
FN-GW MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-Fc his3∆::URA3-PSTE18-Gγcyto-ZWT This study 
FN-GK MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-Fc his3∆::URA3-PSTE18-Gγcyto-ZK35A This study 
FN-GI MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-Fc his3∆::URA3-PSTE18-Gγcyto-ZI31A This study 
FN-G9 MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-Fc his3∆::URA3-PSTE18-Gγcyto-Z955 This study 
FC-W MC-F1 ste18∆::kanMX4-PPGK1-Fc-Ste18C  PHOP2::LEU2-PPGK-ZWT-PHOP2 This study 
FC-K MC-F1 ste18∆::kanMX4-PPGK1-Fc-Ste18C   PHOP2::LEU2-PPGK-ZK35A-PHOP2 This study 
FC-I MC-F1 ste18∆::kanMX4-PPGK1-Fc-Ste18C   PHOP2::LEU2-PPGK-ZI31A-PHOP2 This study 
FC-9 MC-F1 ste18∆::kanMX4-PPGK1-Fc-Ste18C  PHOP2::LEU2-PPGK-Z95-PHOP2 This study 
FN-W MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-Fc    PHOP2::LEU2-PPGK-ZWT-PHOP2 This study 
FN-K MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-Fc   PHOP2::LEU2-PPGK-ZK35A -PHOP2 This study 
FN-I MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-Fc PHOP2::LEU2-PPGK-ZI31A,cyto-PHOP2 This study 
FN-9 MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-Fc PHOP2::LEU2-PPGK-Z955,cyto-PHOP2 This study 
FC-GWW MC-F1 ste18∆::kanMX4-PPGK1-Fc-Ste18C his3∆::URA3-PSTE18-Gγcyto-ZWT   
PHOP2::LEU2-PPGK-ZWT-PHOP2 
This study 
FC-GWK MC-F1 ste18∆::kanMX4-PPGK1-Fc-Ste18C  his3∆::URA3-PSTE18-Gγcyto-ZWT   
PHOP2::LEU2-PPGK-ZK35A -PHOP2 
This study 
FC-GWI MC-F1 ste18∆::kanMX4-PPGK1-Fc-Ste18C  his3∆::URA3-PSTE18-Gγcyto-ZWT   
PHOP2::LEU2-PPGK-ZI31A-PHOP2 
This study 
FC-GW9 MC-F1 ste18∆::kanMX4-PPGK1-Fc-Ste18C his3∆::URA3-PSTE18-Gγcyto-ZWT   
PHOP2::LEU2-PPGK-Z955-PHOP2 
This study 
FC-GKW MC-F1 ste18∆::kanMX4-PPGK1-Fc-Ste18C his3∆::URA3-PSTE18-Gγcyto-ZK35A   
PHOP2::LEU2-PPGK-ZWT-PHOP2 
This study 
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FC-GKK MC-F1 ste18∆::kanMX4-PPGK1-Fc-Ste18C  his3∆::URA3-PSTE18-Gγcyto-ZK35A   
PHOP2::LEU2-PPGK-ZK35A -PHOP2 
This study 
FC-GKI MC-F1 ste18∆::kanMX4-PPGK1-Fc-Ste18C his3∆::URA3-PSTE18-Gγcyto-ZK35A   
PHOP2::LEU2-PPGK-ZI31A-PHOP2 
This study 
FC-GK9 MC-F1 ste18∆::kanMX4-PPGK1-Fc-Ste18C his3∆::URA3-PSTE18-Gγcyto-ZK35A   
PHOP2::LEU2-PPGK-Z955-PHOP2 
This study 
FC-GIW MC-F1 ste18∆::kanMX4-PPGK1-Fc-Ste18C his3∆::URA3-PSTE18-Gγcyto-ZI31A   
PHOP2::LEU2-PPGK-ZWT-PHOP2 
This study 
FC-GIK MC-F1 ste18∆::kanMX4-PPGK1-Fc-Ste18C his3∆::URA3-PSTE18-Gγcyto-ZI31A   
PHOP2::LEU2-PPGK-ZK35A -PHOP2 
This study 
FC-GII MC-F1 ste18∆::kanMX4-PPGK1-Fc-Ste18C  his3∆::URA3-PSTE18-Gγcyto-ZI31A   
PHOP2::LEU2-PPGK-ZI31A-PHOP2 
This study 
FC-GI9 MC-F1 ste18∆::kanMX4-PPGK1-Fc-Ste18C his3∆::URA3-PSTE18-Gγcyto-ZI31A   
PHOP2::LEU2-PPGK-Z955-PHOP2 
This study 
FC-G9W MC-F1 ste18∆::kanMX4-PPGK1-Fc-Ste18C his3∆::URA3-PSTE18-Gγcyto-Z955   
PHOP2::LEU2-PPGK-ZWT-PHOP2 
This study 
FC-G9K MC-F1 ste18∆::kanMX4-PPGK1-Fc-Ste18C his3∆::URA3-PSTE18-Gγcyto-Z955   
PHOP2::LEU2-PPGK-ZK35A -PHOP2 
This study 
FC-G9I MC-F1 ste18∆::kanMX4-PPGK1-Fc-Ste18C his3∆::URA3-PSTE18-Gγcyto-Z955   
PHOP2::LEU2-PPGK-ZI31A-PHOP2 
This study 
FC-G99 MC-F1 ste18∆::kanMX4-PPGK1-Fc-Ste18C his3∆::URA3-PSTE18-Gγcyto-Z955   
PHOP2::LEU2-PPGK-Z955-PHOP2 
This study 
FN-GWW MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-Fc his3∆::URA3-PSTE18-Gγcyto-ZWT   
PHOP2::LEU2-PPGK-ZWT-PHOP2 
This study 
FN-GWK MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-Fc his3∆::URA3-PSTE18-Gγcyto-ZWT  
PHOP2::LEU2-PPGK-ZK35A -PHOP2 
This study 
FN-GWI MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-Fc his3∆::URA3-PSTE18-Gγcyto-ZWT   
PHOP2::LEU2-PPGK-ZI31A-PHOP2 
This study 
FN-GW9 MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-Fc his3∆::URA3-PSTE18-Gγcyto-ZWT   
PHOP2::LEU2-PPGK-Z955-PHOP2 
This study 
FN-GKW MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-Fc his3∆::URA3-PSTE18-Gγcyto-ZK35A   
PHOP2::LEU2-PPGK-ZWT-PHOP2 
This study 
FN-GKK MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-Fc his3∆::URA3-PSTE18-Gγcyto-ZK35A   
PHOP2::LEU2-PPGK-ZK35A -PHOP2 
This study 
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FN-GKI MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-Fc his3∆::URA3-PSTE18-Gγcyto-ZK35A   
PHOP2::LEU2-PPGK-ZI31A-PHOP2 
This study 
FN-GK9 MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-Fc his3∆::URA3-PSTE18-Gγcyto-ZK35A   
PHOP2::LEU2-PPGK-Z955-PHOP2 
This study 
FN-GIW MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-Fc his3∆::URA3-PSTE18-Gγcyto-ZI31A   
PHOP2::LEU2-PPGK-ZWT-PHOP2 
This study 
FN-GIK MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-Fc his3∆::URA3-PSTE18-Gγcyto-ZI31A   
PHOP2::LEU2-PPGK-ZK35A -PHOP2 
This study 
FN-GII MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-Fc his3∆::URA3-PSTE18-Gγcyto-ZI31A   
PHOP2::LEU2-PPGK-ZI31A-PHOP2 
This study 
FN-GI9 MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-Fc his3∆::URA3-PSTE18-Gγcyto-ZI31A   
PHOP2::LEU2-PPGK-Z955-PHOP2 
This study 
FN-G9W MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-Fc his3∆::URA3-PSTE18-Gγcyto-Z955   
PHOP2::LEU2-PPGK-ZWT-PHOP2 
This study 
FN-G9K MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-Fc his3∆::URA3-PSTE18-Gγcyto-Z955   
PHOP2::LEU2-PPGK-ZK35A -PHOP2 
This study 
FN-G9I MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-Fc his3∆::URA3-PSTE18-Gγcyto-Z955   
PHOP2::LEU2-PPGK-ZI31A-PHOP2 
This study 
FN-G99 MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-Fc his3∆::URA3-PSTE18-Gγcyto-Z955  
PHOP2::LEU2-PPGK-Z955-PHOP2 
This study 
MC-ErC MC-F1 ste18∆::kanMX4-PPGK1-EGFRL834R,cyto-Ras1C This study 
MC-EsC MC-F1 ste18∆::kanMX4-PPGK1-EGFRL834R,cyto-Ste18C This study 
MC-EgN MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-EGFRL834R,cyto This study 
ErC-grbG MC-F1 ste18∆::kanMX4-PPGK1-EGFRL834R,cyto-Ras1C  
his3∆::URA3-PSTE18-Grb2-Gγcyto 
This study 
EsC-grbG MC-F1 ste18∆::kanMX4-PPGK1-EGFRL834R,cyto-Ste18C  
his3∆::URA3-PSTE18-Grb2-Gγcyto 
This study 
EgN-grbG MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-EGFRL834R,cyto  
his3∆::URA3-PSTE18-Grb2-Gγcyto 
This study 
ErC-Ggrb MC-F1 ste18∆::kanMX4-PPGK1-EGFRL834R,cyto-Ras1C   
his3∆::URA3-PSTE18 -Gγcyto-Grb2 
This study 
EsC-Ggrb MC-F1 ste18∆::kanMX4-PPGK1-EGFRL834R,cyto-Ste18C   his3∆::URA3-PSTE18 
-Gγcyto-Grb2 
This study 
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EgN-Ggrb MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-EGFRL834R,cyto  
his3∆::URA3-PSTE18 -Gγcyto-Grb2 
This study 
ErC-grbG-grb MC-F1 ste18∆::kanMX4-PPGK1-EGFRL834R,cyto-Ras1C  
his3∆::URA3-PSTE18-Grb2-Gγcyto   PHOP2::LEU2-PPGK-Grb2-PHOP2 
This study 
ErC-grbG-E89K MC-F1 ste18∆::kanMX4-PPGK1-EGFRL834R,cyto-Ras1C  
his3∆::URA3-PSTE18-Grb2-Gγcyto   PHOP2::LEU2-PPGK-Grb2E89K -PHOP2 
This study 
ErC-grbG-R86G MC-F1 ste18∆::kanMX4-PPGK1-EGFRL834R,cyto-Ras1C  
his3∆::URA3-PSTE18-Grb2-Gγcyto    PHOP2::LEU2-PPGK-Grb2R86G-PHOP2 
This study 
ErC-grbG-LEU MC-F1 ste18∆::kanMX4-PPGK1-EGFRL834R,cyto-Ras1C  
his3∆::URA3-PSTE18-Grb2-Gγcyto   PHOP2::LEU2-PHOP2 
This study 
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Table Ⅱ-2. List of plasmids used in this study. 
 
Plasmids Genotype Reference  
pGK425 Expression vector containing PGK1 promoter, 2µ origin and LEU2 marker [110] 
pGK425-Gpa1N N-terminus of Gpa1 (9 a.a.) expression, in pGK425 This study 
pGK425-Ste18C C-terminus of Ste18 (9 a.a.) expression, in pGK425 This study 
pGK425-Ras1C C-terminus of Ras1 (10 a.a.) expression, in pGK425 This study 
pGK425-Gpa1N-Fc Fc protein expression, in pGK425-Gpa1N This study 
pGK425-Fc-Ste18C Fc protein expression, in pGK425-Ste18C This study 
pGK426-GPTK URA3-STE18 promoter-kanMX4-STE18 terminator in pGK426 [48] 
pUMGPTK-Gpa1N-Fc URA3-STE18p-PGK1 promoter -Gpa1N (9 a.a.)-Fc- PGK1 terminator 
-kanMX4-STE18t in pGK426-GPTK 
This study 
pUMGPTK-Fc-Ste18C URA3-STE18p-PGK1 promoter -Fc-Ste18C (9 a.a.)- PGK1 terminator 
-kanMX4-STE18t in pGK426-GPTK 
This study 
pGK413 Expression vector containing PGK1 promoter, CEN/ARS single-copy 
origin and HIS3 marker 
[110] 
pGK413-Gγ-EZWT Gγcyto-ZWT fusion expression, in pGK413 This study 
pGK413-Gγ-EZK35A Gγcyto-ZK35A fusion expression, in pGK413 This study 
pGK413-Gγ-EZI31A Gγcyto -ZI31A fusion expression, in pGK413 This study 
pGK413-Gγ-EZ955 Gγcyto -Z955 fusion expression, in pGK413 This study 
pUSTE18p-Gγcyto URA3-STE18 promoter-Gγcyto-PGK1 terminato in pGK426 This study 
pUSTE18p-Gγcyto-HIS3t URA3-STE18 promoter-Gγcyto-PGK1 terminator-HIS3 terminator in 
pGK426 
This study 
pUSTE18p-Gγcyto-ZWT-H URA3-STE18 promoter-Gγcyto-ZWT-PGK1 terminator in 
pUSTE18p-Gγcyto-HIS3t 
This study 
pUSTE18p-Gγcyto-ZK35A-H URA3-STE18 promoter-Gγcyto-ZK35A-PGK1 terminator in 
pUSTE18p-Gγcyto-HIS3t 
This study 
pUSTE18p-Gγcyto-ZI31A-H URA3-STE18 promoter-Gγcyto-ZI31A-PGK1 terminator in 
pUSTE18p-Gγcyto-HIS3t 
This study 
pUSTE18p-Gγcyto-Z955-H URA3-STE18 promoter-Gγcyto-Z955-PGK1 terminator in 
pUSTE18p-Gγcyto-HIS3t 
This study 
pGK415 Expression vector containing PGK1 promoter, CEN/ARS single-copy 
origin and LEU2 marker 
[110] 
pGK-LsZWTc ZWT expression, in pGK415 [144] 
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pGK-LsZK35Ac ZK35A expression, in pGK415 [144] 
pGK-LsZI31Ac ZI31A expression, in pGK415 [144] 
pGK-LsZ955c Z955 expression, in pGK415 [144] 
pGK-LsZWTc-HOP2p LEU2-PGK promoter -ZWT-PGK terminator -HOP2 promoter in pGK415 This study 
pGK-LsZK35Ac-HOP2p LEU2-PGK promoter -ZK35A-PGK terminator -HOP2 promoter in pGK415 This study 
pGK-LsZI31Ac-HOP2p LEU2-PGK promoter -ZI31A-PGK terminator -HOP2 promoter in pGK415 This study 
pGK-LsZ955c-HOP2p LEU2-PGK promoter -Z955-PGK terminator -HOP2 promoter in pGK415 This study 
pGK425-Gpa1N-EGFR(LR) EGFRL834R,cyto expression, in pGK425-Gpa1N This study 
pGK425-EGFR(LR)-Ste18C EGFRL834R,cyto expression, in pGK425-Ste18C This study 
pGK425-EGFR(LR)-Ste18C EGFRL834R,cyto expression, in pGK425-Ste18C This study 
pUMGPTK-Gpa1N-EGFR(LR) URA3-STE18p-PGK1 promote -Gpa1N (9 a.a.)-EGFRL834R,cyto-PGK1 
terminator -kanMX4-STE18t in pGK426-GPTK 
This study 
pUMGPTK-EGFR(LR)-Ste18C URA3-STE18p-PGK1 promoter-EGFRL834R,cyto-Ste18C (9 a.a.)-PGK1 
terminator -kanMX4-STE18t in pGK426-GPTK 
This study 
pUMGPTK-EGFR(LR)-Ras1C URA3-STE18p-PGK1 promoter -EGFRL834R,cyto-Ras1C (10 a.a.)-PGK1 
terminator -kanMX4-STE18t in pGK426-GPTK 
This study 
pGK413-Grb2-Gγ Grb2-Gγcyto fusion expression, in pGK413 This study 
pGK416 Expression vector containing PGK1 promoter, CEN/ARS single-copy 
origin and URA3 marker 
[110] 
Ste18p-416 URA3-STE18 promoter-PGK1 terminator in pGK416 This study 
pUSTE18p-c-Gγcyto URA3-STE18 promoter-Gγcyto(w/ stop codon)-PGK1 terminator in 
pGK416 
This study 
pUSTE18p-c-Gγcyto-HIS3t URA3-STE18 promoter-Gγcyto(w/ stop codon)-PGK1 terminator-HIS3 
terminator in pGK416 
This study 
pUSTE18p-Grb2-Gγcyto-HIS3t URA3-STE18 promoter-Grb2-Gγcyto-PGK1 terminator in 
pUSTE18p-c-Gγcyto-HIS3t 
This study 
pUSTE18p-Gγcyto-Grb2-HIS3t URA3-STE18 promoter-Gγcyto-Grb2-PGK1 terminator in 
pUSTE18p-Gγcyto-HIS3t 
This study 
pUSTE18p-Grb2(R86G)-Gγcyto
-HIS3t 
URA3-STE18 promoter-Grb2R86G-Gγcyto-PGK1 terminator in 
pUSTE18p-Gγcyto-HIS3t 
This study 
pUSTE18p-Grb2(E89K)-Gγcyto-
HIS3t 
URA3-STE18 promoter-Grb2E89K-Gγcyto-PGK1 terminator in 
pUSTE18p-Gγcyto-HIS3t 
This study 
pGK415-HOP2p URA3-PGK1 promoter-PGK1 terminator-HOP2 promoter in pGK415 This study 
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pGK-LsGrb2-HOP LEU2-PGK1 promoter-Grb2-PGK1 terminator-HOP2 promoter in 
pGK415 
This study 
pGK-LsGrb2(R86G)-HOP LEU2-PGK1 promoter-Grb2R86G-PGK1 terminator-HOP2 promoter in 
pGK415 
This study 
pGK-LsGrb2(E89K)-HOP LEU2-PGK1 promoter-Grb2E89K-PGK1 terminator-HOP2 promoter in 
pGK415 
This study 
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Supplementary information 
 
Table Ⅱ-S1. List of primers used in this study. 
 
No. Primer Name Sequence (5’ to 3’) 
1 Xhol-PGK5'-fw aaaactcgagaaagatgccgatttgggc 
2 PGK5-Gpa1N-MCS-rv ggactagtccatggcttaaggtcgactattgtttgcgtactcactgtacaccccatgctagcgttttatatttgttgtaa 
3 MCS(Gpa1N)-rv ttttagatctacgcgtggatccgaattctctagacccgggactagtccatggcttaagg 
4 PGK5-Ste18C-MCS-rv tgaacgcgtggatccgaattctctagacccgggactagtccatggcttaaggtcgacgctagcgttttatatttgttgta 
5 MCS(Ste18C)-rv ttttagatctttacataagcgtacaacaaacactatttgaacgcgtggatccgaattc 
6 PGK5-Ras1C-MCS-rv ttcacgcgtggatccgaattctctagacccgggactagtccatggcttaaggtcgacgctagcgttttatatttgttgta 
7 MCS(Ras1C)-rv ttttagatctttaacaaattatacaacaaccaccactagattcacgcgtggatccgaattc 
8 Sall-Fc(1-16)-fw aaaagtcgacgggggaccgtcagtct 
9 BamHl-end-Fc-rv ttttggatcctcatttacccggagacaggg 
10 Sall-start-Fc(1-16)-fw aaaagtcgacatggggggaccgtcagtct 
11 BamHl-Fc-rv ttttggatcctttacccggagacagggaga 
12 Xhol-PGK5-fw (In-Fusion) aattctaagactcgagaaagatgccgatttgggc 
13 Xhol-PGK3-rv (In Fusion) aaacagatctctcgagagctttaacgaacgc 
14 Sall-start-Ste18mu-fw aaaagtcgacatgacatcagtt 
15 E domain-Flag-Ste18mu-rv ggcttcatcgtgttgcgccttgtcatcgtcatccttgtagtcaacactatttgagtt 
16 E domain-Z(1-5)-fw gcgcaacacgatgaagccgtaga 
17 EcoRl-end-Z(160-174)-rv tttttgaattcttatttcggcgcctgagc 
18 Xhol-Ste18p-fw aaaactcgagatattatatatatatatagggtcgtatatatatcgtgcgtcttcttcctt 
19 Nhel-Ste18m-rv ttttgctagcaacactatttgagtttgacatttggctatttttttgagcatttttcaaac 
20 Notl-HIS3t-fw aaaagcggccgctgacaccgattatttaaagctgcagcatacgatatatatacatgtgtata 
21 Sacl-HIS3t-rv ttttgagctcggagccataatgacagcagttgggtaggcctttctttggtaaaaggagcc 
22 Sall-EZ(1-15)-fw aaaagtcgacgcgcaacacgatgaagccgtagacaacaaattc 
23 BamHl-end-Z(160-174)-rv ttttggatccttatttcggcgcctgagc 
24 Notl-Hop2p-fw aaaagcggccgcttaaagcaagggtaa 
25 Sacl-Hop2p-rv ttttgagctcatctttcaaatagag 
26 Sall-EGFR(LR)-fw aatagtcgacagtggagaagctcccaaccaagctc 
27 Mlul-end-EGFR(LR)-rv atctacgcgtttatgctccaataaattcactgctt 
28 Sall-start-EGFR(LR)-fw tagcgtcgacatgagtggagaagctcccaaccaag 
29 Mlul-EGFR(LR)-rv catcacgcgttgctccaataaattcactgctttgt 
 98 
30 Sall-start-Grb2-fw(IF) atataaaacgctagcgtcgacatggaagccatcgccaaa 
31 EcoRl-end-Ste18m-rv(IF) tttatttcagatctgaattcttaaacactatttgagttt 
32 Xhol-Ste18p-fw aaaactcgagatattatatatatatatagggtcgtatatatatcgtgcgtcttcttcctt 
33 Nhel-Ste18p-rv ttttgctagctcttagaattattga 
34 Xbal-Ste18m-fw cgggtctagaacatcagttcaaaactct 
35 EcoRl-end-Ste18m-rv atctgaattcttaaacactatttgagtttg 
36 Nhel-start-Grb2-fw aaaagctagcatggaagccatcgc 
37 Xmal-Grb2-rv tagacccggggacgttccggttcacgggggtgaca 
38 Nhel-Grb2-fw tgttgctagcgaagccatcgccaaatatgacttca 
39 Xmal-end-Grb2-rv tagacccgggttagacgttccggttcacgggggtg 
40 Sall-start-Grb2-fw (IF) atataaaacgctagcgtcgacatggaagccatcgccaaa 
41 Xmal-end-Grb2-rv (IF) tctgaattctctagacccgggttagacgttccggttcac 
42 Grb2 R86G-rv ctctcactctcaccgataagaaaggc 
43 Grb2 R86G-fw gcctttcttatcggtgagagtgagag 
44 Grb2 E89K-rv cccaggagcgcttttactctctcggataag 
45 Grb2 E89K-fw cttatccgagagagtaaaagcgctcctggg 
46 Ste18pro-fw atattatatatatatatagggtcgt 
47 Ste18t-rv aaattatagaaagcagtagataaaa 
48 HIS3pro80-URA3-fw tatataaagtaatgtgatttcttcgaagaatatactaaaaaatgagcaggcaagataaacgaaggcaaagttcaattcatcat
tttttttttattctttt 
49 HIS3t end40-rv ggagccataatgacagcagttgggtaggcctttctttggt 
50 Hop2p 150-200-LEU2-fw atacaattaattgacatcagcagacagcaaatgcacttgatatacgcagctcgactacgtcgtaaggccgt 
51 Hop2p 800-rv atctttcaaatagagcctgg 
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Figure Ⅱ-S2. Selection of Z variants binding to membrane-associated target Fc proteins using 
previous and new methods for Gγ recruitment systems.
(A) Previous recipe of the Gγ recruitment system for membrane proteins as targets. (B and C) The 
flow  cytometry  analyses  and  mating  growth  assay.  Fluorescence  and  growth  intensities  of  the 
engineered strains expressing N-terminally membrane-associated Fc via stable integrating into the 
yeast chromosome as well as cytosolic Z variants fused to Gγcyto ‘Y1’ via autonomous replication 
plasmids.  The  control  yeast  shows  the  strain  without  the  expression  of  ‘Y1’  fused  to  Gγcyto 
(transformed with pGK413 mock vector). (D) New recipe of Gγ recruitment system for membrane 
proteins as target. (E and F) Flow cytometric analyses and mating growth assay. The fluorescence and 
growth intensities of the engineered strains expressing N-terminally membrane-associated Fc and 
cytosolic Z variants fused to Gγcyto via stable integration into the yeast chromosome. The control 
yeast shows the strain without the expression of ‘Y1’ fused to Gγcyto (MC-FN in Table 1).
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Figure Ⅱ-S3. Flow diagram of the selection principle behind the competitive Gγ  recruitment 
system for target membrane proteins.
(A) Outline for the selection of desirable affinity-enhanced proteins. The yeast strain expressing target 
membrane protein ‘X’ and the competitor protein ‘Y2’ in the cytosol is transformed with the plasmid or 
integrated to the DNA cassettes expressing the mutant library fused with the Gγ mutant (Gγcyto-Y1) in 
the cytosol. Preferential binding of “X” to “Y1” (Ka1>Ka2) restores the signaling function and permits 
the  selective  screening  of  affinity-enhanced  proteins.  (B)  Outline  for  screening  affinity-attenuated 
proteins. The yeast strain expressing target membrane protein ‘X’ and a competitor protein ‘Y1’ fused 
with the Gγ mutant (Gγcyto-Y1) is transformed with the plasmid or integrated to the DNA cassettes 
expressing  the  mutant  library  in  the  cytosol  (Y2).  Preferential  binding  of  “X”  to  “Y1”  (Ka2<Ka1) 
restores the signaling function and permits the selective screening of affinity-attenuated proteins.  
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Figure.  Ⅱ-S4  Competitive  selection  of  Z  variants  with  higher  affinities  for  membrane-
associated target Fc using previous and new methods for affinity-enhanced systems.
(A) Previous recipe of the affinity-enhanced system for membrane proteins as targets. (B) Flow 
cytometry  analyses  and  mating  growth  assay.  The  fluorescence  and  growth  intensities  of  the 
engineered  strains  expressing  N-terminally  membrane-associated  Fc  and  competitor  ZI31A  as 
cytosolic ‘Y2’ via stable integration into the yeast chromosome as well as cytosolic Z variants ‘Y1’ 
fused to Gγcyto by the autonomous replication plasmids. Control yeast strains lacked the expression 
of  ‘Y1’ fused  to  Gγcyto  (transformed with  pGK413 mock vector).  (C)  New recipe  of  affinity-
enhanced system for membrane proteins as targets. (D and E) Flow cytometry analyses and mating 
growth assay.  The fluorescence and growth intensities  of  the engineered strains expressing N-
terminally membrane-associated Fc and cytosolic Z variants fused to Gγcyto, competitor cytosolic 
Z variants ‘Y2’ and cytosolic Z variants ‘Y1’ fused to Gγcyto via stable integration into the yeast 
chromosome. The control yeast shows the strain without the expression of ‘Y1’ fused to Gγcyto.  
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Figure. Ⅱ-S5 Competitive selection of Z variants with lower affinities for membrane-
associated target Fc using the previous method for affinity-attenuated system.
(A) Previous recipe of the affinity-attenuated system for membrane proteins as targets. (B, 
C)  Flow  cytometry  analyses  and  mating  growth  assay.  The  fluorescence  and  growth 
intensities of the engineered strains expressing N-terminally membrane-associated Fc and 
competitor  ZWT  as  cytosolic  ‘Y1’ fused  to  Gγcyto  via  stable  integration  into  the  yeast 
chromosome and cytosolic Z variants ‘Y2’ viaautonomous replication plasmids. Control 
yeast  shows the strain without  the expression of  ‘Y1’ fused to Gγcyto  and cytosolic  Z 
variants ‘Y2.’  
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Figure  Ⅱ-S6.  Examinations  of  the  lipidation  motifs  for  membrane-associated 
intracellular domain of EGFR and the fusion patterns between Gγcyto and Grb2.
(A)  The  Gγ  recruitment  system for  membrane-associated  intracellular  domain  of  EGFR 
L834R mutant (EGFRL834R,cyto) and C-terminally Gγcyto-fused Grb2 (Grb2-Gγcyto). (B and C) 
The flow cytometric analyses and mating growth assay. Fluorescence and growth intensities 
of  the engineered strains  expressing N-terminally  (Gpa1N) and C-terminally  (Ras1C and 
Ste18C) membrane-associated EGFRL834R,cyto and cytosolic Grb2-Gγcyto via stable integration 
into the yeast chromosome. The control yeast shows the strain without the expression of ‘Y1’ 
fused  to  Gγcyto  (MC-ErC  in  Table  1).  (D)  The  Gγ  recruitment  system  for  membrane-
associated EGFRL834R,cyto and N-terminally Gγcyto-fused Grb2 (Gγcyto-Grb2). (E and F) The 
flow cytometric analyses and mating growth assay. Fluorescence and growth intensities of the 
engineered strains expressing N-terminally (Gpa1N) and C-terminally (Ras1C and Ste18C) 
membrane-associated EGFRL834R,cyto and cytosolic Gγcyto-Grb2 via stable integration into the 
yeast chromosome. The control yeast shows the strain without the expression of ‘Y1’ fused to 
Gγcyto (MC-ErC in Table 1).  
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Expression of varied GFPs in Saccharomyces cerevisiae: codon 
optimization offers a strong impact for expression level and 
brightness 
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Introduction 
 
The green fluorescent protein (GFP) had been discovered more than 50 years ago49, and 
from that point on, it has fueled a new era in cell and molecular biology. Original GFP is a 
protein comprised of 238 amino acid residues (about 27 kDa) that has a β-barrel structure 
consisting of eleven β-strands and exhibits green fluorescence when exposed to blue light52. 
GFP requires no external cofactors without oxygen to form the chromophore unlike the case 
with other proteins (e.g., opsin, β-glucuronidase, β-galactosidase, chloramphenicol 
acetyl-transferase, and luciferase) that demand cofactors or substrates for their activities164. 
Therefore, GFP is excellent as a reporter gene and a fusion tag for the analyses of gene 
regulation, protein localization, and specific organelle labeling in almost every 
organism165–169.  
The budding yeast Saccharomyces cerevisiae is an ideal model for eukaryotic 
organisms, because it permits the simple way for studying protein localization due to the ease 
and tractable genetic modifications168. Recent studies have reached in widespread interests for 
the genome-wide approaches to analyze messenger RNA (mRNA) abundance170,171, 
transcriptional regulation172, protein abundance or localization164,173,174, and protein–protein 
interactions175,176. In many cases, these techniques use the GFP or other chromophoric 
proteins for easy tracking, monitoring and screening of target proteins. Thus, GFP has a 
meaningful connection to yeast S. cerevisiae and makes it an intelligent tool for a multitude 
of biological studies.  
Several varieties of GFPs tested in this study and their properties are listed in Table 1. 
The original GFP isolated from jellyfish Aequorea victoria, has a weak dimeric character, 
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relatively lower molar extinction coefficient (ε), and two excitation maxima (395nm and 
475nm peaks)50,53,54. The enhanced GFP (EGFP), which has been generated as the mutant of 
original GFP through the mutagenesis studies, is one of the most popular and widely used 
monomeric GFP and has a single excitation peak at 488nm55 (Table Ⅲ-1). It contains the 
optimized codons for mammalian cells, and the S65T and F64L mutations to improve the 
spectral characteristics, brightness and stability, and efficiency of protein maturation at 
37°C55,56.  
Recently, GFP variants have been discovered from a wide rage of sources, such as 
different Aequorea species57,58, copepods59, amphioxus60,61 and coral reefs62–65, and they are 
now commercially available. For example, a brilliant green, monomeric GFP variant, 
AcGFP1, isolated from Aequorea coerulescens has a 94% sequence homology to EGFP57 
(Table Ⅲ-1). A monomeric and pH-stable GFP, TagGFP2 (mTagGFP), which is the 
improved variant of TagGFP derived from Aequorea macrodactyla, has a 80% sequence 
homology to EGFP58 (Table Ⅲ-1). Corals-derived GFPs, mUkG162, ZsGreen63 and 
mWasabi65, bear surprisingly scant sequence homology to the original GFPs from Aequorea 
species. Monomeric mUkG1 exhibits brilliant fluorescence and has extremely high pH 
stability that has been yielded by introducing five mutations to the dimeric wild-type 
fluorescent protein UkG1 isolated from the soft coral Sarcophyton sp.62 (Table Ⅲ-1). 
Tetrameric ZsGreen is the Zoanthus sp. fluorescent protein variant with a single amino acid 
substitution to enhance the emission characteristics and shows substantially higher quantum 
yield (QY)63 (Table Ⅲ-1). Substantially bright, monomeric green fluorescent protein 
mWasabi is the variant of monomeric mTFP1, which is derived from the Clavularia sp. 
tetrametic cyan fluorescent protein cFP48465 (Table Ⅲ-1). mNeonGreen is a monomeric 
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yellow-green fluorescent protein and exhibits the brightest green or yellow fluorescence to 
date, which has been generated from a tetrameric yellow fluorescent protein (LanYFP) 
derived from the cephalochordate Branchiostoma lanceolatum by structure-guided directed 
evolution60 (Table Ⅲ-1). As seen above, there exist diverse GFPs to this date and they are 
important tools for versatile experiments; however, it is less well examined which GFP is 
suitable for the expression in S. cerevisiae.  
Here, we expressed seven codon-optimized GFPs and five non codon-optimized GFPs in S. 
cerevisiae, and compared the protein expression levels and the green fluorescence intensities. 
Further, we tested the five GFPs, which showed the relatively good expressions, as the 
reporter genes in fusion forms for detecting protein–protein interaction. Conclusively, we 
disclose the nucleic acid sequences of the codon-optimized GFPs presenting the good 
expression performances and bright green fluorescence in S. cerevisiae.  
 
Protein λex (nm) λem (nm) EC (ε) (M-1cm-1) QY 
RB 
(% of EGFP) 
Association 
state 
Reference 
or source 
EGFP 488 507 56000 0.60 100 Monomer [54] 
AcGFP1 475 505 32500 0.82 79 Monomer Clontech 
TagGFP2 483 506 56500 0.60 101 Monomer Evrogen 
mUkG1 483 499 60000 0.72 129 Monomer [62] 
ZsGreen 493 505 43000 0.91 116 Tetramer [63] 
mWasabi 493 509 70000 0.80 167 Monomer [65] 
mNeonGreen 506 517 116000 0.80 276 Monomer [60] 
 
Table Ⅲ-1. Properties of green fluorescent proteins tested. Along with the common name 
for each GFP, the peak excitation (λex) and emission (λem) wavelengths, molar extinction 
coefficient (EC), quantum yield (QY), relative brightness (RB), association state and 
reference or source are listed. Brightness values were derived from the product of EC and QY, 
divided by the value for EGFP. 
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Results and Discussion 
Expression comparison of varied GFPs in S. cerevisiae 
To examine the expressibility of GFPs in S. cerevisiae, we selected seven GFPs (EGFP, 
AcGFP1, TagGFP2, mUkG1, ZsGreen, mWasabi and mNeonGreen) from varied sources 
(Table Ⅲ-1). The genes coding for the seven GFPs were synthesized as the codon-optimized 
sequences for yeast S. cerevisiae (yEGFP, yAcGFP1, yTagGFP2, ymUkG1, yZsGreen, 
ymWasabi and ymNeonGreen) (Supplementary Table Ⅲ-S1) and inserted into the 
multiple-cloning site of pGK416 single-copy autonomous replicating plasmid to 
constitutively express them under the control of the PGK1 promoter110 (Table Ⅲ-2). The 
constructed plasmids were used to transform yeast BY4741 strain (Table Ⅲ-3 and 
Supplementary Table Ⅲ-S3) and their green fluorescence was evaluated by flow cytometry 
and fluorescence microscopy (Supplementary Fig. Ⅲ-S1). 
The green fluorescence intensities of 10,000 cells were quantitatively measured by flow 
cytometry, and the values were defined as the mean fluorescence intensities (MFIs). 
Momomeric ymUkG1 and tetrametic yZsGreen showed the highest fluorescence intensities 
over 40000–45000 MFIs (Supplementary Fig. Ⅲ-S1A). As the second group, yEGFP, 
yAcGFP1 and yTagGFP2 exhibited respectable intensities about 25000–35000 MFIs 
(Supplementary Fig. Ⅲ-S1A). In contrast, ymWasabi and ymNeonGreen displayed 
remarkably low fluorescence intensities less than 20000 MFIs (Supplementary Fig. 
Ⅲ-S1A), even though both GFPs had been known as one of the brightest green fluorescent 
proteins (mWasabi, ε=70000 M-1cm-1, QY=0.80; mNeonGreen, ε=116000 M-1cm-1, 
QY=0.80)60,65 (Table Ⅲ-1). Fluorescent microscopy observations also exposed the darker 
green fluorescence of these two proteins than those of other five GFPs (Supplementary Fig. 
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S1B). Therefore, we decided to use the five GFPs other than mWasabi and mNeonGreen 
(EGFP, AcGFP1, TagGFP2, mUkG1 and ZsGreen) for further experiments. 
Next, we compared the expressions of codon-optimized sequences and commercially 
available (non codon-optimized for S. cerevisiae) sequences of five GFPs. As the 
commercially available GFP sequences tested, EGFP, AcGFP1 and TagGFP2 used the 
optimized codons for mammalian cells, and ZsGreen and mUkG1 used the original codons 
from the isolated organism species. These genes encoding non codon-optimized GFPs for S. 
cerevisiae were amplified from the commercially available vectors and inserted into the 
multiple-cloning site of pGK416 vector (Table Ⅲ-2). Yeast BY4741 strain (Table Ⅲ-3) 
was similarly transformed with the constructed plasmids (Supplementary Table Ⅲ-S3), and 
their green fluorescence was evaluated by flow cytometry, fluorescence microscopy, sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and visual contact under 
natural light (Figs. Ⅲ-1A–E). The flow cytometry and fluorescence microscopy for 
codon-optimized GFPs represent the same data with Supplementary Figs. Ⅲ-S1A and 
Ⅲ-S1B. Non codon-optimized mUkG1 and ZsGreen that have original codons from the soft 
coral Sarcophyton sp. and the button polyp coral Zoanthus sp. showed decent fluorescence 
intensities (mUkG1, MFI=14194; ZsGreen, MFI=15019) (Fig. Ⅲ-1B). The MFIs of 
codon-optimized GFPs (ymUkG1, MFI=47088; yZsGreen, MFI=44154) were almost 
three-folds different with those of non codon-optimized sequences (Fig. Ⅲ-1B and 
Supplementary Fig. Ⅲ-S2). In contrast, non codon-optimized EGFP, AcGFP1 and 
TagGFP2 for S. cerevisiae (optimized for mammalian cells) unexpectedly exhibited 
considerably lower fluorescence intensities (EGFP, MFI=1490; AcGFP1, MFI=542; 
TagGFP2, MFI=240) (Fig. Ⅲ-1B). The MFIs of these codon-optimized GFPs for S. 
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cerevisiae (yEGFP, MFI=33351; yAcGFP1, MFI=36177; yTagGFP2, MFI=24250) were 
surprisingly 22-, 67- and 101-folds higher than those of non codon-optimized GFPs (Fig. 
Ⅲ-1B and Supplementary Fig. Ⅲ-S2). Observation of fluorescence microscopy revealed 
clear differences in brightness of green fluorescence of codon-optimized and non 
codon-optimized GFPs (Fig. Ⅲ-1C). The SDS-PAGE profiles under reducing conditions 
also showed obviously increased protein expression levels of codon optimized GFPs (approx. 
27 kDa) in S. cerevisiae, although tetrameric yZsGreen seemed to exhibit relatively lower 
expression levels than other monomeric yGFPs (Fig. Ⅲ-1D). Moreover, intriguingly, all 
yeast cells expressing codon-optimized GFPs generated light green colors under natural light, 
whereas non codon-optimized EGFP, AcGFP1 and TagGFP2 never showed green colors (Fig. 
Ⅲ-1E). Among them, the yeasts expressing codon-optimized ymUkG1 and yZsGreen 
displayed especially brilliant light green colors in visual contact (Fig. Ⅲ-1E). 
As shown in Table 4, codon-optimized GFPs for S. cerevisiae presented high codon 
adaptation indexes (CAIs) and moderate GC contents (CAIs=0.87~0.90 and GC 
contents=39.7~40.4%). These codon-optimized GFPs showed quite high green fluorescent 
intensities (MFIs=~47088) (Fig. Ⅲ-1B), and their high expression levels in S. cerevisiae 
(Fig. Ⅲ-1D) enabled to observe the green colors under natural right (Fig. Ⅲ-1E). Even 
ymWasabi and ymNeonGreen, which unfortunately had exhibited relatively lower expression 
levels than other codon-optimized GFPs in S. cerevisiae despite relatively higher molar 
extinction coefficients and quantum yields (Table Ⅲ-1), maintained modest fluorescence 
intensities (ymWasabi, MFI=16987; ymNeonGreen, MFI=5148) (Supplementary Fig. 
Ⅲ-S1A). The reason is unclear; however, the folding efficiencies might have affected the 
expression levels of mWasabi and mNeonGreen. In contrast, commercially available, non 
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codon-optimized EGFP, AcGFP1 and TagGFP2 sequences unexpectedly exhibited much 
lower CAIs and higher GC contents (CAIs=0.50~0.56 and GC contents=59.0~63.6%) 
(TableⅢ-4) and resulted in the extremely lower expression levels in S. cerevisiae (Fig. 
Ⅲ-1), though they had the eukaryotic mammalian codon-usage preferences. It likely misled 
us into thinking that the mammalian cells had reasonably similar codon-usages to the same 
eukaryotic organism, yeast S. cerevisiae. For mUkG1 and ZsGreen, original codons from the 
soft coral Sarcophyton sp. and the button polyp coral Zoanthus sp. were used, unexpectedly 
resulting in the relatively similar codon usage to yeast (CAIs=0.69~0.70 and GC 
contents=44.9~45.0%) (Table Ⅲ-4) and showed decently higher expression levels in S. 
cerevisiae (Fig. Ⅲ-1). These were also supported by our previous result that the ZsGreen 
(original codon) had exhibited brighter fluorescence than the EGFP (non codon-optimized) as 
the fluorescent reporter protein177. From the expression data of the codon-optimized and non 
codon-optimized GFPs (Fig. Ⅲ-1), the codon optimization with careful thinking about CAIs 
and GC contents strongly affected the expression levels of varied GFPs in S. cerevisiae, and 
the impact was stronger than we expected. Among the codon-optimized GFPs tested in this 
study, ymUkG1 presented higher expression level than yZsGreen (Fig. Ⅲ-1D), whereas 
monomeric ymUkG1 and tetrametic yZsGreen exhibited brightest green fluorescence in S. 
cerevisiae (Fig. Ⅲ-1B). 
 113 
Figure Ⅲ-1. Expression comparison of varied GFPs in S. cerevisiae. 
(A) Flow diagram of  GFP detection assays.  The GFP expression plasmids were transformed into 
BY4741 yeast strain, and then the cells were grown and served to the following analyses to examine 
the GFP expressions. (B) Mean GFP fluorescence intensities (MFIs). The MFIs of 10,000 cells were 
measured by flow cytometry. (C) Green fluorescence images of the cells. The images were observed 
by fluorescence microscope equipped with the 60×  objective lens. Exposure time was 1/15 s. (D) 
SDS-PAGE analysis. Crude protein extracts were prepared by an alkaline lysis method. (E) Visual 
images of the cells under natural light. Varied codon-optimized and non codon-optimized GFPs were 
used for the evaluations. Control indicates the BY4741 yeast strain harboring mock pGK416 plasmid.   
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Expression comparison of varied GFPs as fusion tagged proteins to report the 
activation of signal transduction in S. cerevisiae 
The most widely used application of GFP would be as a protein tag or a reporter 
gene165,168,178. To test the applicability of the GFPs tested above, we selected the 
pheromone-responsive FIG1 gene, which is involved in conjugation with cellular fusion 
during the mating processes179. The expression of FIG1 gene is induced responding to the 
activation of yeast mating signaling pathway; thereby, it has been often used to sense the 
promoted signal of mating pathway (Fig. Ⅲ-2A) or the agonist response to the heterologous 
GPCRs using non codon-optimized EGFP as the reporter gene90,112,144,180.  
The codon-optimized and non codon-optimized five GFP genes were respectively 
integrated into the chromosome of BY4741 haploid yeast a-cells to fuse with the FIG1 gene 
at the C-terminus (Table Ⅲ-3 and Supplementary Table Ⅲ-S4). To induce the 
transcription of FIG1-GFPs, the cells were incubated for 6 hours in YPD medium containing 
the a-cell-specific mating pheromone (α-factor) (Fig. Ⅲ-2A). The cultured cells were 
applied to flow cytometric analyses and fluorescence microscopy observation (Figs. Ⅲ-2B 
and Ⅲ-2C).  
All tested GFPs as the fusion reporters displayed drastic increases of green fluorescence 
in response to the addition of α-factor pheromone (Fig. Ⅲ-2B). Although these fusion 
proteins showed lower fluorescence intensities than those of the solely expressed untagged 
GFPs, the MFIs of fusion proteins were basically in almost the same order as the untagged 
GFPs (Figs. Ⅲ-1B and Ⅲ-2B). The declined expression levels of codon-optimized GFPs 
would have dragged down by the expression of N-terminally fused Fig1 protein (non 
codon-optimized, original codon was used). Whereas the increased levels of MFIs were also 
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lower than the cases in the solely expressed GFPs, the fusions of codon-optimized GFPs 
surely improved the MFIs in all five cases when compared to the fusions of non 
codon-optimized GFPs. The pheromone-stimulated cells invoked 22.7~110.6 fold changes of 
the MFIs compared to the relevant unstimulated cells (Fig. Ⅲ-2B). The increases in MFIs of 
Fig1-GFPs by codon optimization were approximately 1.60~2.07-folds. Compared to the 
probably most commonly used non codon-optimized EGFP, codon-optimized ymUkG1 and 
yZsGreen showed apparently higher fluorescence intensities when expressed as the fusion 
genes with FIG1 reporter (FIG1-EGFP, MFI=1469; FIG1-ymUkG1, MFI=6184; 
FIG1-yZsGreen, MFI=7143) and exhibited greater than 4.2- and 4.9-fold increases (Fig. 
Ⅲ-2B). Fluorescence microscope observation of the yeast cells in pheromone-stimulated 
states also proved obviously brighter green fluorescence of Fig1-ymUkG1 and 
Fig1-yZsGreen than that of Fig1-EGFP (cells shapes have been elongated by the excessive 
pheromone stimulation) (Fig. Ⅲ-2C).  
As presented above, corresponding to the results of solely expressed untagged GFPs, 
codon-optimized ymUkG1 and yZsGreen exhibited brightest fluorescence even when 
expressed as the fusion genes with FIG1 reporter. Contrary to our expectation, tetrameric 
yZsGreen was not irrelevant to the fusion reporter with Fig1 protein. The tetrameric 
fluorescent proteins are generally regarded to be unfavorable as the fusion tags because of 
hampering normal function and localization of the target proteins165, and it is profoundly 
reasonable instruction; however, it likely is not necessarily applied to every case. For further 
experiments, we decided to use the monomeric ymUkG1, which seemed to be less constraint 
to many applications but displayed significantly brighter fluorescence than other monomeric 
GFPs in S. cerevisiae. 
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Figure Ⅲ-2.  Expression comparison of varied GFPs as fusion tagged proteins to report the activation of 
signal transduction in S. cerevisiae.
 (A) Flow diagram of GFP transcription assays for detecting the signal transduction. The FIG1-GFP fusion genes 
were substituted with the FIG1 gene in the yeast genome. The cells were grown in the media with and without 5 μM 
α-factor  and  served  to  the  following  analyses  to  examine  the  GFP expressions.  (B)  Mean  GFP fluorescence 
intensities (MFIs). The MFIs of 10,000 cells were measured by flow cytometry. (C) Green fluorescence images of 
the cells. The images were observed by fluorescence microscope equipped with the 60× objective lens. Exposure 
time was 1/4 s. Varied codon-optimized and non codon-optimized GFPs were used for the evaluations. Control 
indicates the BY4741 wild-type yeast strain.
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Application of codon-optimized ymUkG1 to the Gγ recruitment systems to report 
protein–protein interactions in S. cerevisiae 
We had previously developed the methods, the Gγ recruitment systems, to detect 
protein–protein interactions (PPIs)48,100,144,181,182 and to screen the protein variants presenting 
desirable affinities144. The detection method of the Gγ recruitment systems basically based on 
the fundamental principle that yeast pheromone (mating) signaling requires localization of a 
complex between guanine nucleotide binding protein (G-protein) β- and γ-subunits (Gβγ) to 
the inner leaflet of the plasma membrane47. In brief for the machinery to detect PPIs, an 
engineered Gγ mutant (named Gγcyto) lacks a membrane localization sequence (lipidation 
motif) that is normally expressed in the cytosol. In case that the target protein (X) is a soluble 
cytosolic protein, the Gγcyto is prepared in a fused form with a target protein (X) (Gγcyto-X) 
and the library proteins (Y) should be attached to the artificial lipidation site to localize them 
onto the membrane (Supplementary Fig. Ⅲ-S3A)48,144. In contrast, when the target protein 
(X) is a membrane protein, the Gγcyto is prepared in a fused form with the library proteins (Y) 
(Gγcyto-Y) (Supplementary Fig. Ⅲ-S3B)181,182. When existing the interaction between target 
“X” and candidate “Y”, the Gγcyto-X (Supplementary Fig. S3A) or Gγcyto-Y (Supplementary 
Fig. Ⅲ-S3B) fusion protein brings the Gβ onto the membrane and induces the subsequent 
activation of the pheromone signaling pathway. The promoted signaling can be monitored by 
a fluorescent reporter assay or a mating growth assay; thereby, the PPIs are easily detectable 
(Supplementary Fig. Ⅲ-S3C).  
Here, the FIG1–EGFP (non-optimized) has been used as a fluorescent reporter gene in 
the Gγ recruitment systems. Therefore, we tested whether the FIG1-ymUkG1 could improve 
the fluorescent reporting ability in the Gγ recruitment systems. As in the previous system, the 
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Fc protein of human immunoglobulin G (IgG) and the Z domain derived from 
Staphylococcus aureus protein A (ZWT)103 were used for the PPI models. Several Z variants 
(ZK35A, ZI31A and Z955) with varied affinities against the Fc protein were also used for the PPI 
models (ZWT, 5.9×107 M-1; ZK35A, 4.6×106 M-1; ZI31A, 8.0×103 M-1; Z955, none)102,145.  
We first tested the cases for the use of soluble cytosolic target proteins (Supplementary 
Fig. Ⅲ-S3A). The Fc protein was used as the cytosolic target protein ‘X’ and fused with the 
Gγcyto (Gγcyto-Fc). Four Z domain variants were attached to the artificial lipidation motifs 
(derived from Ste18p) as the candidate ‘Y’ proteins localizing on the membrane (Table Ⅲ-3 
and Supplementary Table Ⅲ-S4). After addition of α-factor pheromone, the cells were 
cultured and the GFP signal was measured using flow cytometry (Supplementary Fig. 
Ⅲ-S3C). Both Fig1-EGFP and Fig1-ymUkG1 reporters successfully detected the PPIs 
between Fc and several Z variants (ZWT, ZK35A and ZI31A) (Fig. Ⅲ-3A). However, there was 
much difference in the fluorescence intensities between these two reporters. When comparing 
the cases in ZWT, the Fig1-EGFP and Fig1-ymUkG1 reporters exhibited 21- and 109-times 
higher fluorescence signals than the those of respective negative control cells. The 
fluorescence intensities were 5.2-fold different between Fig1-EGFP (MFI=1276) and 
Fig1-ymUkG1 (MFI=7524). When comparing the cases in other variants (ZK35A and ZI31A), the 
differences in fluorescence intensities were 5.2- (ZK35A) and 7.6-folds (ZI31A) between 
Fig1-EGFP and Fig1-ymUkG1 reporters. When using the Z variant lacking the affinity to Fc 
(Z955), green fluorescence was never observed. The ymUkG1 reporter showed bright 
fluorescence signal (MFI=2682) even for detecting weak PPI between Fc and ZI31A (8.0×103 
M-1), whereas the Fig1-EGFP exhibited faint fluorescence signal (MFI=350).  
Next, we tested the cases for the use of membrane target proteins (Supplementary Fig. 
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Ⅲ-S3B). The Fc protein was used as the membrane target protein ‘X’. To test the positions 
to fuse the lipidation motifs, both C-terminally and N-terminally membrane-associated Fc 
proteins were prepared (C-terminal lipid anchor, derived from Ste18p; N-terminal lipid 
anchor, derived from Gpa1p). Four Z domain variants were used as the cytosolic candidate 
‘Y’ proteins and fused with the Gγcyto (Gγcyto-Z variants) (Table Ⅲ-3 and Supplementary 
Table Ⅲ-S6). The cells were similarly assayed to the previous experiments. First in the case 
with the C-terminally membrane-associated Fc proteins, both Fig1-EGFP and Fig1-ymUkG1 
reporters successfully detected the PPIs with two Z variants (ZWT and ZK35A), although they 
could not detect the PPI with ZI31A (Fig. Ⅲ-3B). This was well corresponded to the previous 
results that had failed the detection of PPI between membrane-associated Fc and Gγcyto fused 
ZI31A, and the weak PPI (8.0×103 M-1) is likely below the detection limitation in the Gγ 
recruitment system when using Fc as the membrane target protein182. As similar to the test for 
the soluble cytosolic target Fc protein (Fig. Ⅲ-3A), much difference in the fluorescence 
intensities between Fig1-EGFP and Fig1-ymUkG1 reporters was observed (Fig. Ⅲ-3B). 
When comparing the cases in ZWT, the Fig1-EGFP and Fig1-ymUkG1 reporters exhibited 37- 
and 131-times higher fluorescence signals than those of the respective negative control cells. 
The fluorescence intensities were 3.6-fold different between Fig1-EGFP (MFI=2380) and 
Fig1-ymUkG1 (MFI=8519). When comparing the cases in ZK35A, the difference in 
fluorescence intensities was 2.4-fold between Fig1-EGFP and Fig1-ymUkG1 reporters. In the 
case using the N-terminally membrane-associated Fc proteins, similar tendencies were 
observed (Supplementary Fig. Ⅲ-S4). When comparing the cases in ZWT and ZK35A 
respectively, the differences in fluorescence intensities were 3.6- and 2.9-folds between 
Fig1-EGFP and Fig1-ymUkG1 reporters. Thus, the codon-optimized ymUkG1 functioned as 
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much brighter fluorescence reporter than the previous non codon-optimized (for S. 
cerevisiae) EGFP even in the Gγ recruitment systems, which are to detect the PPIs both for 
soluble cytosolic target proteins and membrane target proteins. 
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Figure Ⅲ-3. Expression comparison of non codon-optimized EGFP and codon-optimized ymUkG1 as fusion 
tagged proteins to report PPIs using the Gγ recruitment systems.
 (A) Flow cytometry analyses using the Gγ recruitment system for cytosolic target proteins. The Fc protein was used 
as the cytosolic target protein ‘X’ and expressed as the fusion protein with Gγcyto (Gγcyto-Fc). Membrane-anchored 
four Z variants (ZWT, ZK35A,, ZI31A and Z955) were expressed as the ‘Y’ library candidate proteins. Control indicates 
the BFG2118 and UGFG2 yeast strains harboring pGK413 mock plasmid (without the expression of ‘Y’). (B) Flow 
cytometry analyses using the Gγ recruitment system for membrane protein targets. The Fc protein was used as the 
membrane  target  protein  ‘X’ and  expressed  as  membrane-associated  proteins  with  the  C-terminal  lipid  anchor 
(derived from Ste18p).  Four Z variants  (ZWT,  ZK35A,,  ZI31A and Z955)  were used as  the cytosolic  candidate ‘Y’ 
proteins and expressed as the fusion proteins with Gγcyto (Gγcyto-Z variants). Control indicates the FC-G0 and UG2-
FCG0 "yeast  strains  (without  the  expression  of  ‘Gγcyto-Y’).  The  engineered  strains  were  grown  in  the  media 
containing 5 μM α-factor and served to the analyses of mean fluorescence intensities (MFIs). The MFIs of 10,000 
cells were measured by flow cytometry. 
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Flow cytometry analysis of mixture populations of positive and negative cells. 
Flow cytometry is the efficient and accurate way to sort library cells, since FACS 
sorting method is capable of analyzing rare target cells in a larger cell population. To 
evaluate ymUkG1 as reporter gene of the Gγ recruitment system for soluble cytosolic target 
proteins, we used a mixture of positive cells (expressing Gγcyto-Fc and membrane-anchored 
ZWT or ZK35A or ZI31A) and negative cells (expressing Gγcyto-Fc and membrane-anchored Z955) 
and quantified the target population in the total cell mixtures by using flow cytometry. 
First, to determine the gate of positive cells, we made dot-plots of fluorescence 
(GFP-A) against forward scatter (FSC-A) for each engineered strains expressing Gγcyto-Fc 
and membrane-anchored ZWT, ZK35A, ZI31A and Z955 (Fig. Ⅲ-4 and Table Ⅲ-5). We decided 
the region of positive cells (GFP+) by excluding negative cells (expressing Gγcyto-Fc and 
membrane-anchored Z955) and control cells arias. Figure Ⅲ-4 and Table Ⅲ-5 show that 
99.9-85.2% of the 10,000 positive cells (expressed membrane-anchored ZWT, ZK35A and ZI31A) 
have a high fluorescence and include GFP+ region in case of Fig1-ymUkG1 reporter. In 
contrast, Fig1-EGFP reporter could not provide enough rate of GFP+ to positive cells (Fig. 
Ⅲ-4 and Table Ⅲ-5).  
Next, to evaluate the ability of the each reporter GFP genes for flow cytometry, we used 
two type of cell mixture and valuated the content rate of GFP+ region. Table Ⅲ-6 is shown 
mixing rations and a summary of the detected rate of positive cells in 1,000,000 cells. The 
dot-plots of these dates are shown in Fig. Ⅲ-5. Detection of the positive cells was possible in 
all mixtures of cell with 0.1% and 0.01% positive cells in both case of EFGP and ymUkG1 
(Fig. Ⅲ-5A-D). However, dot-plot shows that Fig1-ymUkG1 reporter could provide the 
clear signal-to-noise ratio (S/N ratio). Especially, Fig1-ymUkG1 displayed great ability as 
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reporter gene when lower content rate was used (Table Ⅲ-6). In case of the mixture 
containing 0.01% positive cells, ymUkG1 reporter pushed the 61% of positive cells into 
GFP+ region although EGFP reporter gene found 44% of positive cells (Fig. Ⅲ-5A-D and 
Table Ⅲ-6). Furthermore, in case of using mixture containing weak positive cells expressing 
membrane-anchored ZI31A, there is major difference of ability for reporter gene between 
EGFP and ymUkG1 (Fig. Ⅲ-5E-H and Table Ⅲ-6). The ymUkG1 reporter makes it 
possible to detect and separate positive cell effectively. Therefore, these observations show 
that combination with ymUkG1 reporter gene and FACS offers good experimental strategy 
for the Gγ recruitment system or analysis of yeast cells in large populations. 
In summary, we performed the expression comparison of seven codon-optimized GFPs 
and five non codon-optimized GFPs in S. cerevisiae. The codon optimization for S. 
cerevisiae improved all five non codon-optimized GFPs and surprisingly raised the 
fluorescence intensities maximally up to 101-fold on the basis of commercially available 
GFPs (optimized for mammalian codon usage). The CAIs and GC contents had a higher 
impact on the expression levels of varied GFPs in S. cerevisiae than our expectation. Among 
the codon-optimized GFPs tested, monomeric ymUkG1 and tetrameric yZsGreen showed 
brightest fluorescence in S. cerevisiae and they enabled to observe the green colors of the 
cells in visual judgment under natural light. The protein expression amount of monomeric 
ymUkG1 was higher than that of tetrameric yZsGreen. Both ymUkG1 and yZsGreen were 
available as the fusion reporters tagged to Fig1 protein to monitor the signal transduction, and 
significantly improved the ability as the fluorescent reporters compared to the previously 
used and non codon-optimized EGFP (optimized for mammalian). Finally, the monomeric 
ymUkG1 was successfully applied to improve the PPI detection system using Fig1 reporter. 
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The most commonly used GFP in S. cerevisiae probably commercially available EGFP, 
whose codons are optimized not for S. cerevisiae but for mammalian cells. Because recently 
it is more accessible to the several gene and fragment synthesis services, it is comparatively, 
readily possible to prepare the DNA fragment containing codon-optimized nucleic acid 
sequences. When there is a need for a large amount of protein expression, it might be better 
to check the CAI and GC content and test the codon-optimization of an interest protein. At 
the end, we propose the codon-optimized monomeric ymUkG1 (Supplementary Table 
Ⅲ-S1) is a good choice for GFP experiments using S. cerevisiae. 
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ZWT ZK35A ZI31A
Z955 Control
ZWT ZK35A ZI31A
Z955 Control
(A)
(B)
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GFP+GFP+GFP+
GFP+GFP+
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Figure Ⅲ-4. Fluorescence dot-plots of positive and negative controls used to determine 
the positve region (GFP+).  The analysis  is  presented as a dot-plot  of  fluorescence (GFP) 
against forward scatter (FSC). The Y-axis is an indication of fluorescence and the X-axis is an 
approximation  of  relative  cell  size.  The  positive  cells  express  Gγcyto-Fc  and  membrane-
anchored ZWT or ZK35A or ZI31A. The negative cells express Gγcyto-Fc and membrane-anchored 
Z955.  ‘Control’ indicates  BFG2118 and UGFG2 yeast  strains  harboring the pGK413 mock 
plasmid (without the expression of ‘Y’). (A) Flow cytometry analysis of the EGFP reporter 
fluorescence. (B) Flow cytometry analysis of the ymUkG1 reporter fluorescence.  ‘Control’ 
indicates BFG2118 and UGFG2 yeast strains harboring the pGK413 mock plasmid (without 
the expression of ‘Y’).   
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Figure Ⅲ-5. Fluorescence dot-plots of cell mixture. FACS analysis is presented as a dot-plot 
of  fluorescence  (GFP)  against  forward  scatter  (FSC).  The  Y-axis  is  an  indication  of 
fluorescence and the X-axis is an approximation of relative cell size. Cell mixtures were made 
from  the  positive  cells  (expressing  Gγcyto-Fc  and  membrane-anchored  ZWT  or  ZI31A)  and 
negative cells  (expressing Gγcyto-Fc and membrane-anchored Z955).  (A,  B) Flow cytometry 
analysis of the mixture containing 0.1% or 0.01% target cells expressing ZWT by using the 
EGFP reporter gene. (C, D) Flow cytometry analysis of the mixture containing 0.1% or 0.01% 
target  cells  expressing  ZWT  by  using  the  ymUkG1  reporter  gene.  (E,  F)  Flow  cytometry 
analysis of the mixture containing 0.1% or 0.01% target cells expressing ZI31A by using the 
EGFP reporter gene. (G, H) Flow cytometry analysis of the mixture containing 0.1% or 0.01% 
target cells expressing ZI31A by using the ymUkG1 reporter gene. 
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Methods 
 
Strains and media  
Details on yeast S. cerevisiae BY474199 , BY474299, MC-F1100 and other recombinant 
strains used in this study and their genotypes are outlined in Table 3. The yeast strains were 
grown in YPD media containing 1% (w/v) yeast extract, 2% peptone and 2% glucose or in 
SD media containing 0.67% yeast nitrogen base without amino acids (BD-Diagnostic 
Systems, Sparks, MD, USA) and 2% glucose. Amino acids and nucleotides (20 mg/L 
histidine, 60 mg/L leucine, 20 mg/L methionine, or 20 mg/L uracil) were supplemented into 
SD media to lack the relevant auxotrophic components. Agar (2%; w⁄v) was added to the 
media described above to produce YPD and SD solid media. 
 
Codon optimization and calculation of codon adaptation index (CAI) and GC content 
The nucleic acid sequences for codon-optimized GFPs for S. cerevisiae were designed 
using GeneArt® GeneOptimizer® software (Life Technologies/Thermo Fisher Scientific, San 
Jose, CA, USA). The DNA fragments for codon-optimized GFPs were prepared by GeneArt® 
Strings™ DNA fragments service. Codon adaptation indexes (CAIs) and GC contents before 
and after optimization were determined using GenScript Rare Codon Analysis Tool software 
(GenScript, Piscataway, NJ, USA). 
 
Construction of plasmids 
All plasmids and primers used in this study are listed in Table Ⅲ-2 and Supplementary 
Table Ⅲ-S2. The plasmids used for expression of varied GFPs were constructed as follows. 
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For AcGFP1, TagGFP2 and mUkG1, DNA fragments encoding the GFPs were 
PCR-amplified from pAcGFP1 (Clontech Laboratories/Takara Bio, Shiga, Japan), 
pTagGFP2-tubulin (Evrogen, Moscow, Russia) and pmUkG1-S1 (Medical & Biological 
Laboratories, Nagoya, Japan) using primer pairs 1 and 2, 3 and 4, and 5 and 6, digested with 
SalI+BamHI, and inserted into the same sites between the PGK1 promoter (PPGK1) and the 
PGK1 terminator (TPGK1) on pGK416110, yielding the plasmids pGK416-AcGFP1, 
pGK416-TagGFP2 and pGK416-mUkG1. For EGFP and ZsGreen, previously constructed 
plasmids pGK416-EGFP110 and pGK416-ZsGreen177 were used. The plasmids used for 
expression of codon-optimized GFPs (yEGFP, yAcGFP1, yTagGFP2, ymUkG1, yZsGreen, 
ymWasabi and ymNeonGreen) were constructed as follows. DNA fragments encoding the 
codon-optimized GFPs were PCR-amplified from the GeneArt® Strings™ DNA fragments 
using the primer pairs 7 and 8, 9 and 10, 11 and 12, 13 and 14, 15 and 16, 17 and 18, and 19 
and 20, digested with SalI+BamHI, and inserted into the same sites between the PPGK1 and the 
TPGK1 on pGK416110, yielding the plasmids pGK416-yEGFP, pGK416-yAcGFP1, 
pGK416-yTagGFP2, pGK416-ymUkG1, pGK416-yZsGreen, pGK416-ymWasabi and 
pGK416-ymNeonGreen.  
The plasmids used for integration of the GFP reporter genes at the FIG1 locus on the 
yeast chromosome were constructed as follows. A DNA fragment containing the homologous 
sequence of the FIG1 terminator (downstream of FIG1 gene; 200 bp) was PCR-amplified 
from pBlue-FIG1pt-ZsGreen177 using primer pair 21 and 22. The amplified fragments were 
digested with XhoI+KpnI and inserted into pBlueScript II KS(+) vector, yielding the plasmid 
pBlue-FIG1t. A DNA fragment containing the URA3 selectable marker was PCR-amplified 
from pBlue-FIG1pt-ZsGreen177 using primer pair 23 and 24. DNA fragments containing the 
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GFPs were PCR-amplified from pGK416-AcGFP1, pGK416-TagGFP2, pGK416-mUkG1, 
pGK416-ZsGreen, pGK416-yEGFP, pGK416-yAcGFP1, pGK416-yTagGFP2, 
pGK416-ymUkG1, pGK416-yZsGreen177 using primer pairs 25 and 26, 27 and 28, 29 and 30, 
31 and 32, 33 and 34, 35 and 36, 37 and 38, 39 and 40, and 41 and 42. Primers 25, 27, 29, 31, 
33, 35, 37, 39 and 41 contain the homologous regions of the C-terminus of FIG1 (50bp). 
Then, URA3 fragment and GFP fragment were linked by overlap PCR using primer pairs 25 
and 24, 27 and 24, 29 and 24, 31 and 24, 33 and 24, 35 and 24, 37 and 24, 39 and 24, and 41 
and 24, and the overlap fragments were digested with SacII+XhoI and inserted into 
pBlue-FIG1t, yielding the plasmids pBlue-UFt-AcGFP1, pBlue-UFt-TagGFP2, 
pBlue-UFt-mUkG1, pBlue-UFt-ZsGreen, pBlue-UFt-yEGFP, pBlue-UFt-yAcGFP1, 
pBlue-UFt-yTagGFP2, pBlue-UFt-ymUkG1 and pBlue-UFt-yZsGreen. 
 
Construction of yeast strains 
All strains used in this study are listed in Table Ⅲ-3. Integration of the DNA cassettes 
for expressing GFPs fused FIG1 was achieved as follows. The DNA fragments containing 
FIG1(50bp)-GFP-URA3-TFIG1 (TFIG1: FIG1 terminator) were amplified from 
pBlue-UFt-AcGFP1, pBlue-UFt-TagGFP2, pBlue-UFt-mUkG1, pBlue-UFt-ZsGreen, 
pBlue-UFt-yEGFP, pBlue-UFt-yAcGFP1, pBlue-UFt-yTagGFP2, pBlue-UFt-ymUkG1 and 
pBlue-UFt-yZsGreen using primer pair 43 and 44, respectively. The amplified DNA 
fragments were used to transform BY4741 using the lithium acetate method111. The 
transformants were selected on SD-Ura plate (SD solid medium without uracil, but 
containing leucine, histidine and methionine). After confirming the correct integration, the 
URA3 marker was “popped-out” by homologous recombination using counter-selection with 
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5-fluoroorotic acid (5-FOA, Fluorochem, Derbyshire, UK), to yield BYFAG1, BYFTG1, 
BYFUG1, BYFZG1, BYFEG2, BYFAG2, BYFTG2, BYFUG2 and BYFZG2.  
Substitution of the STE18 gene by kanMX4 in the yeast chromosome was achieved by 
amplifying the DNA fragment containing PSTE18–kanMX4–TSTE18 (PSTE18: STE18 promoter and 
TSTE18: STE18 terminator) from pGK426-GPTK 48 using primer pair 45 and 46. The amplified 
DNA fragment was then used to transform BYFUG2, and the transformant was selected on 
the YPD solid medium containing G418 (500 ng/mL) (Nacalai Tesque, Kyoto, Japan) to 
yield the UGW2 strain.  
Integration of the DNA cassettes for the Gγcyto–Fc protein in the cytosol was achieved as 
follows. The DNA fragments containing URA3-PPGK1-Gγcyto-Fc-TPGK1-THIS3 (THIS3: HIS3 
terminator) were amplified from pUMGP-GγMFcH48 using primer pair 47 (containing the 
homologous regions of the HIS3 promoter) and 48. The amplified DNA fragments were used 
to transform UGW2 using the lithium acetate method. The transformants were selected on the 
SD-Ura plate (containing leucine, histidine and methionine) to yield UGFG2.  
Integration of the DNA cassettes for expressing the membrane-associated Fc protein 
was achieved as follows. The DNA fragments containing 
PSTE18-PPGK1-Fc-Ste18C-TPGK1-kanMX4-TSTE18 and PSTE18-PPGK1-Gpa1N-Fc-TPGK1-kanMX4-TSTE18 
were amplified from pUMGPTK-Fc-Ste18C182 and pUMGPTK-Gpa1N-Fc182 using primer 
pair 45 and 46, respectively. The amplified DNA fragments were used to transform BYFUG2 
using the lithium acetate method. The transformants were selected on the YPD solid medium 
containing G418 (500 ng/mL) to yield BYFUG2-FC and BYFUG2-FN. Integration of the 
DNA cassettes for the Gγcyto–Z domain variants (ZWT, ZK35A, ZI31A and Z955) in the cytosol was 
achieved as follows. The DNA fragments containing URA3-PPGK1-Gγcyto-ZWT(-ZK35A, -ZI31A and 
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-Z955)-TPGK1-THIS3 and URA3-PPGK1-Gγcyto-TPGK1-THIS3 were amplified from 
pUSTE18p-Gγcyto-ZWT(-ZK35A, -ZI31A and -Z955)-HIS3t182 and 
pUSTE18p-Gγcyto-HIS3t182 using primers 47 (containing the homologous regions of the 
HIS3 promoter) and 48. The amplified DNA fragments were used to transform BYFUG2-FC 
and BYFUG2-FN using the lithium acetate method111. The transformants were selected on the 
SD-Ura plate (containing leucine, histidine and methionine) to yield UG2-FCGW, 
UG2-FCGK, UG2-FCGI, UG2-FCG9, UG2-FCG0 and UG2-FNGW, UG2-FCGK, 
UG2-FCGI, UG2-FCG9 and UG2-FCG0. 
The constructed strains were used for the assays or the transformation for introducing 
the plasmids using the lithium acetate method. All strains and transformants used for the 
assays were listed in Supplementary Tables Ⅲ-S3–Ⅲ-S6. 
 
Culture conditions for GFP expressions in yeast cells 
For the expression of varied GFPs (Fig. Ⅲ-1A), the yeast transformants 
(Supplementary Table Ⅲ-S3) were were grown in 5 mL of SD-Ura medium at 30°C 
overnight. The cultured cells were then inoculated in 2 mL of fresh SD-Ura medium to obtain 
an initial optical density at 600 nm (OD600) of 0.1. The cells were then cultivated at 30°C for 
3 hours and harvested. 
The signal transduction assays using FIG1-GFP reporter genes (Fig. Ⅲ-2A) basically 
followed previous methods144, with certain modifications. The engineered yeast a-cells 
(Supplementary Table Ⅲ-S4) were grown in 5 mL of YPD medium 30°C overnight. The 
cultured cells were then inoculated in 2 mL of fresh YPD medium containing 5 μM α-factor 
(Zymo Research, Orange, CA, USA) to obtain an initial OD600 of 0.1. The cells were then 
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cultivated at 30°C for 6 hours and harvested. 
The protein–protein interaction assays using FIG1-GFP reporter genes, followed 
previous methods144. In brief, in the case of the Gγ recruitment system for soluble cytosolic 
target protein (Fig. Ⅲ-3A), the engineered yeast a-cells (Supplementary Table Ⅲ-S5) 
were grown in 5 mL of SD-His medium at 30°C overnight. The cultured cells were then 
inoculated in 2 mL of fresh SD-His medium containing 5 μM α-factor to obtain an initial 
OD600 of 0.1. In the case of the Gγ recruitment system for membrane target protein (Fig. 
Ⅲ-3B and Supplementary Fig. Ⅲ-S5), the engineered yeast a-cells (Supplementary 
TableⅢ-S6) were grown in 5 mL of YPD medium at 30°C overnight. The cultured cells 
were then inoculated in 2 mL of fresh YPD medium containing 5 μM α-factor to obtain an 
initial OD600 of 0.1. In both cases, the cells were then cultivated at 30°C for 6 hours and 
harvested. 
 
Fluorescence microscopy 
Fluorescence microscopy observation was basically following previous procedures183. 
The harvested cells were washed and resuspended in distilled water. The cell suspensions 
were observed using a BIOREVO BZ-9000 fluorescence microscope (Keyence, Osaka, 
Japan). Green fluorescence images were acquired with a 470/40 band-pass filter for 
excitation and a 535/50 band-pass filter for emission. 
 
Flow cytometry 
Flow cytometry analysis was basically following previous procedures184 The harvested 
cells were diluted into test tubes containing sheath solution and GFP fluorescence was 
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measured by using a BD FACSCanto II flow cytometer (BD Biosciences, San Jose, CA). The 
green fluorescence signal from 10,000 cells was excited with a 488-nm blue laser and 
collected through a 530/30-nm band-pass (GFP) filter. The data were analyzed by using BD 
FACSDiva software (version 5.0, BD Biosciences) and FlowJo software version 7.2.2 
(Treestar, Inc., San Carlos, CA) 
 
Detection of target cells from cell mixture by flow cytometer 
To evaluate GFPs reporter of Gγ recruitment system (Fig. Ⅲ-S3), yeast transformants 
(Supplementary Table Ⅲ-S5) were grown in 5 mL of SD-His medium at 30°C overnight. 
Cell mixtures were prepared by mixing the target cells (BFG2118+pGK413-ZWTmem, 
UGFG2+pGK413-ZWTmem, BFG2118+pGK413-ZI31Amem or 
UGFG2+pGK413-ZI31Amem) with negative cells (BFG2118+pGK413-Z955mem or 
UGFG2+pGK413-Z955mem) in the initial ratios. The mixture yeast cells were then 
inoculated into 2 mL of fresh SD-His medium containing 5 μM α-factor to obtain an initial 
OD600 of 0.1. The cells were thereafter cultivated at 30°C for 6 hours, and then 1,000,000 
cells were detected by using a BD FACSCanto II flow cytometer. 
 
SDS-PAGE 
Sample Preparation was performed using an alkaline lysis method185. Protein extract (15 
μl) were run on a 10-20% Extra PAGE One Precast Gel (Nacalai Tesque) and the gel were 
stained with CBB Stain One (Nacalai Tesque). 
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 Table Ⅲ-2. List of plasmids used in this study. 
 
Plasmids Genotype Reference  
pGK416 Expression vector containing PGK1 promoter,  
CEN/ARS single-copy origin and URA3 marker 
[110] 
pGK416-EGFP EGFP expression, in pGK416 [110] 
pGK416-AcGFP1 AcGFP1 expression, in pGK416 This study 
pGK416-TagGFP2 TagGFP2 expression, in pGK416 This study 
pGK416-mUkG1 mUkG1 expression, in pGK416 This study 
pGK416-ZsGreen ZsGreen expression, in pGK416 [177] 
pGK416-yEGFP yEGFP (codon-optimized EGFP) expression, in pGK416 This study 
pGK416-yAcGFP1 yAcGFP1 (codon-optimized AcGFP1) expression, in pGK416 This study 
pGK416-yTagGFP2 yTagGFP2 (codon-optimized TagGFP2) expression, in pGK416 This study 
pGK416-ymUkG1 ymUkG1 (codon-optimized mUkG1) expression, in pGK416 This study 
pGK416-yZsGreen yZsGreen (codon-optimized ZsGreen) expression, in pGK416 This study 
pGK416-ymWasabi ymWasabi (codon-optimized mWasabi) expression, in pGK416 This study 
pGK416-ymNeonGreen ymNeonGreen (codon-optimized mNeonGreen) expression, in pGK416 This study 
pBlueScript II KS(+) Cloning vector Agilent 
Technologies 
pBlue-FIG1pt-ZsGreen PFIG1(300 bp)-URA3-ZsGreen-TFIG1(200 bp) in pBlueScript II KS(+) [177] 
pBlue-FIG1t TFIG1(200 bp) in pBlueScript II KS(+) This study 
pBlue-UFt-AcGFP1  C-terminus of FIG1 (50 bp)-AcGFP1-URA3-TFIG1(200 bp) in pBlueScript II KS(+) This study 
pBlue-UFt-TagGFP2  C-terminus of FIG1 (50 bp)-TagGFP2-URA3-TFIG1(200 bp) in pBlueScript II KS(+) This study 
pBlue-UFt-mUkG1  C-terminus of FIG1 (50 bp)-mUkG1-URA3-TFIG1(200 bp) in pBlueScript II KS(+) This study 
pBlue-UFt-ZsGreen  C-terminus of FIG1 (50 bp)-ZsGreen-URA3-TFIG1(200 bp) in pBlueScript II KS(+) This study 
pBlue-UFt-yEGFP C-terminus of FIG1 (50 bp)-yEGFP-URA3-TFIG1(200 bp) in pBlueScript II KS(+) This study 
pBlue-UFt-yAcGFP1 C-terminus of FIG1 (50 bp)-yAcGFP1-URA3-TFIG1(200 bp) in pBlueScript II KS(+) This study 
pBlue-UFt-yTagGFP2  C-terminus of FIG1 (50 bp)-yTagGFP2-URA3-TFIG1(200 bp) in pBlueScript II 
KS(+) 
This study 
pBlue-UFt-ymUkG1 C-terminus of FIG1 (50 bp)-ymUkG1-URA3-TFIG1(200 bp) in pBlueScript II KS(+) This study 
pBlue-UFt-yZsGreen C-terminus of FIG1 (50 bp)-yZsGreen-URA3-TFIG1(200 bp) in pBlueScript II KS(+) This study 
pGK426 Expression vector containing PGK1 promoter, 2µ origin and URA3 marker [110] 
pGK426-GPTK URA3-PSTE18-kanMX4-TSTE18 in pGK426 [48] 
pUSTE18p-Gγcyto-HIS3t URA3-STE18 promoter-Gγcyto-PGK1 terminator-HIS3 terminator in pGK426 [182] 
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pUMGP-GγMFcH URA3-PSTE18-Gγcyto-Fc-TPGK1 in pUSTE18p-Gγcyto-HIS3t [48] 
pGK413 Expression vector containing PGK1 promoter, CEN/ARS single-copy origin and 
HIS3 marker 
[110] 
pGK413-ZWTmem ZWT and C-terminus of Ste18 (9 a.a.) fusion expression, in pGK413 [144] 
pGK413-ZK35Amem ZK35A and C-terminus of Ste18 (9 a.a.) fusion expression, in pGK413 [144] 
pGK413-ZI31Amem ZI31A and C-terminus of Ste18 (9 a.a.) fusion expression, in pGK413 [144] 
pGK413-Z955mem Z955 and C-terminus of Ste18 (9 a.a.) fusion expression, in pGK413 [144] 
pGK426-GPTK URA3-STE18 promoter-kanMX4-STE18 terminator in pGK426 [48] 
pUMGPTK-Gpa1N-Fc URA3-PSTE18-PPGK1-Gpa1N (9 a.a.)-Fc-TPGK1-kanMX4-TSTE18 in pGK426-GPTK [182] 
pUMGPTK-Fc-Ste18C URA3-PSTE18-PPGK1-Fc-Ste18C (9 a.a.)-TPGK1-kanMX4-TSTE18 in pGK426-GPTK [182] 
pUSTE18p-Gγcyto-HIS3t URA3-PSTE18-Gγcyto-TPGK1-THIS3 in pGK426 [182] 
pUSTE18p-Gγcyto-ZWT-H URA3-PSTE18-Gγcyto-ZWT-TPGK1 in pUSTE18p-Gγcyto-HIS3t [182] 
pUSTE18p-Gγcyto-ZK35A
-HIS3t 
URA3-PSTE18-Gγcyto-ZK35A-TPGK1 in pUSTE18p-Gγcyto-HIS3t [182] 
pUSTE18p-Gγcyto-ZI31A-
HIS3t 
URA3-PSTE18-Gγcyto-ZI31A-TPGK1 in pUSTE18p-Gγcyto-HIS3t [182] 
pUSTE18p-Gγcyto-Z955-
HIS3t 
URA3-PSTE18-Gγcyto-Z955-TPGK1 in pUSTE18p-Gγcyto-HIS3t [182] 
 
 136 
Table Ⅲ-3. Yeast strains used in this study. 
 
Strain Relevant feature Reference  
BY4741 MATa his3∆1 ura3∆0 leu2∆0 met15∆0 [99] 
BY4742 MATα his3∆1 ura3∆0 leu2∆0 lys2∆0 [99] 
MC-F1 BY4741 fig1::FIG1-EGFP [100] 
BYFAG1 BY4741 fig1::FIG1-AcGFP1 This study 
BYFTG1 BY4741 fig1::FIG1-TagGFP2 This study 
BYFUG1 BY4741 fig1::FIG1-mUkG1 This study 
BYFZG1 BY4741 fig1::FIG1-ZsGreen This study 
BYFEG2 BY4741 fig1::FIG1-yEGFP (codon optimized EGFP) This study 
BYFAG2 BY4741 fig1::FIG1-yAcGFP1 (codon optimized AcGFP1) This study 
BYFTG2 BY4741 fig1::FIG1-yTagGFP2 (codon optimized TagGFP2) This study 
BYFUG2 BY4741 fig1::FIG1-ymUkG1 (codon optimized mUkG1) This study 
BYFZG2 BY4741 fig1::FIG1-yZsGreen (codon optimized ZsGreen) This study 
BFG2118 MC-F1 ste18∆::kanMX4 his3∆::URA3-PSTE18-Gγcyto-Fc [48] 
UGW2 BYFUG2 ste18∆::kanMX4 This study 
UGFG2 BYFUG2 ste18∆::kanMX4 his3∆::URA3-PSTE18-Gγcyto-Fc This study 
MC-FC MC-F1 ste18∆::kanMX4-PPGK1-Fc-Ste18C [182] 
MC-FN MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-Fc [182] 
FC-GW MC-F1 ste18∆::kanMX4-PPGK1-Fc-Ste18C his3∆::URA3-PSTE18-Gγcyto-ZWT [182] 
FC-GK MC-F1 ste18∆::kanMX4-PPGK1-Fc-Ste18C his3∆::URA3-PSTE18-Gγcyto-ZK35A [182] 
FC-GI MC-F1 ste18∆::kanMX4-PPGK1-Fc-Ste18C his3∆::URA3-PSTE18-Gγcyto-ZI31A [182] 
FC-G9 MC-F1 ste18∆::kanMX4-PPGK1-Fc-Ste18C his3∆::URA3-PSTE18-Gγcyto-Z955 [182] 
FC-G0 MC-F1 ste18∆::kanMX4-PPGK1-Fc-Ste18C his3∆::URA3 [182] 
FN-GW MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-Fc his3∆::URA3-PSTE18-Gγcyto-ZWT [182] 
FN-GK MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-Fc his3∆::URA3-PSTE18-Gγcyto-ZK35A [182] 
FN-GI MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-Fc his3∆::URA3-PSTE18-Gγcyto-ZI31A [182] 
FN-G9 MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-Fc his3∆::URA3-PSTE18-Gγcyto-Z955 [182] 
FN-G0 MC-F1 ste18∆::kanMX4-PPGK1-Gpa1N-Fc his3∆::URA3 [182] 
BYFUG2-FC BYFUG2 ste18∆::kanMX4-PPGK1-Fc-Ste18C This study 
BYFUG2-FN BYFUG2 ste18∆::kanMX4-PPGK1-Gpa1N-Fc This study 
UG2-FCGW BYFUG2 ste18∆::kanMX4-PPGK1-Fc-Ste18C his3∆::URA3-PSTE18-Gγcyto-ZWT This study 
UG2-FCGK BYFUG2 ste18∆::kanMX4-PPGK1-Fc-Ste18C his3∆::URA3-PSTE18-Gγcyto-ZK35A This study 
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UG2-FCGI BYFUG2 ste18∆::kanMX4-PPGK1-Fc-Ste18C his3∆::URA3-PSTE18-Gγcyto-ZI31A This study 
UG2-FCG9 BYFUG2 ste18∆::kanMX4-PPGK1-Fc-Ste18C his3∆::URA3-PSTE18-Gγcyto-Z955 This study 
UG2-FCG0 BYFUG2 ste18∆::kanMX4-PPGK1-Fc-Ste18C his3∆::URA3 This study 
UG2-FNGW BYFUG2 ste18∆::kanMX4-PPGK1-Gpa1N-Fc his3∆::URA3-PSTE18-Gγcyto-ZWT This study 
UG2-FNGK BYFUG2 ste18∆::kanMX4-PPGK1-Gpa1N-Fc his3∆::URA3-PSTE18-Gγcyto-ZK35A This study 
UG2-FNGI BYFUG2 ste18∆::kanMX4-PPGK1-Gpa1N-Fc his3∆::URA3-PSTE18-Gγcyto-ZI31A This study 
UG2-FNG9 BYFUG2 ste18∆::kanMX4-PPGK1-Gpa1N-Fc his3∆::URA3-PSTE18-Gγcyto-Z955 This study 
UG2-FNG0 BYFUG2 ste18∆::kanMX4-PPGK1-Gpa1N-Fc his3∆::URA3 This study 
 
 
 
 
 
 
Table Ⅲ-4. Codon adaptation index (CAI) and GC content of varied GFPs tested 
 
Protein CAI GC content (%) 
EGFP 0.52 61.8 
AcGFP1 0.56 59.0 
TagGFP2 0.50 63.6 
mUkG1 0.69 45.0 
ZsGreen 0.70 44.9 
yEGFP 0.87 40.4 
yAcGFP1 0.87 40.2 
yTagGFP2 0.87 40.2 
ymUkG1 0.88 40.1 
yZsGreen 0.90 40.0 
ymWasabi 0.87 39.7 
ymNeonGreen 0.90 40.0 
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Table Ⅲ-5. Summary of the FACS analysis of the Gγ recruitment system for cytosolic 
target proteins. The percentages of cells belonging to GFP+ were measured by flow 
cytometry. 
 
Repoter GFP Type of membrane-anchored  
Z variant 
Percentage of GFP+ 
EGFP ZWT 66.1% 
EGFP ZK35A 19.6% 
EGFP ZI31A 4.5% 
EGFP Z955 0% 
EGFP Control 0% 
ymUkG1 ZWT 98.7% 
ymUkG1 ZK35A 96.5% 
ymUkG1 ZI31A 81.7% 
ymUkG1 Z955 0% 
ymUkG1 Control 0% 
 
 
 
Table Ⅲ-6. Summary of the FACS analysis of mixed populations of target cell and 
negative cell. 
 
Reporter GFP Target Initial ratio of target cell  
in mixture 
Ratio of detected number per 
initial number of target cell 
EGFP ZWT 0.1% 46% 
EGFP ZWT 0.01% 44% 
ymUkG1 ZWT 0.1% 59% 
ymUkG1 ZWT 0.01% 61% 
EGFP ZI31A 0.1% 13% 
EGFP ZI31A 0.01% 28% 
ymUkG1 ZI31A 0.1% 75% 
ymUkG1 ZI31A 0.01% 69% 
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Supplementary information  
 
 
Figure Ⅲ-S1. Expression comparison of varied codon-optimized GFPs in S. cerevisiae. 
(A) Mean GFP fluorescence intensities (MFIs). The MFIs of 10,000 cells were measured by flow cytometry. (B) 
Green fluorescence images of the cells. The images were observed by fluorescence microscope equipped with the 
60× objective lens. Exposure time was 1/15 s. These contains the same data with Fig. 1B and 1C.
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Figure Ⅲ-S2. Comparison of histogram plots between codon-optimized and non codon-optimized GFPs 
expressions in S. cerevisiae. The histogram plots show the analytical data for 10,000 cells measured by flow 
cytometer.
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Figure  Ⅲ-S3.  Schematic  diagram of  Gγ  recruitment  systems to  detect  PPIs  of  cytosolic  or 
membrane target proteins. (A) Schematic outline of the Gγ recruitment system for cytosolic target 
proteins. When target protein ‘X’ fused to Gγcyto interacts with candidate protein ‘Y1,’ the Gβ and 
Gγcyto  complex  (Gβγcyto)  migrates  to  the  inner  leaflet  of  the  plasma  membrane  and  restores  the 
signaling function. If protein ‘X’ cannot interact with protein ‘Y,’ Gβγcyto is released into the cytosol, 
and signaling is blocked. (B) Schematic outline of the Gγ recruitment system for membrane protein 
targets. When membrane target protein ‘X’ interacts with candidate protein ‘Y’ fused to Gγcyto, the 
Gβγcyto  complex migrates  to  the inner  leaflet  of  the plasma membrane and restores  the signaling 
function. If membrane protein ‘X’ cannot interact with protein ‘Y,’ Gβγcyto is released into the cytosol, 
and signaling is blocked. (C) Flow diagram of the screening procedure for the Gγ recruitment system. 
Two selection methods are available to screen new binding proteins. One is to use the GFP reporter 
genes. When target candidate proteins are expressed in the yeast cells and interact with each other, 
they induce GFP expression and are isolated by flow cytometry.
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Figure Ⅲ-S4. Expression comparison of non codon-optimized EGFP and codon-optimized ymUkG1 as 
fusion tagged proteins to report PPIs using the Gγ recruitment systems. Flow cytometry analyses using the 
Gγ recruitment system for membrane protein targets. The Fc protein was used as the membrane target protein 
‘X’ and expressed as membrane-associated proteins with the N-terminal lipid anchor (derived from Gpa1p). 
Four Z variants (ZWT, ZK35A,, ZI31A and Z955) were used as the cytosolic candidate ‘Y’ proteins and expressed as 
the fusion proteins with Gγcyto  (Gγcyto-Z variants). Control indicates the FN-G0 and UG2-FNG0 yeast strains 
without the expression of ‘Gγcyto-Y’). The engineered strains were grown in the media containing 5 μM α-factor 
and served to the analyses of mean fluorescence intensities (MFIs). The MFIs of 10,000 cells were measured by 
flow cytometry.
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Supplementary Table Ⅲ-S1. Nucleic acid sequences of codon-optimized GFPs for the 
Saccharomyces cerevisiae. 
 
yEGFP 
ATGGTCAGTAAGGGTGAAGAATTATTCACTGGTGTTGTTCCAATCTTGGTTGAATTGGATGGTGATGTTAACG
GTCACAAGTTTTCTGTTTCTGGTGAAGGTGAAGGTGATGCTACTTATGGTAAATTGACCTTGAAGTTCATCTG
TACCACAGGTAAATTGCCAGTTCCATGGCCAACTTTGGTTACTACTTTGACTTATGGTGTCCAATGCTTCTCT
AGATACCCAGATCATATGAAGCAACACGACTTTTTCAAATCCGCTATGCCAGAAGGTTACGTTCAAGAAAGA
ACCATCTTCTTCAAGGATGACGGTAACTACAAAACTAGAGCCGAAGTTAAGTTCGAAGGTGATACCTTGGTT
AACAGAATCGAATTGAAGGGTATCGACTTCAAAGAAGATGGTAACATCTTGGGTCATAAGTTGGAATACAAC
TACAACTCCCACAACGTTTACATTATGGCCGATAAGCAAAAGAACGGTATCAAGGTTAACTTCAAGATCAGAC
ACAACATCGAAGATGGTAGTGTTCAATTGGCTGATCACTACCAACAAAACACTCCAATTGGTGATGGTCCAG
TTTTGTTGCCAGATAACCATTACTTGTCTACCCAATCTGCTTTGTCTAAGGACCCAAACGAAAAAAGAGATCA
CATGGTCTTGTTGGAATTCGTTACTGCTGCTGGTATTACTTTGGGTATGGACGAATTATACAAGTAA 
 
yAcGFP1 
ATGGTTTCTAAGGGTGCTGAATTATTCACTGGTATCGTTCCAATCTTGATCGAATTGAACGGTGATGTTAACG
GTCACAAGTTTTCTGTTTCTGGTGAAGGTGAAGGTGATGCTACTTATGGTAAATTGACCTTGAAGTTCATCTG
TACCACAGGTAAATTGCCAGTTCCATGGCCAACTTTGGTTACTACTTTGTCTTATGGTGTCCAATGCTTCTCT
AGATACCCAGATCATATGAAGCAACACGACTTTTTCAAATCCGCTATGCCAGAAGGTTACATCCAAGAAAGA
ACCATCTTTTTCGAAGATGACGGTAACTACAAGTCTAGAGCTGAAGTTAAGTTCGAAGGTGATACCTTGGTTA
ACAGAATTGAATTGACCGGTACTGACTTCAAAGAAGATGGTAACATTTTGGGTAACAAGATGGAATACAACTA
CAACGCCCATAACGTTTACATCATGACTGATAAGGCTAAGAACGGTATCAAGGTTAACTTCAAGATCAGACA
CAACATCGAAGATGGTTCAGTTCAATTGGCTGATCACTACCAACAAAACACTCCAATTGGTGATGGTCCAGT
TTTGTTGCCAGATAACCATTACTTGTCTACCCAATCTGCTTTGTCTAAGGACCCAAACGAAAAAAGAGATCAC
ATGATCTACTTCGGTTTCGTTACTGCTGCTGCTATTACTCATGGTATGGACGAATTATACAAGTAA 
 
yTagGFP2 
ATGTCTGGTGGTGAAGAATTATTCGCTGGTATAGTTCCAGTCTTGATCGAATTGGATGGTGATGTTCATGGTC
ACAAGTTTTCTGTTAGAGGTGAAGGTGAAGGTGATGCTGATTATGGTAAATTGGAAATCAAGTTCATCTGCAC
CACAGGTAAATTGCCAGTTCCATGGCCAACTTTGGTTACTACTTTGTGTTACGGTATTCAATGCTTCGCTAGA
TACCCAGAACATATGAAGATGAACGACTTCTTCAAATCCGCTATGCCAGAAGGTTACATTCAAGAAAGAACC
ATTCAATTCCAAGACGACGGTAAATACAAAACCAGAGGTGAAGTTAAGTTCGAAGGTGATACTTTGGTCAAC
AGAATCGAATTGAAGGGTAAGGACTTCAAAGAAGATGGTAACATCTTGGGTCATAAGTTGGAATACTCATTC
AACTCCCACAACGTTTACATCAGACCAGATAAGGCTAACAATGGTTTGGAAGCTAACTTCAAGACCAGACAT
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AATATTGAAGGTGGTGGTGTTCAATTGGCCGATCATTATCAAACTAATGTTCCATTGGGTGACGGTCCAGTTT
TGATTCCAATCAATCATTACTTGTCCACCCAAACTAAGATCTCCAAGGATAGAAATGAAGCCAGAGATCACAT
GGTCTTGTTGGAATCTTTTTCTGCTTGTTGTCATACCCACGGTATGGACGAATTATACAGATGA 
 
ymUkG1 
ATGGTCAGTGTCATCAAAGAAGAAATGAAGATCAAGTTGCACATGGAAGGTAACGTTAATGGTCATGCCTTT
GTTATTGAAGGTGATGGTAAAGGTAAACCATACGATGGTACTCAAACTTTGAACTTGACTGTCAAAGAAGGT
GCTCCATTGCCATTCTCTTACGATATTTTGACTAACGCCTTCCAATACGGTAATAGAGCTTTTACTAAGTACC
CAGCCGATATCCCAGATTACTTTAAGCAAACTTTTCCAGAAGGTTACTCCTGGGAAAGAACTATGTCTTACGA
AGATAACGCTATCTGCAACGTCAGATCCGAAATTTCTATGGAAGGTGATTGCTTCATCTACAAGATCAGATTC
GATGGTAAGAACTTTCCACCAAATGGTCCAGTCATGCAAAAAAAGACTTTGAAGTGGGAACCATCCACCGAA
ATGATGTATGTTAGAGATGGTTTCTTGATGGGTGATGTCAATATGGCTTTGTTGTTGGAAGGTGGTGGTCATC
ATAGATGTGATTTCAAGACTTCTTACAAGGCCAAGAAGGTTGTTCAATTGCCAGATGCTCATAAGATCGATCA
CAGAATCGAAATCTTGTCCCACGATAGAGATTACTCCAAGGTTAAGTTGTACGAAAACGCTGTTGCTAGAAA
CTCTTTGTTGCCATCTCAAGCTTCTAAGTAA 
 
yZsGreen 
ATGGCTCAATCCAAACATGGTTTGACCAAAGAAATGACCATGAAGTACAGAATGGAAGGTTGTGTTGATGGT
CACAAGTTCGTTATTACTGGTGAAGGTATTGGTTACCCATTCAAAGGTAAGCAAGCTATCAACTTGTGTGTTG
TTGAAGGTGGTCCATTGCCATTTGCTGAAGATATTTTGTCTGCTGCTTTCATGTACGGTAACAGAGTTTTTAC
TGAATACCCACAAGATATCGCCGACTACTTTAAGAATTCATGTCCAGCTGGTTACACCTGGGATAGATCTTTT
TTGTTTGAAGATGGTGCTGTCTGTATCTGCAACGCTGATATTACTGTTTCCGTTGAAGAAAACTGCATGTACC
ACGAATCTAAGTTCTACGGTGTTAATTTTCCAGCTGATGGTCCAGTTATGAAGAAGATGACTGATAATTGGGA
ACCATCCTGCGAAAAGATTATTCCAGTTCCAAAGCAAGGTATCTTGAAGGGTGATGTTTCTATGTACTTGTTA
TTGAAGGACGGTGGTAGATTGAGATGTCAATTCGATACTGTTTACAAGGCCAAGTCTGTTCCAAGAAAAATG
CCTGATTGGCATTTCATCCAACATAAGTTGACCAGAGAAGATAGATCCGATGCCAAAAATCAAAAGTGGCAT
TTGACCGAACATGCTATTGCTTCAGGTTCTGCTTTGCCATAA 
 
ymWasabi 
ATGGTCAGTAAGGGTGAAGAAACTACTATGGGTGTTATCAAGCCAGACATGAAGATCAAGTTGAAGATGGAA
GGTAACGTTAACGGTCATGCCTTTGTTATTGAAGGTGAAGGTGAAGGTAAACCATACGATGGTACTAATACC
ATTAACTTGGAAGTCAAAGAAGGTGCTCCATTGCCATTCTCTTACGATATTTTGACTACCGCTTTCTCATACG
GTAATAGAGCTTTTACTAAGTACCCAGATGACATCCCAAACTACTTCAAGCAATCTTTTCCAGAAGGTTACTC
TTGGGAAAGAACTATGACTTTCGAAGATAAGGGTATCGTCAAGGTTAAGTCCGATATCTCTATGGAAGAAGA
TTCCTTCATCTACGAAATCCACTTGAAGGGTGAAAATTTCCCACCAAATGGTCCAGTCATGCAAAAAGAAACA
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ACTGGTTGGGATGCTTCTACCGAAAGAATGTATGTTAGAGATGGTGTCTTGAAAGGTGACGTCAAAATGAAG
TTGTTGTTGGAAGGTGGTGGTCATCATAGAGTTGATTTCAAGACTATCTACAGAGCTAAGAAGGCTGTTAAG
TTGCCAGATTACCATTTCGTTGATCACAGAATCGAAATCTTGAACCACGATAAGGATTACAACAAGGTTACCG
TTTACGAAATTGCTGTTGCTAGAAACTCTACCGATGGTATGGATGAATTATACAAGTAA 
 
ymNeonGreen 
ATGGTCAGTAAGGGTGAAGAAGATAACATGGCTTCTTTGCCAGCTACTCATGAATTGCATATTTTCGGTTCCA
TCAACGGTGTTGATTTCGATATGGTTGGTCAAGGTACTGGTAATCCAAATGATGGTTACGAAGAATTGAACTT
GAAGTCTACTAAGGGTGACTTGCAATTCTCTCCATGGATTTTGGTTCCACATATTGGTTACGGTTTCCACCAA
TATTTGCCATATCCAGATGGTATGTCTCCATTTCAAGCTGCTATGGTTGATGGTTCTGGTTACCAAGTTCATA
GAACCATGCAATTTGAAGATGGTGCTTCTTTGACCGTCAACTACAGATATACTTACGAAGGTTCCCATATCAA
AGGTGAAGCTCAAGTTAAGGGTACTGGTTTTCCAGCTGATGGTCCAGTTATGACTAATTCTTTGACTGCTGCT
GATTGGTGCAGATCTAAAAAGACTTACCCAAACGATAAGACCATCATCTCTACTTTCAAGTGGTCTTACACTA
CTGGTAACGGTAAGAGATATAGATCTACTGCTAGAACTACTTACACCTTCGCTAAACCTATGGCTGCTAACTA
CTTGAAGAATCAACCTATGTACGTTTTCAGAAAGACCGAATTGAAGCACTCCAAAACTGAATTGAATTTCAAA
GAATGGCAAAAGGCCTTCACCGATGTTATGGGTATGGATGAATTATACAAGTAA 
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Supplementary Table Ⅲ-S2. List of primers. 
 
No. Name Sequence (5’ to 3) 
1 Sall-start-AcGFP1-fw aaaagtcgacatggtgagcaagggc 
2 BamHl-end-AcGFP1-rv ttttggatcctcacttgtacagctcat 
3 Sall-start-TagGFP2-fw aaaagtcgacatgagcgggggcgaggag 
4 BamHl-end-TagGFP2-rv ttttggatccttacctgtacagctcgtc 
5 Sall-start-mUkG1-fw aaaagtcgacatggtgagtgtgattaaa 
6 BamHl-end-mUkG1-rv ttttggatccttacttcgaagcctgact 
7 Sall-start-EGFP(Yeast)-fw aaaagtcgacatggtcagtaagggtgaa 
8 BamHl-end-EGFP(Yeast)-rv ttttggatccttacttgtataattcgtc 
9 Sall-start-AcGFP1(Yeast)-fw aaaagtcgacatggtttctaagggtgct 
10 BamHl-end-AcGFP1(Yeast)-rv ttttggatccttacttgtataattcgtc 
11 Sall-start-TagGFP2(Yeast)-fw aaaagtcgacatgtctggtggtgaagaa 
12 BamHl-end-TagGFP2(Yeast)-rv ttttggatcctcatctgtataattcgtc 
13 Sall-start-mUkG1(Yeast)-fw aaaagtcgacatggtcagtgtcatcaaaga 
14 BamHl-end-mUkG1(Yeast)-rv ttttggatccttacttagaagcttgagatg 
15 Sall-start-ZsGreen(Yeast)-fw aaaagtcgacatggctcaatccaaacat 
16 BamHl-end-ZsGreen (Yeast)-rv ttttggatccttatggcaaagcagaacc 
17 Sall-start-mWasabi (Yeast)-fw tagcgtcgacatggtgagcaagggcgagg 
18 BamHl-end-mWasabi (Yeast)-rv tagacccgggttacttgtataattcatccataccatcgg 
19 Sall-start-mNeonGreen(Yeast)-fw agcgtcgacatggtcagtaagggtgaaga 
20 BamHl-end-mNeonGreen (Yeast)-rv cgggggatccttacttgtataattcatc 
21 XhoI-FIG1down-fw ggggctcgagttttatcctcaaataaacat 
22 KpnI-FIG1down-rv ccccggtaccaacagacggtaatgattaga 
23 TFIG1hr40-URA3-fw ttttatcctcaaataaacatataagttttgagcggatattttttttgttcttttttttgattccg 
24 Xhol-URA3-rv gaggataaaactcgaggggtaataactgatataatt 
25 Sacll-FIG1end50-AcGFP1-fw aaaaccgcggataggtacaataactactcttcggattcatctacattgcattccaaagttgtgagcaa
gggcgccgagctgttcaccggc 
26 AcGFP1-TFIG1hr40-rv aatatccgctcaaaacttatatgtttatttgaggataaaatcacttgtacagctcatccatgccgtgggt 
27 Sacll-FIG1end50-TagGFP2-fw aaaaccgcggataggtacaataactactcttcggattcatctacattgcattccaaagttagcggggg
cgaggagctgttcgccggc 
28 TagGFP2-TFIG1hr40-rv aatatccgctcaaaacttatatgtttatttgaggataaaattacctgtacagctcgtccatgccg 
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29 Sacll-FIG1end50-mUkG1-fw aaaaccgcggataggtacaataactactcttcggattcatctacattgcattccaaagttgtgagtgtg
attaaagagga 
30 mUkG1-TFIG1hr40-rv aatatccgctcaaaacttatatgtttatttgaggataaaattacttcgaagcctgacttggcagc 
31 Sacll-FIG1end50-ZsGreen-fw aaaaccgcggataggtacaataactactcttcggattcatctacattgcattccaaagttgctcagtca
aagcacggtct 
32 ZsGreen-TFIG1hr40-rv aatatccgctcaaaacttatatgtttatttgaggataaaatcagggcaatgcagatccggatgca 
33 Sacll-FIG1end50-EGFP(Y)-fw aaaaccgcggataggtacaataactactcttcggattcatctacattgcattccaaagttgtcagtaag
ggtgaagaattattcactggt 
34 EGFP(Y)-TFIG1hr40-rv aatatccgctcaaaacttatatgtttatttgaggataaaattacttgtataattcgtccataccc 
35 Sacll-FIG1end50-AcGFP1(Y)-fw aaaaccgcggataggtacaataactactcttcggattcatctacattgcattccaaagttgtttctaagg
gtgctgaatt 
36 AcGFP1(Y)-TFIG1hr40-rv aatatccgctcaaaacttatatgtttatttgaggataaaattacttgtataattcgtccatacca 
37 Sacll-FIG1end50-TagGFP2(Y)-fw aaaaccgcggataggtacaataactactcttcggattcatctacattgcattccaaagtttctggtggtg
aagaattatt 
38 TagGFP2(Y)-TFIG1hr40-rv aatatccgctcaaaacttatatgtttatttgaggataaaatcatctgtataattcgtccataccg 
39 Sacll-FIG1end50-mUkG1(Y)-fw aaaaccgcggataggtacaataactactcttcggattcatctacattgcattccaaagttgtcagtgtc
atcaaagaaga 
40 mUkG1(Y)-TFIG1hr40-rv aatatccgctcaaaacttatatgtttatttgaggataaaattacttagaagcttgagatggcaac 
41 Sacll-FIG1end50-ZsGreen(Y)-fw aaaaccgcggataggtacaataactactcttcggattcatctacattgcattccaaagttgctcaatcc
aaacatggttt 
42 ZsGreen(Y)-TFIG1hr40-rv aatatccgctcaaaacttatatgtttatttgaggataaaattatggcaaagcagaacctgaagca 
43 FIG1end50-fw ataggtacaataactactcttcggattcat 
44 TFIG200-rv aacagacggtaatgattagagtttaggtaa 
45 Ste18pro-fw atattatatatatatatagggtcgt 
46 Ste18t-rv aaattatagaaagcagtagataaaa 
47 HIS3pro80-URA3-fw tatataaagtaatgtgatttcttcgaagaatatactaaaaaatgagcaggcaagataaacgaaggc
aaagttcaattcatcattttttttttattctttt 
48 HIS3t end40-rv ggagccataatgacagcagttgggtaggcctttctttggt 
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Supplementary Table Ⅲ-S3. List of yeast transformants used for expression of various 
GFPs 
 
Transformant Expression of protein Figure 
BY4741 (Control)  Fig.1 
BY4741 + pGK416-EGFP EGFP (mammalian codon-optimized) Figs.1 and S2 
BY4741 + pGK416-AcGFP1 AcGFP1 (mammalian codon-optimized) Figs.1 and S2 
BY4741 + pGK416-TagGFP2 TagGFP2 (mammalian codon-optimized) Figs.1 and S2 
BY4741 + pGK416-mUkG1 mUkG1 Figs.1 and S2 
BY4741 + pGK416-ZsGreen ZsGreen Figs.1 and S2 
BY4741 + pGK416-yEGFP EGFP (yeast codon-optimized) Figs.1 , S1 and S2 
BY4741 + pGK416-yAcGFP1 AcGFP1 (yeast codon-optimized) Figs.1 , S1 and S2 
BY4741 + pGK416-yTagGFP2 TagGFP2 (yeast codon-optimized) Figs.1 , S1 and S2 
BY4741 + pGK416-ymUkG1 mUkG1 (yeast codon-optimized) Figs.1 , S1 and S2 
BY4741 + pGK416-yZsGreen ZsGreen (yeast codon-optimized) Figs.1 , S1 and S2 
BY4741 + pGK416-ymWasabi mWasabi (yeast codon-optimized) Fig. S1 
BY4741 + pGK416-ymNeonGreen mNeonGeen (yeast codon-optimized) Fig. S1 
 
 
Supplementary Table Ⅲ-S4. List of yeast strains used for expression of various 
Fig1-GFPs as fusion tagged reporters 
 
Strain Expression of protein Figure 
BY4741 (Control)  Fig. 2 
MC-F1 Fig1-EGFP (mammalian codon-optimized) Fig. 2 
BYFAG1 Fig1-AcGFP1 (mammalian codon-optimized) Fig. 2 
BYFTG1 Fig1-TagGFP2 (mammalian codon-optimized) Fig. 2 
BYFUG1 Fig1-mUkG1 Fig. 2 
BYFZG1 Fig1-ZsGreen Fig. 2 
BYFEG2 Fig1-EGFP (yeast codon-optimized) Fig. 2 
BYFAG2 Fig1-AcGFP1 (yeast codon-optimized) Fig. 2 
BYFTG2 Fig1-TagGFP2 (yeast codon-optimized) Fig. 2 
BYFUG2 Fig1-mUkG1 (yeast codon-optimized) Fig. 2 
BYFZG2 Fig1-ZsGreen (yeast codon-optimized) Fig. 2 
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Supplementary Table Ⅲ-S5. List of yeast transformants of the Gγ recruitment system 
for soluble cytosolic target protein 
 
 
Transformant Target  
X (cytosol) 
Candidate  
Y (membrane) 
Repoter GFP Figure 
BFG2118 + pGk413 (Control) Fc - EGFP Fig. 3(A) 
BFG2118 + pGK413-ZWTmem Fc ZWT EGFP Fig. 3(A) 
BFG2118 + pGK413-ZK35Amem Fc ZK35A EGFP Fig. 3(A) 
BFG2118 + pGK413-ZI31Amem Fc ZI31A EGFP Fig. 3(A) 
BFG2118 + pGK413-Z955mem Fc Z955 EGFP Fig. 3(A) 
UGFG2 + pGk413 (Control) Fc - ymUkG1 Fig. 3(A) 
UGFG2 + pGK413-ZWTmem Fc ZWT ymUkG1 Fig. 3(A) 
UGFG2 + pGK413-ZK35Amem Fc ZK35A ymUkG1 Fig. 3(A) 
UGFG2 + pGK413-ZI31Amem Fc ZI31A ymUkG1 Fig. 3(A) 
UGFG2 + pGK413-Z955mem Fc Z955 ymUkG1 Fig. 3(A) 
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Supplementary Table Ⅲ-S6. List of yeast strains of the Gγ recruitment system for 
membrane target protein 
 
 
Strain Target  
X (membrane) 
Candidate  
Y (cytosol) 
Repoter GFP Figure 
FC-G0 (Control) C-terminally membrane-associated Fc - EGFP Fig. 3(B) 
FC-GW C-terminally membrane-associated Fc ZWT EGFP Fig. 3(B) 
FC-GK C-terminally membrane-associated Fc ZK35A EGFP Fig. 3(B) 
FC-GI C-terminally membrane-associated Fc ZI31A EGFP Fig. 3(B) 
FC-G9 C-terminally membrane-associated Fc Z955 EGFP Fig. 3(B) 
FN-G0 (Control) N-terminally membrane-associated Fc - EGFP Fig. S4 
FN-GW N-terminally membrane-associated Fc ZWT EGFP Fig. S4 
FN-GK N-terminally membrane-associated Fc ZK35A EGFP Fig. S4 
FN-GI N-terminally membrane-associated Fc ZI31A EGFP Fig. S4 
FN-G9 N-terminally membrane-associated Fc Z955 EGFP Fig. S4 
UG2-FCG0 C-terminally membrane-associated Fc - ymUkG1 Fig. 3(B) 
UG2-FCGW C-terminally membrane-associated Fc ZWT ymUkG1 Fig. 3(B) 
UG2-FCGK C-terminally membrane-associated Fc ZK35A ymUkG1 Fig. 3(B) 
UG2-FCGI C-terminally membrane-associated Fc ZI31A ymUkG1 Fig. 3(B) 
UG2-FCG9 C-terminally membrane-associated Fc Z955 ymUkG1 Fig. 3(B) 
UG2-FNG0 N-terminally membrane-associated Fc - ymUkG1 Fig. S4 
UG2-FNGW N-terminally membrane-associated Fc ZWT ymUkG1 Fig. S4 
UG2-FNGK N-terminally membrane-associated Fc ZK35A ymUkG1 Fig. S4 
UG2-FNGI N-terminally membrane-associated Fc ZI31A ymUkG1 Fig. S4 
UG2-FNG9 N-terminally membrane-associated Fc Z955 ymUkG1 Fig. S4 
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GENERAL CONCLUSION 
 
The present studies were carried out with the aim to improve the Gγ recruitment system 
to detect protein-protein interaction and screen protein variants. The Gγ recruitment system 
was based on the fundamental principle that yeast mating signaling requires localization of a 
complex between G-protein β and γ-subunits (Gβγ) to the inner leaflet of the plasma 
membrane. The improvement of Gγ recruitment system allowed the selection of both 
affinity-enhanced and affinity-attenuated protein variants and employed the cytosolic 
expression of a third protein as a competitor, allowing targeting of a specified affinity 
threshold. In addition, this system was suitable for evaluating both soluble cytosolic and 
membrane target proteins. Moreover, as a new GFP reporter gene, ymUkG1, it enabled to 
increase the higher signal-to-noise (S/N) ratio of the system. 
First, to improve selectivity of the Gγ recruitment system, we redesigned the system to 
allow desirable and reliable selection of both affinity-enhanced and affinity-attenuated 
protein variants. In this method, we tried to express a third protein as a competitor in the 
system, allowing targeting of a specified affinity threshold. We succeeded to develop a high 
selective screening system, which will be a great tool for innovative drug development and 
protein engineering. 
Next, to increase versatility of the Gγ recruitment system, we considered new protocols 
for the Gγ recruitment systems that suitable for evaluating membrane proteins as targets. 
Membrane-mediated PPIs play central roles in vital biological processes and are prime drug 
targets, such as a membrane receptor and ligand, a tyrosine protein kinase and adaptor protein 
and other signal transducers. Particularly, we could verify this method as reliable by using 
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EGFR kinase domain as a membrane target. The updated method allows the Gγ recruitment 
system to be used in the analysis of both cytoplasmic and membrane target proteins and this 
new method would find the molecules for inhibiting or promoting PPIs mediated membrane 
proteins. 
Additionally, to make the Gγ recruitment system to have a high sensitivity, we 
explored high performance GFPs in S. cerevisiae. By comparing various codon-optimized 
and non codon-optimized GFPs, we found that yeast codon-optimized mUkG1 (ymUkG1) 
isolated from the soft coral Sarcophyton sp. is good expression performances and bright 
green fluorescence. Therefore, to adjust ymUkG1 to reporter gene of the Gγ recruitment 
system, it could provide a higher signal-to-noise (S/N) ratio than existing EGFP reporter gene. 
The results successfully showed the Gγ recruitment system become more convenient for the 
flow cytometric sorting. 
Protein-protein interactions (PPIs) are crucial for all biological processes. Especially, 
since PPIs significantly affect the signal transduction, transcription and metabolism in cell, 
the molecules that can control these PPIs have attracted attention in the drug industry. Protein 
drugs are promising candidates for these molecules. Directed evolution is a mighty approach 
to novel proteins with desirable properties not found in nature, such as antibody drugs and 
other protein drugs. Therefore, large-scale and simple screening systems based on PPIs have 
great potential to find novel therapeutic molecules.  
The improved Gγ recruitment system is a ‘swingable’ screening methodology, which 
allows screening based on both affinity-enhancement and affinity-attenuation, would allow 
the selective isolation of protein variants with desired affinities to a cytosolic soluble and a 
membrane target protein. In addition, by changing EGFP into ymUkG1 for GFP reporter gene, 
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the improved system could gain a higher sensitivity. Compared to the previous system, the 
improved systems could be useful systems. 
In conclusion, various development and improvements of the Gγ recruitment system for 
screening protein variants were succeeded. The improved systems have a variety of attractive 
abilities such as, high selectivity, versatility and sensitivity. Enormous efforts and fund are 
still required to develop biological medicines; however, it will be significantly promoted by 
the progress of protein engineering and screening methods. The improved Gγ recruitment 
system will contribute to searching next-generation biological drugs. 
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